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Abstract: Helicobacter pylori is a gram-negative bacterium colonizing the stomach mucosa of half of
the world‘s population. Persistent infections with H. pylori are linked to gas- tritis and carriers are
predisposed to an elevated gastric cancer risk. However, the host is not able to clear the infection
leading to a persistence of H. pylori and a con- comitant chronic inflammation. These persistent effects
of H. pylori have likely de- veloped as a by-product of more than 60.000 years of co-evolution with the
human host. H. pylori has evolved both innate and adaptive immune evasion strategies that allow it
to overcome host defenses. Besides its well known negative consequences, chronic H. pylori infections
also exert beneficial effects. Epidemiological and animal studies inversely link H. pylori infection to the
risk of developing allergic asthma and inflammatory bowel diseases, especially when infection occurs
early in life. In previ- ous studies, we have shown that the tolerogenic activity of DCs and the IL-18-
dependent expansion of Treg cells are essential for asthma protection driven by H. pylori. However, little
was known about the molecular mechanisms promoting toler- ogenic responses of dendritic cells and the
different contribution of the various mye- loid resident populations in the stomach mucosa to tolerance
and immunity to H. pylori. We observed that CX3CR1hi macrophages, monocytes and CD11b+ DCs
take up H. pylori and NLRP3 expression is required for the differentiation of CD11b+ DCs. In ad- dition,
CD11b+ DCs seem to have a tolerogenic phenotype as the deficiency in these cells leads to an overshooting
TH1 response. In contrast, BATF3-dependent CD103+ DCs are necessary for an H. pylori-specific TH1
response in the stomach lamina pro- pria. We could further show that CD103+ DCs and IL-10 expression
of CD11c+ cells are essential for allergic asthma protection by regulating allergen-specific TH2 responses.
We identified ￿-catenin signaling in CD11c+ DCs to be required for allergen specific asthma protection.
Focusing on the role of bacterial factors, we found the two im- munoregulatory factors, GGT and VacA,
to be sufficient for asthma protection. The protection conferred by purified VacA from H. pylori culture
supernatant is depend- ent on IL-18, IL-10 and CD103+ DCs. The activation of IL-18 was dependent on
H. py- lori urease inducing TLR2 to upregulate NLRP3 transcription and the subsequent ac- tivation of
the NLRP3 inflammasome. Urease-expressing H. pylori, TLR2 and NLRP3 are all essential for asthma
protection with live bacteria. Further, we could identify TLR2 and NLRP3 expression to be upregulated
in macrophages and CD11b+ DCs take up H. pylori in the stomach lamina propria. This finding supports
their importance as immunosuppressive mediators during H. pylori infection. Overall, our results show a
division of labor among different gastric phagocytosing cell subsets. We identified CD103+ DCs, IL-10
production and ￿-catenin signaling in CD11c+ cells, as well as the urease/TLR2/IL-18 axis as essential
mediators of H. pylori- induced immune tolerance. With these findings, we contribute to a better under-
standing of tolerance induction by this important human pathogen.
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ous	 studies,	 we	 have	 shown	 that	 the	 tolerogenic	 activity	 of	 DCs	 and	 the	 IL-18-
dependent	 expansion	of	 Treg	 cells	 are	 essential	 for	 asthma	protection	driven	by	H.	
pylori.	However,	little	was	known	about	the	molecular	mechanisms	promoting	toler-
ogenic	responses	of	dendritic	cells	and	the	different	contribution	of	the	various	mye-
loid	 resident	 populations	 in	 the	 stomach	mucosa	 to	 tolerance	 and	 immunity	 to	H.	
pylori.	
We	 observed	 that	 CX3CR1hi	 macrophages,	 monocytes	 and	 CD11b+	DCs	 take	 up	H.	
pylori	and	NLRP3	expression	is	required	for	the	differentiation	of	CD11b+	DCs.	In	ad-
dition,	CD11b+	DCs	seem	to	have	a	tolerogenic	phenotype	as	the	deficiency	in	these	

















Overall,	our	 results	 show	a	division	of	 labor	among	different	gastric	phagocytosing	
cell	 subsets.	We	 identified	CD103+	DCs,	 IL-10	production	and	β-catenin	 signaling	 in	
CD11c+	cells,	as	well	as	the	urease/TLR2/IL-18	axis	as	essential	mediators	of	H.	pylori-










Helicobacter	 pylori	 (H.pylori)	 ist	 ein	 gram-negatives	 Bakterium,	 das	 den	 menschli-
chen	Magen	besiedelt	und	zu	einer	chronischen	Infektion	führen	kann.	Solche	persis-
tenten	 Infektionen	 stehen	 im	 engen	 Zusammenhang	mit	 chronischer	Gastritis	 und	
einem	erhöhten	Magenkrebsrisiko.	Diese	Persistenz	ist	die	Folge	verschiedener	Me-
chanismen	 der	 Anpassung	 von	H.	 pylori,	 entwickelt	 um	 die	 angeborene	 und	 auch	
adaptive	 Immunantwort	des	menschlichen	Wirtes	 zu	umgehen.	Neben	den	negati-
ven	 Effekten	 zeigen	 epidemiologische	 und	 experimentelle	 Studien	 aber	 auch,	 dass	
eine	H.	pylori	 Infektion	 zusätzliche	positive	Effekte	 für	das	menschliche	 Immunsys-
tem	hat.	Dies	wird	durch	eine	inverse	Korrelation	zwischen	H.	pylori	Infektionen	und	
der	Erkrankung	an	Allergien	wie	Asthma	und	chronisch-entzündlichen	Darmerkran-
kungen	 deutlich.	 In	 vorhergehenden	 Studien	 konnten	 wir	 zeigen,	 dass	 tolerogene	





Infektion	 zu	 Grund	 liegen.	 Zusätzlich	 sollte	 die	 Funktion	 verschiedener	 myeloider	
Zellen	in	der	Entwicklung	von	inflammatorischen	und	tolerogenen	Immunantworten	











Als	 bakterielle	 Faktoren	 sind	 zwei	 immunoregulatorische	 Proteine,	 VacA	 und	GGT,	











on.	 Des	 Weitern	 konnten	 wir	 die	 IL-10	 Produktion	 und β−Catenin	 Aktivierung	 in	
CD11c+	Zellen	sowie	den	Urease/TLR2/IL18-	Signalweg	als	wichtige	Mechanismen	im	




















I	will	 try	 to	sum	up	the	 latest	 insight	 in	this	chapter.	Common	myeloid	progenitors	




still	 under	debate	 5.	 The	MDPs	 further	differentiate	 into	dendritic	 cells	 and	mono-
cytes/macrophages.	The	two	lineages	diverge	when	the	MDPs	give	rise	to	common	
monocyte	 progenitors	 (cMoP)	 and	 conventional	 dendritic	 cell	 precursors	 (CDPs),	
which	differentiate	 in	 an	 FLT3-dependent	manner	 6,7.	 CDPs	 give	 rise	 to	 pre-DCs	or	
plasmacytoid	DCs	(pDC),	which	enter	the	bloodstream	and	migrate	to	lymphoid	and	
non-lymphoid	tissues.	pDCs	depend	on	E2-2	expression	whereas	pre-DCs	(CD8+	and	




























(NLN)	 tissue	 and	 lymph	 nodes	 (LN)	 is	 dependent	 on	 the	 protein	 FLT3	 11,12.	
Consequently,	 FLT3	 receptor-	 and	 FLT3	 ligand-deficient	mice	 show	a	 strong	 reduc-
tion	of	all	DC	subsets.		
In	the	following	chapter,	 I	will	discuss	the	function	of	preDCs	and	macrophages	fo-
cusing	 on	 the	 gastrointestinal	 tract	 in	 general,	 as	 nothing	 yet	 is	 known	 about	 the	
gastric	lamina	propria	(LP),	the	sight	of	H.	pylori	colonization.	From	previous	studies	












microorganisms.	 DCs	 are	 thought	 to	 direct	 and	 regulate	 local	 innate	 immune	 re-




















ogenic	 DCs	 do	 not	 mature	 completely	 but	 reside	 in	 a	 semi-mature	 state	
characterized	by	 low	surface	 levels	of	MHC	class	 II	and	costimulatory	molecules	 21.	
This	leads	to	a	differentiation	of	Treg,	which	release	anti-inflammatory	cytokines	such	
as	 IL-10	 and	 TGF-β1	 and	 thereby	maintain	 peripheral	 tolerance.	 Furthermore,	DCs	
are	 able	 to	 respond	 to	 virus	 infections	 by	 cross-presenting	 antigens	 via	MHCI	 and	
thereby	inducing	CD8+	cytotoxic	T	cells	22.	All	this	underlines	that	DCs	are	a	very	het-
































Classical	 DCs	 can	 be	 divided	 into	 two	 lineages	 depending	 on	 the	 lineage-defining	
transcription	factors	25.	 In	non-lymphoid	tissues	the	 first	branch	of	 IRF8-dependent	
DC	subsets	expresses	CD103+	 and	 the	second	 IRF4-dependent	DC	subset	expresses	
CD11b+.	Both	have	resident	counterparts	in	the	lymph	nodes:	IRF8-dependent	CD8a+	
DCs	and	 IRF4-dependent	CD11b+	DCs.	 In	addition,	 lymph	nodes	comprise	migratory	
CD103+	 and	 CD11b+	 DCs,	 which	 originate	 from	 the	 drained	 tissue	 11.	 The	 two	
branches	 can	be	distinguished	by	mutually	 exclusive	expression	of	CXCR1	on	 IRF8+	
cDCs	and	the	expression	of	signal	regulatory	protein	α	(SIRPa)	on	IRF4+	cDCs,	which	is	
independent	of	their	activation	stage	(Figure	3)	26,27.		
IRF8-dependent	DCs	 require	 the	 transcription	 factors	 IRF8	 and	BATF3	 10.	 In	 steady	






such	 as	 dermis,	 kidney	 or	 liver,	 IFR4-dependent	 DCs	 could	 not	 be	 detected.	 This	
leads	to	the	hypothesis	of	a	mucosal	CD11b+	DC	population	29.	Murphy	et	al.	go	even	
further	 to	 suggest	 that	 IRF4	 is	 only	 required	 for	 some	minor	 function	 and	 not	 DC	





ina	 propria	 as	 well	 as	 gut-associated	 lymphoid	 tissue	 and	 Peyer`s	 patches.	 Until	
recently,	 the	 intestine	 was	 considered	 unique	 as	 it	 harbors	 an	 IRF4-dependent	
CD11b+CD103+	population.	Only	recently	this	population	was	also	found	in	the	nasal	
mucosa	 during	 homeostasis,	 however	 not	much	 is	 known	 about	 it	 yet	 31.	 Besides	
this,	 the	 intestine	 harbors	 a	 not	 well	 described	 CD103-CD11b+CX3CR1dim	 DC	






































































sion	of	CD103+CD11b+	DCs	 is	 special	 for	 the	 intestine;	Scott	et	al.	hypothesize	 that	








mechanism	 tightly	 linked	 to	 retinoic	 acid	 (RA)	 and	 TGF-β1	 induction	 35.	
CD103+CD11b-	DCs	 express	 higher	 amounts	 of	 RALDH2	 compare	 to	 CD103+CD11b+	
DCs,	which	converts	retinol	 into	retinoic	acid	(RA).	RA	 itself	 induces	 IL-10	secretion	
and	 the	 expression	of	 the	 gut-homing	 receptors	 CCR9	 and α4β7	on	naive	 T	 and	B	




that	 CD103+	DCs	 control	 TH17	 differentiation	 via	 IL-2	 and	 IL-23	 secretion	 41.	 Two	





















IRF8-dependent	 CD8a+	DCs	 and	 CD103+	DCs	 share	 common	 functions	 in	 regulating	
TH1	responses.	They	are	specialized	in	cross-presentation	and	the	activation	of	CD8+	
effector	T	cell	to	cytotoxic	T	cells	(Figure	4)	45.	This	ability	depends	on	the	XCR1	ex-
pression	 limited	 to	 BATF3-dependent	DCs,	 the	 ligand	 of	which	 is	 expressed	 by	 Teff	





caused	 by	 an	 increase	 in	 inflammatory	 cytokines	 in	 the	 intestine	 or	 the	 direct	 re-





responses	 whereas	 KLF4	 expression	 is	 important	 mainly	 for	 the	 TH2	 immune	 re-
sponse	30,51.	Schlitzer	et	al.	 identified	IRF4+	DCs	in	lung	and	colon	to	be	essential	to	
build	 up	 a	 TH17	 cell	 response	 during	 an	 Aspergillus	 fumigates	 infection	 29.	
Notch2+CD11b+	DCs	differentiate	naive	T	cells	into	TH17	cells	through	the	secretion	of	
IL-23,	IL-6,	and	TGF-β	52,53.	In	vitro,	IL-6	secretion	is	induced	mostly	by	TLR2,	5	and	9	
activation.	 This	 argues	 that	 additional	 inflammatory	 signals	might	 be	 necessary	 to	
induce	TH17	differentiation.	However,	the	full	mechanisms	remain	unclear	52.	In	ad-





ing	 that	 specific	 functions	are	not	 limited	 to	one	DC	 subset	 38,50,54.	 It	 rather	 shows	
























Transcription	 factor	 dependencies	 identify	 four	 subsets	 of	 DC	whose	 actions	 are	 directed	






Figure 1. Dendritic cell subsets serve distinct immune effector modules
Transcription factor dependencies identify four subsets of DC whose actions are directed 
primarily t ward distinct immune effector modules. Irf8+ DCs c mprise plasmacytoid DC 
(pDC) and one branch of classical DC (cDC). Irf4+ DCs are heterogeneous by surface 
mar ers, ut display at least two transcriptional programs directed at different types of 
immune responses.
Murp y et al. Page 27















blood	monocytes.	Nowadays,	we	know	 from	 fate-mapping	experiments,	 that	most	
tissue	macrophages	develop	prenatally	 from	yolk	sac	or	 fetal	 liver	macrophages	56.	
These	 cells	 are	 characterized	by	 long-term	persistence	with	 self-renewing	 capacity	
and	are	 therefore	 independent	of	bone	marrow	hematopoiesis.	Organs,	which	are	
exposed	to	microorganisms	and	thereby	show	inflammatory	conditions,	 like	the	 in-
testine	 and	 skin,	 are	 an	 exception	 to	 this	 rule.	 At	 the	 time	 of	weaning	 fetal	 liver-
derived	 macrophages	 are	 replaced	 out	 by	 bone	 marrow-derived	 Ly6hi	monocytes,	
mainly	driven	by	the	increased	microbiota	and	commensal	bacterial	colonization	of	










monocytes	 differentiate	 further	 into	 macrophages	 in	 a	 process	 termed	monocyte	





















Under	 steady	 state	 conditions,	 Ly6Chi	 blood	 monocytes	 constitutively	 enter	 the	 intestinal	









in	 large	 numbers.	 They	 produce	 pro-inflammatory	 cytokines,	 which	 may	 support	 the	
maintenance	of	other	effector	cells	such	as	IFNγ-producing	T	cells.	In	addition,	they	secrete	
inflammatory	 chemokines,	 which	 lead	 to	 the	 recruitment	 of	 innate	 effector	 cells.	 During	




Intestinal	macrophages	 are	 characterized	by	 high	 expression	of	 the	 chemokine	 re-























































Regulation of TNF  & ROS 
production by neutrophils
Neutrophil




































stances,	 incoming	 monocytes	 do	 not	 develop	 further	 but	 rather	 arrest	 in	 a	




primary-response	 protein	 88-deficient	 (MyD88-/-)	 mice	 have	 shown	 a	 CCR7-
dependent	migration	of	 CX3CR1hi	macrophages	 towards	 the	MLNs.	Along	with	 this	
line,	MyD88-/-	mice	 in	which	 bacterial	 sensing	 is	 diminished,	 have	 a	 reduced	 IL-10	









macrophages	 further	 transfer	 antigen	 via	 a	 Connexin43-dependent	 direct	 cell-cell	
gap	 junction	mechanism	to	CD103+CD11b+	DCs	73.	These	DCs	are	able	to	migrate	 in	
steady	 state	 and	 inflammation	 to	 the	 MLN	 in	 a	 CCR7-dependent	 manner.	 Even	
though	the	Treg	priming	occurs	mainly	in	the	MLN,	CX3CR1hi	macrophages,	as	well	as	
CD11b+C103+	DC,	 retain	 the	 capacity	 to	promote	Treg	 cell	 generation	 in	 the	 lamina	
propria	 74,75.	DC	primed	T	cells	upregulate	α4β7	and	migrate	back	 to	 the	 intestine.	













like	 receptors	 (TLR)	 in	 human	 in	 1997,	 showed	 that	 the	 innate	 immune	 system	 is	
specific	 and	 detects	 conserved	 structures	 of	 the	 pathogen,	 so-called	 pathogen-
associated	 molecular	 pattern	 (PAMPs)	 76.	 Pattern	 recognition	 receptors	 (PRR)	 are	
expressed	on	mononuclear	phagocytes,	T	cells,	and	epithelial	cells.	They	can	be	di-










and	TLR5	 to	 flagellin.	Upon	 ligand	binding	 individual	 TLRs	 recruit	different	adaptor	
molecules	 and	 thereby	 trigger	 different	 immune	 responses.	 The	 adaptor	molecule	
MyD88	 is	 universally	 involved	 except	 in	 TLR3	 signaling	 and	 activates	 NF-κB	 and	








































binding	 of	 the	 TIR	 domain	 to	 either	 myeloid	 differentiation	 primary-response	 protein	 88	
(MyD88)	 or	 TIR	 domain-containing	 adaptor	 protein	 inducing	 TFNβ	 (TRIF)	 and	 TRIF-related	
adaptor	molecule	 (TRAM))	 (TLR3	and	TLR4).	 TLR4	 is	 able	 to	migrate	 to	 the	endosome	and	
signal	 via	 TRIF.	 This	 favors	 several	downstream	 targets.	 These	 include	 the	 interactions	be-
tween	IL-1R-associated	kinases	(IRAKs)	and	the	adaptor	molecules	TNF	receptor-associated	






































































Figure 1 | Mammalian TLR signalling pathways. A detailed knowledge 
 w mammalia  T ll lik  c t  T  ig al a  d v l d v  t e 
past 15 years. TLR5, TLR11, TLR4, and the heterodimers of TLR2–TLR1 or 
T –T  i d t  t i  ctiv  liga d  at t  c ll ac , w as 
T , T –T , T  a d T  l caliz  t  t  d m , w  t y 
 mic ial a d t d iv d cl ic acid . T  l caliz  at t  t e 
plasma membrane and the endosomes. TLR signalling is initiated by ligand-
induced dimerization of eceptors. Following this, the Toll–IL i t ce 
TI  d mai   T  gag  TI  d mai c tai i g ada t  t i s 
it  my l id di tiati  ima y  t i   YD  a d 
MYD88 ada t lik  t i  A ,  TI  d mai c tai i g ada t r 
otein inducing IFN  T IF  a d T IF lat d ada t  m l c l  T A . 
T  m v  m t  la ma m m a  t  t  d m  i  d  to 
switch signalling om MYD88 to TRIF. Engagement of the signalling adap
t  m l c l  tim lat  d w t am ig alli g at way  t at i v lve 
interactions between IL-1R-associated kinases (IRAKs) and the adaptor 
m l c l  T F c t a ciat d act  T AF , a d t at l ad t  t e 
activati   t  mit g activat d t i  ki a  APK  N 
N-terminal kinase (JNK) and p38, and to the activation of transcription fac
t . Tw  im ta t amili   t a c i ti  act  t at a  activat d 
downstream of TLR signalling are nuclear factor B ( F B) and the inter
g lat y act  I F , t t  t a c i ti  act , c  as 
cyclic AMP-responsive element-binding otein (CREB) and activator 
t i   AP , a  al  im ta t. A ma  c q c   T  ig alli g is 
the induction of o-inflammatory cytokines, and in the case of the endo
somal TLRs, the induction of type I interferon (IFN). dsRNA, double-
stranded RNA; IKK, inhibitor of NF- B ki a ; P , li ly acc a id ; 
KK, AP ki a  ki a ; IP , c t i t racti g t i  ; A, 
ribosomal RNA; ssRNA, single-stranded RNA; TAB, TAK1 i di g t i ; 
TAK, TGF -activated kinase; TBK1, TANK-binding kinase 1.
PERSPECT IVES




The	 second	 family	of	PRRs	are	 cytosolic	proteins,	named	Nod-like	 receptors	 (NLR).	
After	 ligand	binding,	most	NLR	assembles	 in	an	oligomeric	structure	82.	NLR	can	be	
divided	into	the	NLRP	and	NLRC	subfamily.	The	most	prominent	member	of	the	NLRP	







tion.	TLR2	activation	has	been	 linked	to	NLRP3	and	 IL-1β	activation	 in	Helicobacter	
pylori	(H.	pylori)-infected	BMDCs	85.	
Although	 TLR	 signaling	 was	 thought	 to	 induce	 mainly	 immunity,	 TLR2	 signaling	 is	
specifically	as	it	also	activates	an	anti-inflammatory	phenotype	86.	Zymosan,	a	fungal	
cell	wall	 ligand,	which	signals	 through	Dectin-1	and	the	TLR2&6	dimer,	 induces	the	
expression	of	IL-10	and	RALDH	via	the	extracellular	signal-related	kinase	(ERK)	path-
way	 87,88.	 This	 induces	 SOCS3,	which	 inhibits	 p38MAPK	 and	 proinflammatory	 cyto-
kines.	 A	 comparable	 ERK-dependent	 suppression	 of	 IL-12	was	 observed	with	 TLR2	
activation	 by	 Lactobacillus	 16,89.	 Moreover,	 further	 studies	 suggest	 that	 TLR2	
signaling	 induces	β-catenin	and	 its	 target	genes	 favoring	a	 tolerogenic	 immune	 re-














protein	 (Figure	8).	Wnt	binds	 to	 the	 seven-pass	 transmembrane	Frizzled	 family	 re-
ceptors	 (Fzd).	 This	 binding	 can	 activate	 the	 canonical	 and	 also	 the	 β-catenin	
independent	non-canonical	pathway.	Here,	I	will	focus	on	the	canonical	pathway.	
In	the	absence	of	Fzd	ligands,	β-catenin	is	removed	by	the	destruction	complex.	This	
consists	 of	 Axin	 and	 adenomatous	 polyposis	 coli	 (APC),	 scaffolding	 proteins	 and	 a	
Ser/Thr	 kinase,	 caseinkinase1a	 (CK1a)	 as	 well	 as	 glycogen	 synthase	 kinase	 3β	
(GSK3β)	(Figure	8)	93.	GSKβ	phosphorylates	β-catenin	and	thereby	marks	it	for	ubiq-
uitination	and	proteasomal	degradation	by	β-Trcp	and	WTX	proteins	94.	In	contrast,	
ligand	binding	 increases	 the	β-catenin	 level	 in	 the	cytoplasm.	 It	 recruits	 two	cofac-
















acts	 with	 β-catenin	 to	 induce	 its	 phospho-inactivation.	 Phospho-β-catenin	 is	 promoted	 to	
ubiquitination	and	proteasomal	degradation	by	β-Trcp	and	WTX	proteins.	In	the	presence	of	
Wnt	 ligands,	 β-catenin	 levels	 in	 the	 cytoplasm	 are	 upregulated	 and	 regulate	 cell	 signaling	
through	 the	 following	 steps.	 First,	Wnts	 bind	 to	 Frizzled	 (Fzd)	 receptors	 and	 interact	with	
adjacent	LRP5/6	co-receptors.	This	complex	recruits	DVL	to	the	cytoplasmic	tail	of	Fzd	recep-
tors,	which	in	turn	recruits	the	destruction	complex	to	the	Fzd/LRP5/6	complex.	The	Ser/Thr	
kinases	such	as	GSK3β	phosphorylate	the	co-receptor	 instead	of	β-catenin.	 Instead,	Axin	 is	
targeted	 for	proteasomal	degradation	which	 supports	disruption	of	 the	β-catenin	destruc-
tion	complex.	The	cytosolic	β-catenin	translocate	to	the	nucleus	which	leads	to	a	dislocation	
of	the	co-repressor	Groucho	on	the	TCF/LEF	transcription	factor	by	β-catenin.	This	 leads	to	
the	 recruitment	 of	 several	 co-activators	 and	 the	 transcription	 of	 target	 genes.	 Beside	 this	
activation	of	β-catenin	signaling	can	be	induced	by	the	disruption	of	epithelial	cadherin	 (E-
cadherin)–E-cadherin	 interactions.	This	breaks	the	association	of	β-catenin	to	the	cytoplas-
mic	 domain	 of	 E-cadherin	 and	 leads	 to	 its	 cytoplasmic	 accumulation.	 Abbreviations:	 APC,	
adenomatous	polyposis	coli;	CK1α,	casein	kinase	1α;	GSK3β,	glycogen	synthase	kinase	3β;	β-
Trcp,	 β-transducin	 repeat-containing	 protein;	 TNKS,	 tankyrase-1;	 LRP5/6,	 low-density	 lipo-







tion	 is	 known	 to	 induce	 β-catenin	 signaling.	 β-catenin	 can	 be	 induced	 by	 TLR2	
Introduction	
	22	
signaling	 through	 the	 PI3K/AKT	 pathway.	 Akt	 thereby	 phosphorylates	β-catenin	 at	
Ser552	and	induces	 its	nuclear	translocation.	 In	the	meantime,	AKT	phosphorylates	
GSK3β	 at	 Ser9	and	 inhibits	 its	 function	 to	phosphorylate	β-catenin	and	mark	 it	 for	
degradation	 99.	 Besides	TLR2,	 also	other	pathways	 like	 FAS	and	TGF-β	 can	activate	
β-catenin	in	DCs	100,101.	Some	of	the	β-catenin	target	genes	are	the	anti-inflammatory	
cytokines	IL-10	and	IL-27.	This	shows	that	the	β-catenin	pathway	works	synergistical-





















cal	Wnt/Fzd	 signaling,	 stimulation	 of	 TLRs	 such	 as	 TLR2	with	 antigen	 and	 subsequent	 ERK	
signaling	and	Fas	 receptor	activation.	Beside	 this	also	 the	disruption	of	E-cadherin	 interac-
tions	with	β-catenin,	or	activation	of	other	pattern-recognition	receptors	can	induce	nuclear	
β-catenin	 translocation.	 This	 intersects	 in	 β-catenin-mediated	 association	 of	 the	 TCF/LEF	
transcription	factor	with	various	co-activators	that	leads	finally	to	the	expression	of	several	
anti-inflammatory	cytokines,	such	as	IL-10	and	IL-27,	which	induce	Tr1	cells	or	CD8+IL-10+	T	
cells.	TGF-β	and	RALDH	1/2	expression	 in	DCs	 induce	Treg	cells.	Accumulation	of	Tregs	 in	the	
tissue	microenvironment	may	result	in	inhibition	of	Th1/Th17	cells	or	CD8+	cytotoxic	T	cells.	
Abbreviations:	Fzd,	Frizzled;	TLR,	Toll-like	 receptor;	ERK,	extracellular	 signal-related	kinase;	














This	 highlights	 the	 importance	 of	 β-catenin	 signaling	 for	 homeostasis	 and	 makes	
clear	that	aberrant	β-catenin	signaling	may	have	negative	consequences	for	tissues.	
β-catenin	signaling,	 for	 instance,	protects	from	inflammatory	diseases,	 in	a	dextran	
sodium	sulfate-induced	colitis	model	104.	
This	regulatory	pathway	is	predestined	and	one	example	of	many	to	be	hijacked	and	
activated	by	pathogens	or	by	 cancer	 cells	 to	 consequently	 evade	 the	 immune	 sys-
tem.	 H.	 pylori	 has	 developed	 several	 mechanisms	 to	 evade	 the	 immune	 system	
which	 leads	 to	 its	 persistence	 in	 the	 stomach.	 One	 of	 these	 is	 the	 release	 of	
β-catenin	 from	E-cadherin,	 in	an	H.	pylori	CagA-dependent	manner	106.	 In	addition,	
further	 virulence	 factors	 like	 VacA	 can	 induce	 the	 phosphorylation	 of	 AKT,	 which	
further	 phosphorylates	 GSK3β	 and	marks	 it	 for	 ubiquitin-mediated	 proteolysis	 107.	
Increased	β-catenin	activation	 in	APCs	 is	observed	 in	over	50%	of	adenocarcinoma	

























Infection	 with	H.	 pylori	 is	 mainly	 acquired	 during	 early	 childhood	 and	 can	 persist	
lifelong,	 in	the	absence	of	antimicrobial	treatment	117.	H.	pylori	colonization	causes	
gastric	inflammation,	but	most	infections	stay	asymptomatic.	However,	the	presence	













Vacuolating	 cytotoxin	A	 (VacA)	 is	 an	88kDa	 toxin,	which	 induces	 vacuolization	 and	
mitochondrial	alteration	120	followed	by	impaired	cell	cycle	progression	and	apopto-
sis	121.	VacA	is	either	secreted	into	the	extracellular	space	122	or	persists	at	the	sur-































terium	able	 to	 evade	 the	 immune	 system?	The	most	 efficient	 adaptation	H.	 pylori	
evolved	will	be	discussed	in	the	following	chapter.	
One	way	of	adaptation	H.	pylori	developed	 is	 to	evade	detection	by	PRR.	TLR4	de-










thermore,	 DC-SIGN	 detects	 the	 fucose	 residue	 of	 H.	 pylori	 LPS,	 which	 disrupts	
signaling	downstream	of	DC-SIGN,	to	induces	IL-10	and	inhibit	IL-12	production,	and	
suppresses	TH1	response	(Figure	10)	138.	The	failure	of	the	immune	system	to	elimi-




















type.	H.	pylori	 LPS	 is	 less	bioactive	 than	 the	 LPS	of	other	gram-negative	pathogens	due	 to	
Introduction	
	 27	
specific	 lipid	A	modifications	 that	prevent	detection	by	 TLR4.	H.	pylori	 flagella	 are	not	de-
tected	by	TLR5	due	to	mutations	in	the	TLR5	binding	site	of	flagellin.	The	bacterium's	DNA	is	
detected	by	TLR9	and	H.	pylori	LPS	possibly	by	TLR2.	These	TLRs	predominantly	activate	anti-
inflammatory	 signaling	 pathways.	 5‘	 triphosphorylated	 RNA	 is	 detected	 by	 the	 RLR	 RIG-I,	
which	activates	 the	 transcription	 factors	 IRF3	and	 IRF7	 to	 induce	 type	 I	 IFN	expression.	H.	
pylori	RNA	is	potentially	detected	also	by	TLR8	in	endosomes.	The	fucosylated	DC-SIGN	lig-
ands	suppress	activation	of	the	signaling	pathways	downstream	of	this	CLR	and	activate	anti-
inflammatory	 genes.	 DD,	 death	 domain;	 TIR,	 Toll/Interleukin-1	 receptor	 domain;	 CARD,	








and	 IL-1β-dependent	 inflammatory	 response.	 However	 H.	 pylori-activated	 NLRP3	











gramed	 towards	 a	 tolerogenic,	 semi-mature,	 phenotype.	 DCs	 secrete	 IL-10	 and	
thereby	 induce	Treg	cell	proliferation	and	consequently,	the	 inhibition	of	TH1/17	Teff	



























All	H.	pylori	 strains	express	 the	secreted	virulence	 factors	VacA	and	GGT.	Thereby	 they	di-
rectly	inhibit	T-cell	activation,	proliferation	and	effector	functions.	Hexameric	VacA	binds	to	








actions	at	 the	T-cell/DC	 synapse	 include	MHCII	binding	 to	 the	T-cell	 receptor,	which	 facili-
tates	Ca2+	 release	 in	 the	cell,	and	binding	of	costimulatory	molecules	CD80/CD86	 to	CD28.	













on	 the	host	 side.	 In	 the	second	half	of	 the	 last	 century,	 the	 incidences	of	H.	pylori	





Asthma	 is	 a	 global	 health	 problem	with	 around	 300	million	 affected	 people	 and	 a	
further	 increasing	 number	 mainly	 in	 developing	 countries	 (rev.	 148,149).	 Asthmatic	
patients	have	a	chronic	inflammatory	disorder,	which	is	characterized	by	a	bronchial	
hyperactivity,	mucus	overproduction,	airway	wall	remodeling	in	line	with	airway	nar-
rowing.	 150.	 Environmental	 risk	 factors	 are	 exposure	 to	 allergens,	 viral	 respiratory	
infections,	air	pollution	or	cigarette	smoke	151-153.	But	also	obesity,	as	well	as	atopic	
diseases,	 are	 risk	 factors	 153.	 Even	 though	 many	 people	 suffer	 from	 this	 disease	
treatment,	methods	 are	 non-curative	mainly	 because	 of	 the	 heterogeneity	 of	 this	




cient	 to	 induce	 allergic	 sensitization	 and	 CD103+	DCs	 induce	 tolerance	 towards	 in-
haled	 allergens.	 CD11b+	DCs	 present	 the	 allergen	 to	 naive	 CD4+	T	 cells	 in	 the	 lung	
















costeroid,	 which	 suppresses	 the	 inflammation	 and	 a	 β-adrenergic	 agonist,	 which	
opens	the	constricted	bronchial	muscles.	However,	 in	5-10%	of	patients,	this	treat-
ment	 is	 inefficient,	 underlining	 the	 need	 for	 new	 alternative	methods.	 Alternative	
treatments	 are	monoclonal	 antibody	 therapies	 against	 IgE,	 IL-4,	 IL-5	 and	 also	 Il-13	
with	 several	 ongoing	 phases	 2	 and	 phase	 3	 trials.	Omalizumab,	 a	 humanized	mAb	
against	 the	FC	portion	of	 IgE	on	 several	 cells,	 controls	moderate	 to	 severe	asthma	
159,160.	Moreover,	 clinical	 trials	 are	 done	with	 cytokine	 inhibitors.	 Here,	 a	 phase	 III	






ed	 in	 the	 loss	 of	 microbiota	 hypothesis,	 that	 a	 gradual	 reduction	 of	 commensal	
bacteria	 such	as	H.	pylori,	which	 favors	a	 tolerogenic	phenotype,	 leads	 to	a	steady	






tolerogenic	 T	 cells	migrate	 to	 the	 lung	where	 they	 can	 suppress	 the	 inflammatory	
immune	response	of	asthmatic	mice	(Figure	13).	Transfer	of	Treg	cells	 from	infected	
mice	conferred	protection	in	asthmatic	mice	arguing	that	Treg	cells	are	sufficient	for	
this	 protection	 163.	 Oertli	 et	 al.	 reviled	 that	 the	 infected	DCs	 revile	 a	 semi-mature	
state	that	renders	Treg	priming.	Further	this	semi-mature	state	was	dependent	on	IL-
18	 secretion;	 consequently	 IL-18	 deficient	 mice	 are	 not	 protected	 from	 allergic	


































tors	 GGT	 and	 VacA	 promote	 chronic	 infection	 by	 tolerizing	 DCs	 and	 thereby	 favoring	 Treg	









more	 knowledge	was	 gained	 concerning	 its	microbial	 composition,	 but	 still	 little	 is	
known	regarding	the	myeloid	compartment	 in	steady	state	or	during	 infection,	e.g.	
with	H.	pylori	166.	H.	pylori	 infection	is	not	only	a	risk	factor	for	the	development	of	
gastric	 adenocarcinoma	but	 evidence	 from	epidemiological	 studies	 and	 our	 recent	
work	 identified	H.	pylori	as	beneficial	 in	 the	context	of	allergic	diseases115,163,167.	 In	
this	regard	we	have	identified	DCs	as	mediators	of	H.	pylori-induced	immune	toler-
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The prevalence of allergic asthma and other atopic diseases has
reached epidemic proportions in large parts of the developed
world. The gradual loss of the human indigenous microbiota
has been held responsible for this trend. The bacterial pathogen
Helicobacter pylori is a constituent of the normal gastric micro-
biota whose presence has been inversely linked to allergy and
asthma in humans and experimental models. Here we show that
oral or i.p. tolerization with H. pylori extract prevents the airway
hyperresponsiveness, bronchoalveolar eosinophilia, pulmonary in-
flammation, and Th2 cytokine production that are hallmarks of aller-
gen-induced asthma in mice. Asthma protection is not conferred by
extracts from other enteropathogens and requires a heat-sensitive
H. pylori component and the DC-intrinsic production of IL-10. The
basic leucine zipper ATF-like 3 (BATF3)-dependent CD103+CD11b−
dendritic cell lineage is enriched in the lungs of protected mice
and strictly required for protection. Two H. pylori persistence deter-
minants, the γ-glutamyl-transpeptidase GGT and the vacuolating
cytotoxin VacA, are required and sufficient for asthma protection
and can be administered in purified form to prevent asthma. In con-
clusion, we provide preclinical evidence for the concept that the
immunomodulatory properties of H. pylori can be exploited for
tolerization strategies aiming to prevent allergen-induced asthma.
bacterial immunomodulation | allergy and asthma prevention |
tolerogenic dendritic cells | bacterial persistence determinants
The prevalence of asthma and other allergic diseases has in-creased steadily in the course of the second half of the 20th
century in both adult and pediatric, developed and developing
populations (1). The lack of early childhood infections or mi-
crobial exposure due to improved sanitation, and the gradual loss
of the indigenous microbiota have alternately been proposed to
account for this major public health trend (2, 3). Epidemiological
and experimental studies have consistently shown a strong in-
verse association of chronic infection with the human gastric
bacterial pathogen Helicobacter pylori with the risk of developing
allergic asthma (4–9). Chronic infection with H. pylori is less
common in allergic individuals presenting with asthma, hay fe-
ver, or eczema than in the general population; this is especially
true in children and in patients with early-onset disease (4–8).
We have reported earlier that experimental infection of C57/BL6
mice with a mouse-colonizing human isolate of H. pylori confers
robust protection against allergen-induced asthma, with partic-
ularly strong protective effects observed upon early-life exposure
(9). Asthma protection could be attributed to H. pylori-specific
tolerogenic reprogramming of dendritic cells in vitro and in vivo
and to the induction of highly suppressive regulatory T cells (9,
10). Despite its striking immunomodulatory properties (11) and
remarkable inverse link to various allergic diseases, the use of
live H. pylori as a therapeutic intervention or preventive measure
is unattractive due to the well-documented carcinogenic poten-
tial of chronic infection with this organism. H. pylori induces
gastric and duodenal ulcers (12), and is also widely accepted to
be the leading cause of gastric adenocarcinoma (13). Here, we
have devised a strategy of H. pylori-specific tolerization that
harnesses the bacteria’s immunomodulatory properties for the
prevention of asthma while avoiding the risks associated with live
infection and have elucidated several key determinants of
asthma protection in both the bacteria and the host.
Results
H. pylori Whole Cell Extract Protects Against Allergen-Induced
Asthma. To assess whether regular administration of H. pylori
extract protects against allergen-induced asthma and thus reca-
pitulates the effects of live infection, we treated mice with weekly
doses of intragastrically administered whole cell extract from age
day 7 onwards before subjecting them to ovalbumin sensitization
and challenge. Control mice that had received ovalbumin but no
H. pylori extract developed airway hyperresponsiveness to
methacholine (Fig. 1 A and B and Fig. S1 A–D) and bron-
choalveolar immune cell infiltration and eosinophilia (Fig. 1 C
and D), as well as histologically evident lung inflammation and
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goblet cell metaplasia (Fig. 1 E–G). The restimulation of single
cell lung preparations with ovalbumin induced the production of
high levels of the Th2 cytokines IL-5 and IL-13 (Fig. 1 H and I).
In contrast, mice that had received H. pylori extract were pro-
tected against airway hyperresponsiveness (Fig. 1 A and B and
Fig. S1 A–D), and exhibited significantly lower levels of bron-
choalveolar and pulmonary inflammation, eosinophilia and
goblet cell metaplasia (Fig. 1 C–G). Th2 cytokine production
upon allergen restimulation of lung preparations was also re-
duced (Fig. 1 H and I). The failure of extract-treated mice to
develop allergen-induced symptoms of asthma was not due to
an impaired primary response to the allergen, as the levels of
ovalbumin-specific serum IgE were similar in all sensitized mice
(Fig. S1E).
To address the specificity of the observed effects and elucidate
key prerequisites of protection, we examined various adminis-
tration routes and regimens, ages at treatment onset, and
extracts from other gastrointestinal pathogens. Interestingly,
the systemic (intraperitoneal) administration of H. pylori ex-
tract was as efficient as the intragastric route at conferring
protection against allergen-induced asthma (Fig. S1 F–I). Intra-
gastric treatment was less effective when initiated in adult mice
as opposed to neonates, and four consecutive doses of extract
administered to young mice before weaning were insufficient to
induce full protection (Fig. S1 F–I). Heat-inactivated H. pylori
extract, as well as identical amounts of extracts generated from
cultures of Escherichia coli or Salmonella typhimurium, failed to
confer protection against the examined hallmarks of allergic
airway disease (Fig. S1 F–I). In conclusion, the beneficial effects
of extract treatment are specific to H. pylori and require a heat-
sensitive component of the bacteria, and are most pronounced if
the treatment is initiated in young mice.
Successful Tolerization Against Allergen-Induced Asthma Requires IL-
10 and IL-18, but Not Regulatory T Cells.H. pylori is known to induce
the production of IL-10 in various immune cell compartments
(14, 15) and high gastric levels of IL-10 ensure H. pylori persis-
tence and promote H. pylori-specific immune tolerance (16, 17).
We have shown previously that dendritic cells (DCs) play a crit-
ical role in immune tolerance to live H. pylori; the depletion of
CD11c-positive DCs breaks tolerance and promotes clearance of
the bacteria (10). To assess whether DCs produce IL-10 not only
in response to live infection as shown (10), but also in response
to H. pylori extract, cultured murine bone marrow-derived (BM)
DCs were treated with increasing concentrations of extract. In-
deed, BM-DCs produced and secreted large amounts of IL-10,
and this was dependent on TLR2 and MyD88 signaling, but in-
dependent of TLR4 (Fig. 2A). A clear dose-dependent secretion
of IL-10 could also be observed in human blood-derived DCs
from six independent donors cultured with H. pylori extract (Fig.
2B). To address whether IL-10 is required for asthma protection
conferred by extract tolerization or live infection, we adminis-
tered two doses of IL-10 receptor (IL-10R)-neutralizing antibody
during the challenge phase of the protocol to mice that had ei-
ther received extract from the neonatal period onwards or had
been infected as neonates. IL-10 signaling was required for
protection against asthma in both scenarios (Fig. 2 C–F). We
further examined the effects of extract tolerization and live in-
fection in mice that are deficient for IL-10 production specifi-
cally in the CD11c+ immune cell compartment. Although not
entirely resistant to extract treatment or the beneficial effects of
live infection, CD11c-Cre.IL-10fl/fl mice were less well protected
than their Cre-negative littermates, i.e., exhibited significantly
higher eosinophil counts, lung inflammation and goblet cell
metaplasia (Fig. 2 G–J). The overall secretion of IL-10 by al-
lergen-restimulated lung cells was reduced in CD11c-Cre.IL-10fl/fl
mice (Fig. S2A), implying that CD11c+ cells represent a major
source of pulmonary IL-10 in this setting. In summary, we con-
clude that H. pylori extract induces IL-10 production in both
murine and human DCs and that IL-10 produced by CD11c+
DCs/mononuclear phagocytes, in the lungs and/or at other sites,
contributes critically to protection.
Having shown previously that DC-derived IL-18 is a critical
mediator of H. pylori-induced immune tolerance (10), we next
examined the effects of H. pylori extract and live infection on IL-
18R−/− mice. IL-18 signaling was absolutely required for the
protective effects of live bacteria as well as extract treatment
(Fig. S2 B–E), underscoring the tolerance-promoting role of this
cytokine in the context of the H. pylori/host interaction. To fur-
ther address whether Tregs were required for extract-mediated
protection (as they are for live infection; ref. 9), we depleted
CD25+ Tregs (>90% depletion efficiency in the lungs, Fig. S2F)
by applying two doses of a CD25-specific antibody before oval-
bumin challenge. Treg depletion had no effect on the protection
from allergic asthma conferred by H. pylori extract (Fig. S1 G–J);
this result was consistent with a lack of protective activity of
CD25+ Tregs that were adoptively transferred from extract-
treated mice to naive recipients (Fig. S1 G–J). H. pylori extract
treatment of BM-DCs, in contrast to live infection, further failed
to promote the expression of the Treg lineage-defining tran-
scription factor FoxP3 in cocultured naive T cells (Fig. S2K),
suggesting that H. pylori extract exerts its protective activity
through the DC-intrinsic production of IL-10 (and IL-18), but
independently of Tregs.
BATF3-Dependent DC Lineages Are Required for H. pylori-Induced
Protection Against Allergic Airway Inflammation. Having identified
DCs as critical mediators of H. pylori-specific tolerance (10) and
Fig. 1. Experimentally induced asthma is alleviated by treatment with
H. pylori extract. (A–I) Mice were sensitized i.p. with alum-adjuvanted oval-
bumin at 8 and 10 wk of age and challenged with aerosolized ovalbumin 2 wk
after the second sensitization to induce asthma-like symptoms. Mock-
sensitized mice served as negative controls. One group received once-
weekly doses of 200 μg H. pylori extract intragastrically from day 7 of age until
the second sensitization. (A and B) Airway hyperresponsiveness in response to
increasing doses of methacholine and the highest dose of 100 mg/mL,
respectively. (C and D) Total cells and eosinophils contained in 1 mL of BALF.
(E–G) Tissue inflammation and goblet cell metaplasia as assessed on H&E and
PAS-stained tissue sections; representative micrographs taken at 100× (H&E)
and 400× (PAS) original magnification are shown in G. Pooled data from five
independent studies are shown in A–F. (H and I) IL-5 and IL-13 secretion by
single cell lung preparations restimulated with ovalbumin, as assessed by
ELISA. Pooled data from two studies are shown in H and I. In scatter plots,
each symbol represents one mouse; horizontal lines indicate the medians.














as key producers of protective IL-10 (Fig. 2), we next sought to
dissect the role of specific DC subsets in the context of H. pylori
infection and tolerization. To this end, we generated single cell
lung preparations from extract-treated, infected, and positive as
well as negative control mice and subjected them to quantitative
flow cytometric analysis of various lung-infiltrating DC pop-
ulations. Interestingly, despite the fact that the mice examined in
this fashion exhibited very typical levels of protection (Fig. S3 A–
D), their lungs were infiltrated with the same overall numbers of
CD11c+ MHCII+ DCs as the lungs of asthmatic mice (Fig. 3A).
However, when we distinguished between conventional and
plasmacytoid DCs (cDCs, pDCs) based on their expression of
B220 (also known as CD45R, a marker of the B-cell lineage that
is also shared by pDCs, Fig. S3E), we found that CD11c+
MHCIIhi B220− cDCs were relatively more abundant in asth-
matic mice, whereas CD11clo MHCIIlo B220+ pDCs were more
abundant in the lungs of protected mice (Fig. 3 B–D). Further-
more, the total numbers of lung-infiltrating pDCs were higher
than in nonsensitized negative controls (Fig. S3F), indicating that
pDCs are actively recruited to the lungs of allergen-challenged
mice that are either infected with H. pylori or treated with
H. pylori extract. Another interesting difference was found among
asthmatic and protected mice when we discriminated between
CD11b+ and CD103+ cDC subsets (Fig. S3G). Strikingly,
whereas the asthmatic lungs of positive control mice were pre-
dominantly infiltrated by CD11b+ cDCs, the lungs of protected
mice were relatively more infiltrated by CD103+ cDCs (Fig. 3 E–
G). Again, CD103+ cDCs appeared to be specifically recruited to
the lungs of allergen-challenged mice either infected with
H. pylori or treated with H. pylori extract (Fig. S3H).
To assess the functional relevance of CD103+ lung-infiltrating
DCs in asthma protection in our model, we examined mice
lacking the transcription factor basic leucine zipper ATF-like 3
(BATF3), which has previously been shown to direct the de-
velopment of CD8α+ lymphoid tissue DCs as well as CD103+
CD11b− DCs in the lungs, intestine and skin (18). We were able
to confirm that the lungs of BATF3−/− mice are entirely devoid
of CD103+ DCs, and exhibit normal and higher frequencies of
pDCs and CD11b+ DCs, respectively (Fig. S3 I and J). In-
terestingly, pure populations of mesenteric lymph node-derived
DCs from BATF3−/− mice failed to express IL-10 upon treat-
ment with increasing doses of H. pylori extract ex vivo (Fig. 3H).
BATF3−/− mice were significantly less protected than wild-type
mice against allergen-induced asthma upon infection with
H. pylori, and upon treatment with H. pylori extract (Fig. 3 I–L),
despite being colonized at comparable levels (Fig. S3K). In sum-
mary, BATF3-dependent CD103+ DC lineages infiltrate the lungs
of protected mice, and are required for the H. pylori-driven,
IL-10-mediated protection from allergic asthma.
The H. pylori Persistence Determinants γ-Glutamyl Transpeptidase
and Vacuolating Cytotoxin Are Required and Sufficient for Protection
Against Allergic Airway Inflammation. We have shown recently that
two H. pylori virulence determinants encoded by all clinical iso-
lates investigated to date, the γ-glutamyl transpeptidase GGT and
the vacuolating cytotoxin VacA, promote persistence through
tolerogenic reprogramming of DCs (19). To examine whether
GGT and/or VacA contribute to asthma protection conferred by
extract tolerization, we compared the protective properties of
extracts from wild-type bacteria and from GGT- or VacA-
deficient isogenic mutants. Interestingly, both mutant extracts
were consistently less efficient than wild-type extract at protecting
allergen-sensitized and -challenged mice against bronchoalveolar
and pulmonary inflammation, eosinophilia, and goblet cell meta-
plasia (Fig. 4 A–D). To examine whether either factor alone is
sufficient to provide protection, we intraperitoneally administered
either recombinant GGT or oligomeric VacA purified from culture
supernatants of H. pylori once weekly from day 7 of age onwards.
No adverse effects were observed in any of the mice, despite their
young age at the time of the first doses. Strikingly, both VacA and
GGT provided a level of protection against asthma that was
comparable to the protection conferred by parallel whole cell ex-
tract treatment (Fig. 4 E–H). VacA was somewhat more protective
than GGT at identical concentrations. VacA lacking an amino-
terminal hydrophobic region of three tandem GXXXG motifs that
is essential for VacA‘s cytotoxic activity (20) failed to protect
against asthma (Fig. 4 E–H). Wild-type, but not mutant, VacA had
similar effects on pulmonary Th2 cytokine production and DC
infiltration (Fig. S4 A–E) as liveH. pylori or whole cell extract (Figs.
1 and 3). IL-10R neutralization during ovalbumin challenge ab-
rogated the protective activity of VacA, which was observed not
only upon intraperitoneal administration, but also upon oral ad-
ministration, and in adult as well as neonatally treated mice (Fig.
S4 F–I). We conclude that GGT and VacA are key determinants of
H. pylori-induced asthma protection and may be administered in
purified form to prevent allergic asthma.
Fig. 2. IL-10 is required for H. pylori-induced protection against allergic
asthma. (A and B) IL-10 secretion by murine bone-marrow-derived DCs of the
indicated genotypes and human monocyte-derived DCs from six healthy
volunteers after exposure to H. pylori extract. One representative experi-
ment of three is shown in A, and pooled data for all six donors is shown in B.
(C–F) Mice were treated as described in Fig. 1 or were neonatally infected
with H. pylori; the indicated groups received 2 doses of anti-IL-10R antibody
during ovalbumin challenge. (G–J) CD11c-Cre.IL-10fl/fl mice and their IL-10fl/fl
littermates were either neonatally infected or received H. pylori extract
before being subjected to ovalbumin sensitization and challenge as de-
scribed in Fig. 1. Total cells (C and G) and eosinophils (D and H) contained in 1 mL
of BALF. Tissue inflammation (E and I) and goblet cell metaplasia (F and J).





We have devised here a strategy of active tolerization for the
prevention of allergic asthma that exploits the immunomodula-
tory properties of H. pylori without exposing to the risks as-
sociated with live infection. By orally or intraperitoneally
administering H. pylori whole cell extract to allergen-sensitized
mice, we were able to achieve a level of protection against
asthma that was equivalent to the protection conferred by live
infection (9). Extract-mediated protection was highly specific to
H. pylori, i.e., was not conferred by extract from other Gram-
negative enteropathogens such as E. coli or Salmonella typhi-
murium. The treatment was particularly successful when initiated
in young mice, an observation that is in line with the superior
protection afforded by experimental (live) infection of neonatal
relative to adult mice (9). The differential susceptibility to suc-
cessful tolerization of neonates and adults may be attributable to
the general tolerogenic bias of the immature neonatal immune
system, with its higher Treg/Teffector cell ratios and Treg-pre-
dominant responses to foreign antigens (21). Our results are in
line with the epidemiological finding that children benefit more
from harboring H. pylori than adults in terms of their asthma risk
(6); similarly, early onset asthma in adolescents and young adults
is more strongly inversely correlated with H. pylori seropositivity
than adult-onset asthma (5). The data presented here thus imply
that children at high risk of developing asthma are more likely
than adults to benefit from H. pylori-specific tolerization
strategies.
Having shown earlier that H. pylori-specific immune tolerance
is a consequence of tolerogenic reprogramming of DCs by the
bacteria (10), we set out to examine the contribution of specific
DC lineages and their immunomodulators to immune tolerance
and asthma protection in the settings of neonatal infection and
neonatal-onset tolerization with H. pylori extract. A careful
immunophenotypic analysis of the DC subsets infiltrating the
lungs of protected mice revealed a preferential recruitment of
CD103+CD11b− conventional DCs, and to a lesser extent of
B220+ plasmacytoid DCs. The contribution of CD103+ DCs to
asthma protection was further functionally assessed in mice
lacking the BATF3 transcription factor, which drives the de-
velopment of CD8α+ lymphoid tissue-resident DC lineages and
of the closely related CD103+CD11b− DC lineages in various
tissues including the lung, intestine and skin (18). We were able
to confirm that CD103+CD11b− DCs are completely absent
from the lungs of BATF3−/− mice, whereas all other examined
subsets are present in normal numbers. BATF3−/− animals were
equally susceptible to allergen-induced asthma as wild-type mice;
Fig. 3. CD103+ conventional DCs accumulate in the lungs of H. pylori-infected and extract-treated mice and are required for protection. (A–G) Groups of
mice treated as described in Figs. 1 and 2 were analyzed with respect to lung infiltration by pDCs and two lineages of cDCs. Data are pooled from three
independent studies. (A) Total infiltration of CD11c+MHC+ cells. (B and C) Frequencies of B220− cDCs and B220+ pDCs among all CD11c+MHC+ cells. (D) Ratios
of pDCs to cDCs as calculated per mouse. (E and F) Frequencies of CD103+ and CD11b+ cells among all cDCs. (G) Ratios of CD11b+ and CD103+ cDCs as
calculated per mouse. (H) IL-10 transcript levels normalized to GAPDH, of immunomagnetically isolated CD11c+ DCs from mesenteric lymph nodes of WT and
BATF3−/−mice, treated with the indicated increasing doses of H. pylori extract. (I–L) Wild-type and BATF3−/−mice were treated or infected as described in Figs.
1 and 2 and subjected to ovalbumin sensitization and challenge. (I and J) Total cells and eosinophils contained in 1 mL of BALF. (K and L) Tissue inflammation
and goblet cell metaplasia.














however, neither regular extract treatment nor H. pylori coloni-
zation had any detectable beneficial effect on the examined
hallmarks of asthma in this strain, indicating that BATF3-
dependent DCs are strictly required for protection in both sce-
narios. We further found that lymph node-derived DCs from
BATF3−/− mice fail to produce IL-10 upon treatment with
H. pylori extract ex vivo. This observation is well in line with the
requirement for IL-10 signaling proficiency and, more specifi-
cally, for the DC-intrinsic production of IL-10 for optimal
H. pylori-mediated protection against allergic asthma. We con-
clude from the combined results that BATF3-dependent DC
lineages suppress pulmonary allergen-specific immune responses
by production of IL-10; in contrast, Tregs are not critically re-
quired for H. pylori extract-mediated protection, as their de-
pletion fails to abrogate protection.
Another cytokine known to be induced by H. pylori, IL-18 (22),
also turned out to be absolutely essential for asthma prevention
in the course of our studies. IL-18 is produced upon inflamma-
some activation by H. pylori in a variety of cell types, including
DCs, and promotes Treg differentiation and H. pylori-specific
tolerance in vitro and in vivo (10, 22). Whether the DC-intrinsic
production of IL-18 is required for H. pylori (extract)-mediated
protection against asthma remains to be addressed with suitable
mouse strains.
Our data further show that two H. pylori determinants, GGT
and VacA, are required for extract-mediated protection and can
be administered in purified form to prevent allergic asthma.
These findings are in line with earlier reports showing that both
factors have a critical role in H. pylori persistence and immune
modulation. Mutants lacking the ggt gene are incapable of col-
onizing mice persistently (19, 23), and this phenotype has been
attributed to DC tolerization by GGT in vitro and in vivo (19).
Similarly, a vacA gene deletion mutant fails to tolerize DCs and
to induce Tregs in vivo, and is therefore effectively controlled or
even cleared upon onset of an adaptive immune response (19).
The fact that a mutant form of VacA lacking an amino-terminal
hydrophobic region of three tandem GXXXG motifs fails to
protect against asthma when administered to mice in purified
form suggests that membrane insertion by VacA is required for
its immunomodulatory effects. The exact mechanism and rele-
vant target cell types of VacA in vivo remain to be elucidated in
detail. Taken together, our data demonstrate, to our knowledge
for the first time, that the immunomodulatory properties of
a very common infectious agent in humans, H. pylori, can be
exploited for therapeutic purposes in an allergy model and lend
Fig. 4. H. pylori GGT and VacA are required and sufficient for protection against asthma. (A–D) Groups of mice were treated as described in Fig. 1 with
H. pylori extract generated from either wild-type (WT) or Δggt or ΔvacAmutant bacteria, and were subjected to ovalbumin sensitization and challenge. (E–H)
Mice were i.p. injected weekly with 25 μg per dose of either recombinant GGT or purified wild-type or mutant (Δ6–27) VacA starting on day 7 of age until the
second sensitization. Total cells (A and E) and eosinophils (B and F) contained in 1 mL of BALF. Tissue inflammation (C and G) and goblet cell metaplasia (D and H).




support to H. pylori-specific tolerization as a viable strategy for
asthma prevention in high-risk individuals.
Materials and Methods
Animal Experimentation. C57BL/6, BATF3−/−, IL-18R−/−, and CD11c-Cre.IL-10fl/fl
mice were orally infected with H. pylori PMSS1 as described (16) or received
either once-weekly oral or i.p. doses of 200 μg of extract of H. pylori wild-type
PMSS1, PMSS1Δggt or PMSS1ΔvacA (19), Salmonella typhimurium, or E. coli or
once-weekly i.p. doses of 25 μg of recombinant GGT, or of s1m1 type VacA
(wild type or Δ6–27, ref. 20) purified from H. pylori strain 60190. Mice were
sensitized by i.p. injection of 20 μg of ovalbumin (Sigma-Aldrich) emulsified in
2.25 mg of aluminum hydroxide (Alum Imject; Pierce) at 8 and 10 wk of age
and challenged with 1% aerosolized ovalbumin using an ultrasonic nebulizer
(NE-U17; Omron) for 20 min daily on days 31, 32, and 33 after initial sensiti-
zation. Airway resistance measurements were performed on anesthetized,
intubated and mechanically ventilated mice (FinePointe Resistance and Com-
pliance System, Buxco Electronics) in response to increasing doses of inhaled
metacholine. In vivo blocking of IL-10 signaling and depletion of Tregs was
achieved by two i.p. injections of 250 μg of anti-IL-10R antibody (clone 1B1.3A)
and anti-CD25 antibody (clone PC-61.5, both BioXCell), respectively, during the
challenge phase. CD4+CD25+ Tregs were adoptively transferred as described
(9). Lungs were lavaged via the trachea with 1 mL of PBS. Broncho-alveolar
lavage fluid (BALF) cells were counted using trypan blue dye exclusion. Dif-
ferential cell counts of macrophages, lymphocytes, neutrophils, and eosino-
phils were performed on cytocentrifuged preparations stained with the
Microscopy Hemacolor-Set (Merck). For lung histopathology, lungs were fixed
by inflation and immersion in 10% (vol/vol) formalin and embedded in par-
affin. Tissue sections were stained with H&E and periodic acid-Schiff and ex-
amined in blinded fashion on a BX40 Olympus microscope. Peribronchial
inflammation was scored on a scale from 0 to 4. PAS-positive goblet cells were
quantified per 1 mm of basement membrane. All animal experimentation was
performed in accordance with federal, cantonal and institutional guidelines,
and approved by the Zurich Cantonal Veterinary Authorities (no. 170/2009
to A.M.).
Preparation of H. pylori Extract and Purification of GGT and VacA. H. pylori was
cultured in Brucella broth supplemented with 10% FCS, pelleted by centri-
fugation, and washed once with PBS. Bacteria were subjected to three
freeze/thaw cycles and disrupted by three passes through a French pressure
cell press (Stansted Fluid Power, Cell Pressure Homogenizer) at 30,000 bar.
Cell debris was removed by centrifugation and the supernatant filtered
through a 2-μm filter. Protein concentrations were determined by BCA
Protein Kit (R&D Systems). H. pylori VacA was purified using published
procedures (24, 25), with the following slight modifications. H. pylori strain
60190 was cultured in sulfite-free Brucella broth containing either choles-
terol or 0.5% charcoal. After centrifugation of the culture, supernatant
proteins were precipitated with a 50% saturated solution of ammonium
sulfate. The oligomeric form of VacA was isolated by gel filtration chro-
matography with a Superose 6 HR 16/50 column in PBS containing 0.02%
sodium azide and 1 mM EDTA. H. pylori GGT was purified as described (19).
Protocols for lung single cell preparation, flow cytometry, cytokine ELISAs,
and preparation of murine and human DCs and DC/T-cell cocultures can be
found in SI Materials and Methods.
Statistics. All statistical analysis was performed using Graph Pad prism 5.0
software. The Mann–Whitney test was used throughout. P values <0.05 were
considered significant.
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SI Materials and Methods
Lung Single Cell Preparation, Flow Cytometry, and Th2 Cytokine
ELISAs. Lungs were dissected, enzymatically digested with 0.5
mg/mL collagenase type IA (Sigma-Aldrich) and pushed through
a 70-μm nylon cell strainer. The antibodies used for staining were
anti-MHCII (clone M5/114.15.2), anti-B220 (RA3-6B2), anti-
CD11c (clone HL3), anti-CD103 (clone M290), and anti-CD11b
(clone M1/70; all BD Pharmingen). FACS analyses were per-
formed on a FACSCanto2 cytometer (BD Biosciences); post-
acquisition analysis was done using FlowJo software (Tree Star).
Cytokines in lung single-cell cultures restimulated for 72 h with
250 μg/mL ovalbumin were quantified by ELISA (IL-5, BD
Pharmingen; IL-13, R&D Systems).
Preparation of Murine and Human DCs and IL-10 ELISA. For generation
of murine bone-marrow-derived dendritic cells (BM-DCs), bone
marrow isolated from the hind legs of donor mice (BL/6.TLR2−/−,
BL/6.TLR4−/−, BL/6.MyD88−/− mice, all from Jackson Labs) was
seeded at 50,000 cells per well in 96-well plates in RPMI/10%
(vol/vol) FCS and 4 ng/mL GM-CSF and cultured for 5 d. For
the isolation of MLN-DCs, mesenteric lymph nodes were digested
in 1 mg/mL collagenase (Sigma-Aldrich) for 30 min at 37 °C with
shaking before filtering through a cell strainer (40 μm; BD Bio-
sciences) and immunomagnetic isolation of DCs using mouse-
specific CD11c microbeads (Miltenyi Biotec). BM-DCs and MLN-
DCs were stimulated with the indicated amounts of Helicobacter
pylori PMSS1 extract for 16 h, and supernatants were subjected to
mIL-10 ELISA (BD Pharmingen). Human monocyte-derived
dendritic cells were generated from peripheral blood mononuclear
cells. Venous blood was drawn from six healthy volunteers ac-
cording to protocols approved by the Institutional Review
Board of Leiden University Medical Center. Cells were col-
lected after density gradient centrifugation on Ficoll, and
CD14+ monocytes were positively isolated by magnetic-acti-
vated cell sorting (MACS) using CD14 microbeads (Miltenyi
Biotec). Cells were cultured in RPMI-1640 (Invitrogen) supple-
mented with penicillin (100 U/mL, Astellas Pharma), streptomycin
(100 μg/mL, Sigma), pyruvate (1 mM, Sigma), glutamate (2 mM,
Sigma), 10% FCS, 20 ng/mL human recombinant granulocyte-
macrophage colony-stimulating factor (rGM-CSF, Invitrogen/
Life Technologies), and 0.86 ng/mL human rIL-4 (R&D Sys-
tems) for 6 d. On day 3, the medium and the supplements
were refreshed. Monocyte-derived DCs were stimulated with
H. pylori extract for 48 h. Secretion of IL-10 by the DCs in the
supernatant was measured by ELISA (Sanquin).
DC/T-Cell Cocultures. For Treg differentiation ex vivo, BM-DC
cultures were infected overnight with wild-type H. pylori PMSS1
or treated with 25 μg/mL H. pylori extract. Bacteria were killed
with 200 U penicillin/0.2 mg streptomycin/mL for 6 h before the
addition of T cells. CD4+CD25− T cells were prepared from single-
cell suspensions of naive C57BL/6 spleens by immunomagnetic
sorting (R&D Systems). DCs were cocultured with CD4+CD25−
T cells at a ratio of 1:2 (0.5 × 105 DC to 1 × 105 T cells) in RPMI
containing 10% FCS, 10 ng/mL rTGF-β (PeproTech), 10 ng/mL
rIL-2 (R&D Systems) and 1 μg/mL anti-CD3e (BD Bioscience).
After 72 h of coculture, the cells were stained first for CD4 and
CD25 and then, after fixation and permeabilization, for FoxP3
(FoxP3-APC, eBioscience). The percentage of FoxP3+ CD4+
T cells was assessed by FACS on a Cyan ADP 9 instrument
(Beckman Coulter) and analyzed using FlowJo software
(TreeStar).
Processing of Gastric Tissue for Plating and Colony Counting. Stom-
achs were retrieved and dissected longitudinally. For the quan-
titative assessment of H. pylori colonization, a stomach section
containing representative amounts of antral and corpus tissue
was homogenized in Brucella broth and serial dilutions were
plated on horse blood plates for colony counting as described (1).
1. Arnold IC, et al. (2011) Tolerance rather than immunity protects from Helicobacter pylori-
induced gastric preneoplasia. Gastroenterology 140(1):199–209.
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Fig. S1. The protection against asthma conferred by treatment with whole cell extract is specific to H. pylori, depends on a heat-sensitive component of the
bacteria, and is most efficient when initiated in newborn mice. (A–E) Mice were sensitized i.p. with alum-adjuvanted ovalbumin at 8 and 10 wk of age and
challenged with aerosolized ovalbumin 2 wk after the second sensitization to induce asthma-like symptoms. Mock-sensitized mice served as negative controls.
One group received once-weekly doses of 200 μg of H. pylori extract from day 7 of age until the second sensitization. (A–D) Airway hyperresponsiveness in
response to the indicated increasing doses of methacholine. (E) Ovalbumin-specific serum IgE titers of the groups shown in A–D. (F–I) Mice were treated as
described in A–E, with the following modifications: Hpneo, extract administered orally from day 7 to the second sensitization, exactly as described above; Hpi.p.,
extract administered i.p. from day 7 to the second sensitization; Hpad, extract administered orally to adult mice for 4 wk before the second sensitization; Hp4x,
extract administered four times orally in the first 3 wk of life only; Hph.i., heat-inactivated extract administered orally from day 7 to the second sensitization;
Stneo/ad, Ecneo, Salmonella typhimurium and Escherichia coli extract administered orally either beginning in the neonatal period or to adults, respectively. (F and
G) Total cells and eosinophils contained in 1 mL of BALF. (H and I) Tissue inflammation and goblet cell metaplasia. Data points are pooled from two in-
dependent studies.




Fig. S2. The protection against asthma conferred by H. pylori depends on IL-10 and IL-18, but not on regulatory T cells. (A) CD11c-Cre.IL-10fl/fl mice and their
IL-10fl/fl littermates were treated with H. pylori extract before being subjected to ovalbumin sensitization and challenge as described in Fig. 2 G–J. IL-10 se-
cretion by single cell lung preparations restimulated with ovalbumin, as assessed by ELISA. (B–E) WT C57BL/6 and IL-18R−/− mice were neonatally infected with
H. pylori or treated with H. pylori extract before being subjected to ovalbumin sensitization and challenge as described in Fig. 1. (B and C) Total cells and
eosinophils contained in 1 mL of BALF. (D and E) Tissue inflammation and goblet cell metaplasia. (F–J) Wild-type C57BL/6 mice were treated with H. pylori
extract before being subjected to ovalbumin sensitization and challenge. One group received two doses of anti-CD25 antibody during ovalbumin challenge.
Additional sensitized and challenged groups received 100,000 immunomagnetically isolated CD4+CD25+ T cells from either neonatally infected donors or
extract-treated donors i.v. 2 d before the first ovalbumin challenge. (F) Lung infiltration of CD4+CD25+FoxP3+ T cells as assessed in lung single cell preparations
of individual mice. (G and H) Total cells and eosinophils contained in 1 mL of BALF. (I and J) Tissue inflammation and goblet cell metaplasia. (K) BM-DCs were
either infected overnight with live H. pylori or treated with 25 μg/mL H. pylori extract. Bacteria were killed with antibiotics before the addition of splenic
CD4+CD25− T cells at a DC:T-cell ratio of 1:2. DC/T-cell cocultures were supplemented with rTGF-β, rIL-2and anti-CD3e. After 72 h of coculture, the cells were
stained for CD4, CD25, and FoxP3 and the fraction of FoxP3+ CD4+ T cells was assessed by FACS.




Fig. S3. CD103+ conventional DCs accumulate in the lungs of H. pylori-infected and extract-treated wild-type mice, but not basic leucine zipper ATF-like 3
(BATF3)−/− mice. (A–D) Total cells and eosinophils contained in 1 mL of BALF, as well as tissue inflammation and goblet cell metaplasia as assessed on H&E and
PAS-stained tissue sections, of all mice for which lung DC populations are shown in Fig. 3 A–G. (E) Plasmacytoid DCs (pDCs) and conventional DCs (cDCs)
differentially express B220; a representative scatter plot is shown for all CD11c+ MHCII+ DCs of an extract-treated mouse. (F) Total numbers of B220+ pDCs
infiltrating the lungs of the mice shown in Fig. 3 A–G. (G) Two distinct cDC lineages can be discriminated in the lung based on CD103 and CD11b expression;
a representative scatter plot is shown for an extract-treated mouse (gated on CD11c+MHCII+ B220− DCs). (H) Total CD103+ cDC infiltration into the lungs of the
mice shown in Fig. 3 A–G. (I and J) BATF3−/− mice lack CD103+ cDCs, but retain CD11b+ cDCs and normal frequencies of pDCs. (K) H. pylori colonization of
neonatally infected WT C57BL/6 and BATF3−/− mice as determined by plating of gastric mucosal homogenates on horse blood plates and colony counting.




Fig. S4. VacA protects against allergic asthma when administered intraperitoneally or intragastrically. (A–E) Mice were i.p. injected weekly with 25 μg per
dose of either recombinant GGT or purified wild-type or mutant (Δ6–27) VacA starting on day 7 of age until the second sensitization as described in Fig. 4 E–H
(a subset of the mice of Fig. 4 E–H is shown here). (A and B) IL-13 and IL-5 secretion, as assessed by ELISA, of single cell lung preparations restimulated with
ovalbumin. (C and D) Frequencies of CD103+ and CD11b+ cells among all CD11c+MHC+B220− cDCs infiltrating the lungs of the indicated groups of mice. (E)
Ratios of CD11b+ and CD103+ cDCs as calculated per mouse. (F and G) Purified wild-type VacA was either administered intraperitoneally (i.p.) or intragastrically
(p.o.) as indicated. Mice received either 5 μg or 20 μg of VacA (as indicated), either from age day 7 onwards until 2 wk before challenge (as indicated by
subscript “a”) or three doses only (delivered in weeks 1, 2, and 3 of life, denoted by subscript “b”) or as adults (denoted by subscript “c”). Two doses of IL-10R
blocking antibody were administered during challenge where indicated. (F and G) Total cells and eosinophils contained in 1 mL of BALF. (H and I) Tissue
inflammation and goblet cell metaplasia. Three doses of VacA delivered before weaning were insufficient to provide full protection (“b”). Treatment of adults
was almost as protective as neonatal-onset treatment (compare “c” and “a”; note that the total cell count in the adult-treated group is inconsistent with the
other three readouts for reasons that are not clear); the 5-μg and 20-μg doses provided similar levels of protection; blocking IL-10 signaling abrogated
protection.




















The Journal of Clinical Investigation   B R I E F  R E P O R T
3 2 9 7jci.org   Volume 125   Number 8   August 2015
Introduction
Persistent infection of the gastric mucosa with H. pylori causes 
gastritis (1) and represents a major risk factor for the development 
of gastric cancer (2) but has also been inversely linked to the risk 
of allergic and chronic inflammatory diseases (3, 4). The outcome 
of the H. pylori/host interaction is determined both by host and 
bacterial genetic factors (5) as well as the infected individual’s pre-
dominant T cell response to H. pylori: whereas asymptomatic carri-
ers generate H. pylori–specific Tregs, patients with peptic ulcer are 
characterized by Th1/Th2-biased, pathogenic T effector responses 
(6). Treg-predominant responses are particularly pronounced 
in children (7) and can be recapitulated in experimental models 
of neonatal H. pylori infection (8), in which they are required for 
protection against allergen-induced asthma (9). H. pylori acti-
vates caspase-1 (CASP1) in infected macrophages and DCs and 
induces the processing and secretion of the CASP1-dependent 
cytokines IL-1β and IL-18 by triggering the assembly and activa-
tion of an ASC- and NLRP3-containing inflammasome (10–12). 
CASP1 activation by H. pylori has both proinflammatory and anti-
inflammatory consequences that are differentially mediated by its 
cytokine substrates (10). IL-1β exerts proinflammatory effects that 
promote Th1- and Th17-driven H. pylori control and gastric immu-
nopathology (10, 11); in contrast, IL-18 signaling restricts severe 
gastric immunopathology and contributes to asthma protection 
by promoting Treg differentiation (10, 13). Here, we show using in 
vitro and in vivo infection models that NLRP3 inflammasome acti-
vation by H. pylori requires licensing through TLR2. A saturating 
transposon (tn) library screen revealed a critical and previously 
unrecognized role for H. pylori’s urease enzyme in promoting the 
TLR2-dependent transcriptional activation of NLRP3 expression, 
CASP1 activation, and cytokine processing as well as Treg differ-
entiation and asthma protection.
Results and Discussion
H. pylori activates CASP1 and induces IL-1β secretion by DCs in an 
ASC-, NLRP3-, and TLR2-dependent manner. Having shown pre-
viously that H. pylori exposure activates CASP1 and induces the 
secretion of mature IL-1β and IL-18 in bone marrow–derived DCs 
(BMDCs) (10), we sought to identify host determinants of inflam-
masome activation by H. pylori. BMDCs from WT, Nlrc4–/–, Nlrp6–/–, 
Nlrp3–/–, Aim2–/–, and Asc–/– mice, and from mice lacking various 
TLRs and adaptor molecules, were cocultured with two different 
strains of H. pylori and examined with respect to CASP1 activation 
and IL-1β secretion. Whereas the inflammasome sensors NLRC4, 
NLRP6, and AIM2 were dispensable for CASP1 activation and IL-1β 
secretion, both processes were found to be dependent on the bipar-
tite adaptor protein ASC as well as the cytoplasmic inflammasome 
sensor NLRP3 (Figure 1, A–D, and Supplemental Figure 1, A–E; sup-
plemental material available online with this article; doi:10.1172/
JCI79337DS1). Surprisingly, we found that CASP1 activation and 
IL-1β secretion, but not the transcriptional activation of IL-1β, 
required surface-exposed TLR2 (Figure 1, E–G). Other surface and 
endosomal TLRs known to contribute to innate immune recog-
nition of Gram-negative pathogens, i.e., TLR4, TLR5, and TLR9 
or the IL-1 receptor, were not required for IL-1β secretion (Figure 
1, E–G, and Supplemental Figure 2, A–I). Similarly, we could not 
Inflammasome activation and caspase-1–dependent (CASP1-dependent) processing and secretion of IL-1β and IL-18 are critical 
events at the interface of the bacterial pathogen Helicobacter pylori with its host. Whereas IL-1β promotes Th1 and Th17 
responses and gastric immunopathology, IL-18 is required for Treg differentiation, H. pylori persistence, and protection against 
allergic asthma, which is a hallmark of H. pylori–infected mice and humans. Here, we show that inflammasome activation 
in DCs requires the cytoplasmic sensor NLRP3 as well as induction of TLR2 signaling by H. pylori. Screening of an H. pylori 
transposon mutant library revealed that pro–IL-1β expression is induced by LPS from H. pylori, while the urease B subunit 
(UreB) is required for NLRP3 inflammasome licensing. UreB activates the TLR2-dependent expression of NLRP3, which 
represents a rate-limiting step in NLRP3 inflammasome assembly. ureB-deficient H. pylori mutants were defective for CASP1 
activation in murine bone marrow–derived DCs, splenic DCs, and human blood-derived DCs. Despite colonizing the murine 
stomach, ureB mutants failed to induce IL-1β and IL-18 secretion and to promote Treg responses. Unlike WT H. pylori, ureB 
mutants were incapable of conferring protection against allergen-induced asthma in murine models. Together, these results 
indicate that the TLR2/NLRP3/CASP1/IL-18 axis is critical to H. pylori–specific immune regulation.
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lower levels and exhibited higher gastric mucosal IFN-Ȗ expression 
(Figure 1, J and K), which correlates well with higher frequencies 
of IFN-Ȗ–expressing CD4+ T cells in the mesenteric lymph nodes 
(MLNs) of Tlr2–/– mice relative to those in WT mice (Supplemental 
Figure 2T). The combined results suggest that H. pylori activates 
the inflammasome in a TLR2- and NLRP3-dependent manner and 
benefits from this process because it promotes H. pylori persistence.
Genome-wide screening for factors involved in IL-1β secretion 
reveals a role for H. pylori LPS and urease. Known activators of the 
NLRP3 inflammasome include both foreign and endogenous 
compounds, with the best-understood being urate crystals, asbes-
tos, ATP, and bacterial pore-forming toxins (15). We were able 
to exclude a role for the H. pylori immunomodulator Ȗ-glutamyl- 
transpeptidase GGT and the Cag pathogenicity island in CASP1 
activation and IL-1β secretion (Supplemental Figure 3, A and B). 
To search for H. pylori factors involved in inflammasome activa-
tion in a genome-wide manner, we took advantage of a previously 
described tn mutant library (16). As IL-1β secretion by H. pylori–
detect a contribution of the Nod-like receptor NOD2 or of the ATP 
sensor P2X7R to these processes (Supplemental Figure 2, J–L). Of 
two known adaptor molecules relaying signals downstream of the 
TLRs, only MyD88, but not TRIF, was involved in IL-1β expression 
and secretion (Figure 1, E–G, and Supplemental Figure 2, M and N). 
A recently identified noncanonical inflammasome activation path-
way involving TRIF- and IRF3/7-mediated type I IFN production 
and signaling (14) was dispensable for H. pylori–induced inflam-
masome activation (Supplemental Figure 2, N–R). The critical role 
of TLR2, MyD88, and NLRP3 in H. pylori–induced IL-1β secretion 
was confirmed with immunomagnetically isolated CD11c+ splenic 
DCs (Figure 1H and Supplemental Figure 2S). IL-18 secretion by 
splenic DCs also required TLR2 and NLRP3 (Figure 1I).
CASP1–/– mice, and mice lacking either IL-18 or its receptor, 
control Helicobacter infections more effectively than WT animals, 
because they fail to peripherally induce Tregs (10, 13). Experimen-
tal infection of Nlrp3–/– and Tlr2–/– mice with the H. pylori isolate 
PMSS1 recapitulates this phenotype: both strains were colonized at 
Figure 1. CASP1 activation by H. pylori depends on NLRP3, ASC, and TLR2.  (A–G) BMDCs from mice of the indicated genotypes were infected overnight 
with H. pylori NSH57, G27, and/or PMSS1. (A, C, and E) Western blot analysis of CASP1 activation (p10) in the cell supernatant compared to full-length 
CASP1 p45 and GAPDH in the extract. Representative results of 3 independent experiments are shown (n = 3). (B, D, and F) IL-1β ELISA of culture superna-
tants; cells were prestimulated with E. coli LPS prior to infection. Uninf, uninfected. (G) Il1b transcription, as measured by qRT-PCR (normalized to Gapdh 
and to uninfected controls). Mean + SD of 3 independent experiments is shown (n = 3). (H and I) CD11c+ splenic DCs were infected overnight with G27. (H) 
IL-1β and (I) IL-18 secretion was measured by ELISA. Representative data of 3 independent experiments are shown (n = 3). (J and K) Mice were infected for 
1 month with PMSS1 prior to the quantification of (J) gastric colonization and (K) Ifng expression. Pooled data from 2 studies are shown (n = 2). Horizontal 
lines indicate medians. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, Mann-Whitney U test. Error bars represent mean + SD.
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B and C). IL-1β expression upon stimulation with both types of LPS 
was MyD88- and TLR4-dependent (Supplemental Figure 4D).
Remarkably, of the 8 tn insertions mapping to the urease 
gene cluster, all affected 2 genes encoding the structural urease 
subunits, ureA or ureB (Supplemental Table 1). A gene-specific 
deletion mutant lacking both UreA and UreB proteins (G27ǻure, 
Supplemental Figure 5A) phenocopied the effect of the tn inser-
tion mutants, which could be attributed to its failure to activate 
CASP1 (Figure 2, C and D). In contrast, Il1b transcription was nor-
mal (Figure 2E). Coculturing of murine splenic CD11c+ DCs and 
human blood-derived DCs confirmed the defect of the H. pylori 
ǻure and ǻ146 mutants with respect to IL-1β secretion; in contrast, 
the secretion of IL-18, which does not require transcriptional acti-
vation, was almost at WT levels in the case of the ǻ146 mutant 
(Figure 2, F–H). In summary, our screen identified H. pylori factors 
regulating CASP1-dependent cytokine secretion at two distinct 
levels, one transcriptional and one posttranslational.
exposed DCs is dependent on CASP1 (10), we opted for IL-1β ELISA 
as a screening readout (Supplemental Figure 3C). The insertion 
sites of 64 mutants with defects in inducing IL-1β secretion (<25% 
of the corresponding WT infection) were sequenced and mapped 
to 32 different loci (Supplemental Table 1). Loci belonging to two 
mutant categories were identified repeatedly; these harbored tn 
insertions in genes involved in LPS biosynthesis and in the urease 
gene cluster (Figure 2, A and B). The LPS synthesis gene hit most 
often was LPS-1,2-glycosyltransferase (HPG27_146). LPS from 
H. pylori deficient for this gene lack the O-side chain and there-
fore Lewis antigens (Supplemental Figure 4A). A gene-specific 
deletion mutant (ǻ146) in strain G27 recapitulated the tn mutant 
phenotype, as it failed to induce IL-1β secretion in BMDCs (Figure 
2C). The phenotype of this mutant was attributable to its failure 
to induce pro–IL-1β expression at the transcriptional level, rather 
than to a defect in CASP1 activation, and could be rescued by 
E. coli or H. pylori LPS (Figure 2, C–E, and Supplemental Figure 4, 
Figure 2. IL-1β secretion upon H. pylori infection requires LPS-induced transcriptional activation of pro–IL-1β and urease- and TLR2-dependent 
expression of NLRP3.  (A) Genome-wide screening for H. pylori tn mutants incapable of IL-1β secretion identifies the indicated mutant categories. R-M, 
restriction modification. (B) Relative IL-1β secretion of individual tn clones with insertions in ureA, ureB, and HPG27_146. (C–E and I–M) Murine BMDCs,  
(F and G) splenic CD11c+ DCs, and (H) human blood-derived DCs were infected overnight or for the indicated time points with G27 WT, ǻure, or ǻ146 
strains of H. pylori and analyzed by (C, F, H, K, and M) IL-1β ELISA; (G) IL-18 ELISA; (D, J, and L) CASP1 p10 and p45, pro–IL-1β, and NLRP3 Western blot-
ting; and (E and I) qRT-PCR (normalized to Gapdh and to uninfected controls). BMDCs were prestimulated with E. coli LPS where indicated, and 1 ȝg/ml 
recombinant GST-tagged UreA, UreB (native or heat-inactivated [HI] for 10 minutes at 70°C), or GST was added to cocultures as noted. Pooled data from 
3 to 4 independent experiments are show in C, E, I, K, and M; a representative of 2 experiments is shown in F–H. *P ≤ 0.05, **P ≤ 0.01, Mann-Whitney U 
test. Error bars represent mean + SD.
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no effect on the two processes (Figure 2M and data not shown). 
Taken together, the results suggest that UreB signals via TLR2 to 
prime NLRP3 expression, which appears to be a rate-limiting step 
in H. pylori–induced inflammasome activation and IL-1β process-
ing. This is particularly interesting because TLR2 has not yet been 
described to be activated by bacterial (non-lipo-) proteins.
H. pylori urease is required for CASP1 activation, Treg responses, 
and asthma protection in vivo. To investigate the consequences of 
LPS and urease deficiency in vivo, ǻure and ǻ146 mutants were 
generated in the mouse-colonizing strains PMSS1 and/or SS1 and 
used for experimental infections of adult or neonatal C57BL/6 
mice. Whereas ǻ146 failed to colonize under all circumstances 
(data not shown), the PMSS1ǻure mutant colonized adult infected 
mice at WT levels for at least 3 months, without evidence of 
having regained urease expression (Supplemental Figure 6, A 
and B). In contrast, SS1ǻure consistently failed to colonize (data 
Given the similarities in outcome of TLR2 deficiency of the 
host on the one hand and urease deficiency of the bacteria on 
the other (i.e., lack of CASP1 activation), we hypothesized that H. 
pylori urease might provide a TLR2-mediated signal to promote 
inflammasome/CASP1 activation. As NLRP3 expression can be 
primed by TLR signaling, we asked whether NLRP3 transcript 
and protein levels in BMDCs are affected by H. pylori exposure. 
Indeed, WT H. pylori infection efficiently induced NLRP3, but not 
AIM2 or NLRC4, expression at the transcript and protein levels in 
a TLR2-, MyD88-, and NF-țB–dependent manner; this was not 
observed in BMDCs infected with ǻure H. pylori (Figure 2, I and J; 
Supplemental Figure 5, B–H; and data not shown). Interestingly, 
the defect of the ǻure mutant with respect to CASP1 activation and 
IL-1β secretion could be rescued by recombinant UreB, but not 
UreA or the GST tag control; this effect was only seen in WT, but 
not in Tlr2–/–, BMDCs (Figure 2, K–M). Heat-inactivated UreB had 
Figure 3. H. pylori urease is required for CASP1 activation, persistence, and asthma protection in neonatally infected mice. (A–E) Neonatal C57BL/6 
mice were infected for 1 month with WT or ǻure H. pylori PMSS1 and assessed with respect to (A) gastric colonization, (B) gastric mucosal NLRP3 and 
CASP1 (asterisk indicates the NLRP3-specific band), (C) Nlrp3 expression, (D) IL-18, and (E) Ifng expression, as analyzed by (B) Western blotting, (D) ELISA, 
and/or (C and E) qRT-PCR. (F–M) Neonatally infected mice were additionally sensitized and challenged (s.c.) with (F–I) ovalbumin or (J–M) house dust mite 
(HDM) allergen starting at 4 weeks after infection to induce allergic asthma; ĮIL-18 mAb was administered weekly starting at the time of infection. Inf, 
infection. (F and J) Eosinophils in 1 ml of bronchoalveolar lavage fluid (BALF). (G) IL-5 ELISA of ovalbumin-restimulated lung single cell preparations.  
(H and L) Lung inflammation, as assessed on H&E-stained sections. (I and M) Goblet cell metaplasia, as quantified on PAS-stained sections. BM, base-
ment membrane. (K) House dust mite–specific serum IgE, as determined by ELISA. (N) H. pylori colonization of WT, Tlr2–/–, and Nlrp3–/– mice 1 month after 
infection. Symbols represent individual animals, and horizontal lines indicate the medians. Pooled data from 2 (A–E and N) and 3 (F–M) independent 
experiments are shown. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, Mann-Whitney U test.
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plemental Figure 8). Infection with urease gene deletion mutants 
phenocopies the effects of TLR2 and NLRP3 deficiency. The com-
bined results confirm a critical contribution of the TLR2/NLRP3/
CASP1/IL-18 axis to microbially induced immune regulation and 
introduce the H. pylori urease as a novel immunomodulator of this 
important human pathobiont.
Methods
Animal experimentation. C57BL/6 WT, Casp1–/–, Tlr2–/–, Tlr4–/–, Tlr5–/–, 
Tlr9–/–, Myd88–/–, Trif–/–, Nlrp3–/–, Ifnar–/–, Irf7–/–, Nod2–/–, P2rx7–/–, and 
Aim2–/– mice were originally obtained from Charles River Labora-
tories. Nlrc4–/– and Asc–/– mice were provided by Genentech. Nlrp6–/– 
mice were provided by Millenium Pharmaceuticals. Il1r–/– mice were 
provided by Manfred Kopf. Mice were infected orally with 108 CFU 
H. pylori PMSS1 at 6 weeks or 7 days of age. Bacterial colonization 
was assessed by colony counting. The procedures used for asthma 
induction and cytokine quantification by qPCR, ELISA, and FACS are 
described in the Supplemental Methods.
H. pylori strains, infection of DCs, and tn library screening. H. pylori 
strains and culture conditions as well as the procedures used for the dif-
ferentiation and immunomagnetic isolation of DCs and for tn library 
screening are described in the Supplemental Methods, along with pro-
tocols for Western blotting and purification of recombinant proteins.
Statistics. GraphPad Prism (GraphPad Software) was used for statis-
tical analyses. All P values were calculated by Mann-Whitney U test.
Study approval. All animal experimentation was reviewed and 
approved by the Veterinary Office of the canton of Zurich (Zurich, 
Switzerland) (licenses 24/2013 and 170/2014 to A. Müller).
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not shown), confirming that urease proficiency is required for 
mouse colonization in certain strain backgrounds (17). Interest-
ingly, PMSS1ǻure induced significantly less gastric production 
of IL-1β and IL-18 and less active CASP1 than the parental WT 
strain (Supplemental Figure 6, C–E). In line with the increased 
gastric IFN-Ȗ expression of Tlr2–/– and Nlrp3–/– animals (Figure 
1K), ǻure-infected mice exhibited higher gastric mucosal IFN-Ȗ 
expression and more IFN-Ȗ+CD4+ cells in the MLNs than infected 
WT animals (Supplemental Figure 6, F and G). A similar pattern 
was observed in neonatally infected animals, in which CASP1 acti-
vation, NLRP3 expression, and IL-18 secretion were also found to 
depend on urease proficiency of H. pylori; moreover, colonization 
levels of the ǻure mutant were strongly reduced relative to the 
WT strain in neonatally infected mice (Figure 3, A–D). As in adult 
infected mice, the ǻure mutant elicited higher Ifng expression 
(Figure 3E). Interestingly, H. pylori urease was further required 
for the efficient protection against allergen-induced asthma that 
is a hallmark of neonatally infected mice. All examined parame-
ters of ovalbumin-induced allergic asthma, i.e., bronchoalveolar 
eosinophilia, lung inflammation, and goblet cell metaplasia as 
well as pulmonary Th2 cytokine production, were clearly reduced 
in infected WT animals but not in ǻure-infected animals (Figure 
3, F–I, and Supplemental Figure 7A). Similar results were obtained 
in the house dust mite model of allergic asthma (Figure 3, J–M). 
Moreover, protection was abrogated by a blocking antibody tar-
geting IL-18 and in Tlr2–/– mice (Figure 3, J–M), which, similar to 
Nlrp3–/– mice, had a lower bacterial burden than WT mice (Fig-
ure 3N). Protection against ovalbumin-induced asthma could be 
adoptively transferred via immunomagnetically purified CD25+ 
Tregs from H. pylori infected WT donors but not ǻure-infected 
donors; Tregs from H. pylori infected WT Tlr2–/– and Nlrp3–/– ani-
mals also failed to confer protection (Supplemental Figure 7, B 
and C). The quantification of CD25+FoxP3+ Tregs in MLNs further 
revealed lower Treg frequencies in ǻure-infected mice relative to 
infected WT mice and Tlr2–/– mice relative to WT mice (Supple-
mental Figure 7, D and E). In summary, the findings described here 
document a previously unrecognized role of H. pylori urease in 
innate immune recognition and H. pylori persistence that presum-
ably is unrelated to its function in acid resistance. Here, we show 
that UreB promotes the TLR2-dependent expression of NLRP3, 
a critical component of the inflammasome that is required for 
CASP1 activation and IL-1β/IL-18 processing (see model in Sup-
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Supplemental Figure 1 
 
Suppl. Figure 1: IL-1β secretion by H. pylori-infected DCs depends on NLRP3 and ASC, but is 
independent of NLRC4, NLRP6 and AIM2. (A-E) BMDCs generated from mice of the indicated 
genotypes were infected overnight with H. pylori NSH57 and G27 at an MOI of 50, with or without 
prior E. coli LPS stimulation. (A and B) IL-1β ELISA of samples generated as shown in main Figure 
panels 1B and 1D, but without prior E. coli LPS stimulation. Pooled data of 3 independent 
experiments are shown (n=3). (C) WB analysis of caspase-1 activation (p10) in the cell supernatant 
compared to full length caspase-1 (p45) and GAPDH in the cell extract. One representative experiment 
of 3 is shown (n=3). (D and E) IL-1β ELISA of samples stimulated with 5ng/ml E. coli LPS for 3h 
prior to infection (D) or w/o prestimulation (E). Pooled data of 3 independent experiments (n=3) are 














Supplemental Figure 2 
 
Suppl. Figure 2: Caspase-1 activation and IL-1β secretion by H. pylori-infected DCs is 
independent of TLR5 and TLR9, IL-1R, Nod2, P2X7R and the TRIF-IRF7-IFNaR axis. (A-R) 
BMDCs generated from mice of the indicated genotypes were infected overnight at an MOI of 50 with 
H. pylori NSH57, G27, SS1 and/or PMSS1. (A, D, G, J, O and Q) WB analysis of caspase-1 
activation (p10) in the cell supernatant compared to actin expression in the cell extract. Lanes in the 
p10 WB in panels A, J and Q were run on the same gel, but were noncontiguous. (B, E, H, K, L, N, P 
and R) IL-1β secretion was analyzed by IL-1β ELISA of cell supernatants. (C, F, I and M) Il1b 
transcription was measured by qRT-PCR (normalized to Gapdh). (S) Il1b transcription in spleen DCs 
was measured by qRT-PCR and normalized to Gapdh and to uninfected controls. (T) MLN single cell 
suspensions derived from individual mice were re-stimulated with PMA/ionomycin and stained for 
IFNγ and CD4. Representative experiments are shown throughout (A-I, L, O, P and T: n=2); J and K: 
n=4; M, N, and Q-S: n=3).  Each symbol represents one mouse. Horizontal lines indicate the median; 






Supplemental Figure 3 
Suppl. Figure 3: IL-1β secretion by H. pylori-infected DCs is independent of known H. pylori 
virulence factors. (A and B) BMDCs generated from wild type mice were infected overnight with H. 
pylori G27 wild type and the indicated mutants and assessed with respect to caspase-1 activation (by 
quantification of Western blot signals for the p10 subunit, (A)) and IL-1β secretion (by ELISA, (B)). 
At least two and up to four experiment are pooled in A and B. Data represent mean ± SD. (C) 
Representative 96 well plate IL-1β ELISA result of the transposon mutant library screen, where all 
clones (in red) exhibiting IL-1β expression levels under the 75% reduction cut-off (indicated by the 






















Supplemental Figure 4 
 
Suppl. Figure 4: H. pylori LPS induces the transcription of Il1b via TLR4 and MyD88. (A) 
Western blot of Lewis antigen expression of wild type G27 and the ∆146 mutant strain. One 
representative blot of 3 is shown (n=3). (B) Wild type BMDCs were infected overnight with H. pylori 
G27 wild type and the ∆146 mutant in the absence or presence of 1µg/ml purified H. pylori LPS, and 
assessed with respect to IL-1β secretion by ELISA. Pooled data of 3 independent experiments are 
shown (n=3). Data represent mean ± SD; statistics: Mann-Whitney U test. (C) BMDCs were treated as 
described in B and analyzed for proIL-1β expression by Western blotting of cell extract (lanes were 
run on the same gel, but are not contiguous). One representative experiment of 2 is shown (n=2). (D) 
Wild type, Myd88-/- and Tlr4-/- BMDCs were treated overnight with either purified E. coli or H. pylori 
LPS at the indicated concentrations and assessed with respect to Il1b expression by qRT-PCR 
















Supplemental Figure 5 
 
Suppl. Figure 5: Urease-proficient H. pylori induces the transcription of Nlrp3, but not of Aim2 
and Nlrc4, via TLR2, MyD88 and NF-κB. (A) UreA- and UreB-specific Western blot of extracts 
generated from PMSS1 and G27 wild type and ∆ure strains. One representative blot of 3 is shown 
(n=3). (B-H) BMDCs of the indicated genotypes were infected overnight with H. pylori G27 wild type 
and the ∆ure mutant as indicated and assessed with respect to IL-1β secretion by ELISA, and proIL-
1β, AIM2, NLRC4 and NLRP3 expression by Western blotting and/or qRT-PCR. (B) IL-1β ELISA of 
the 24h-infected samples shown in Figure 2I, along with parallel samples that were additionally pre-
stimulated with E. coli LPS for 3h. Pooled data of 3 independent experiments are shown (n=3). (C and 
D) qRT-PCR for Aim2 (C) and Nlrc4 (D) of the samples shown in Figure 2I. Pooled data of 4 
independent experiments are shown (n=4). (E-G) Wild type BMDCs were treated with DMSO or the 
NF-κB inhibitor BAY11 for 1h prior to infection with wild type G27. Transcription of Nlrp3 (E) and 
Il1b (F) was analyzed at the indicated time points using qRT-PCR (normalized to Gapdh and to 
completely untreated, uninfected controls). Pooled data of 3 independent experiments are shown in E 
and F (n=3). (G) NLRP3 and proIL-1β expression as analyzed by Western blotting of cell extracts 
relative to actin as loading control. One representative experiment of 3 is shown (n=3). (H) WT, Tlr2-/- 
and Myd88-/- BMDCs were infected for the indicated time points with wild type G27; NLRP3 and 
proIL-1β expression was analyzed by Western blotting of cell extracts relative to actin as loading 
control. One representative experiment of 3 is shown (n=3). Data in B-F represent mean ± SD; 








Supplemental Figure 6 
 
Suppl. Figure 6: H. pylori urease is required for inflammasome activation in adult-infected mice. 
(A-G) Mice were infected at 6 weeks of age with H. pylori PMSS1 wild type or the ∆ure mutant. (A) 
Gastric H. pylori colonization at the indicated time points post infection, as determined by plating and 
colony counting. (B) UreA- and UreB-specific Western blot of H. pylori re-isolates recovered after 28 
days of infection. Each lane represents pooled re-isolates from one animal. (C and D) IL-1β (C) and 
IL-18 (D) ELISA of gastric mucosal homogenates obtained at the indicated time points post infection. 
Each symbol represents one animal. (E) Western blotting analysis of activated caspase-1 p10, full-
length caspase-1 p45 and actin as loading control of gastric mucosal homogenates after 28 days of 
infection. Each lane represents one animal. (F) Ifng expression in the gastric mucosa after 90 days of 
infection, as measured by qRT-PCR and normalized to Gapdh. (G) MLN single cell suspensions 
derived from individual mice were re-stimulated with PMA/ionomycin and stained for IFNγ and CD4. 
Each symbol represents one mouse. Horizontal lines indicate the median; statistics: Mann-Whitney U 
test. Pooled data from 2 independent experiments are shown throughout (n=2); note that for technical 














Supplemental Figure 7 
 
Suppl. Figure 7: TLR2, NLRP3 and H. pylori urease are required for the generation of asthma-
suppressing Tregs. (A) Representative images of H&E- (upper panel, magnification 100x) and PAS- 
(lower panel, magnification 400x) stained sections of the lungs described and scored in main Figure 
3H and 3I. (B and C) Neonatal wild type, Tlr2-/- and Nlrp3-/- mice were infected with either wild type 
PMSS1 or its ∆ure mutant for 28 days. CD4+CD25+ Tregs were immunomagnetically isolated from 
Peyer’s patches and MLNs of these donor mice and adoptively transferred i.v. to ovalbumin-sensitized 
wild type recipients one day before ovalbumin challenge (s/c, sensitized/challenged). Lung 
inflammation (B) and goblet cell metaplasia (C) was quantified on H&E- and PAS-stained tissue 
sections, respectively (BM, basement membrane). Pooled data of 3 experiments are shown (n=3). (D 
and E) Neonatal wild type and Tlr2-/- mice were infected with either wild type PMSS1 or the ∆ure 
mutant for 28 days. MLNs were isolated and stained for CD4, CD25 and FoxP3. Representative FACS 
plots of the CD4+ gate (D) are shown along with quantitative data for all animals (E). Horizontal lines 
indicate the median; statistics: Mann-Whitney U test. Data in D and E are representative of 2 






Supplemental Figure 8 
 
Suppl. Figure 8: Model of H. pylori-induced inflammasome activation. H. pylori LPS and the 
urease B subunit (UreB) collaborate to promote NLRP3 inflammasome and caspase-1 activation as 
well as IL-1β and IL-18 processing and secretion. H. pylori LPS signals via TLR4, MyD88 and NF-
κB to activate Il1b transcription (indicated by red arrows), whereas UreB signals via TLR2, MyD88 
and NF-κB to activate Nlrp3 transcription (green arrows). The assembly of NLRP3, ASC and pro-
caspase-1 is triggered through an as yet unknown mechanism leading to caspase-1 activation, and to 
the processing of proIL-1β and proIL-18. The mature cytokines are released and promote Th1 
differentiation and H. pylori clearance in the case of IL-1β, and Treg differentiation, immune tolerance 
and persistence in the case of IL-18. Note that the pro-form of IL-18 is constitutively expressed in 
DCs. While shown representatively for a dendritic cell, other immune cells and gastric epithelial cells 
may activate the NLRP3 inflammasome in a similar manner upon exposure to H. pylori and may 










Supplemental Table 1 
gene # gene name # of hits 
LPS synthesis 
HPG27_38 mannose-6-phosphate isomerase 3 
HPG27_39 GDP-D-mannosedehydratase 4 
HPG27_104 L-fuculose 1-phosphate aldolase 1 
HPG27_146 lipopolysaccharide1,2-glycosyltransferase 5 
HPG27_437 DD-heptosyl transferase 1 
Urease gene cluster 
HPG27_67 ureaseB 3 
HPG27_68 ureaseA 5 
Restriction-modification system 
HPG27_436 type II methyltransferase 1 
HPG27_746 putative type I R-M enzyme 1 
HPG27_806 type I restriction enzyme M protein 1 
HPG27_945 
phage/colicin/tellurite resistance cluster Y 
protein 1 
HPG27_1316 type III restriction enzyme R protein 1 
HPG27_1328 putative type III restriction enzyme R 2 
HPG27_1444 type III R-M system modification enzyme 1 
Chemotaxis 
HPG27_95 methyl-accepting chemotaxis protein 8 
Outer membrane proteins 
HPG27_739 outer membrane protein 1 
HPG27_1501 putative outer membrane lipoprotein 1 
Hypothetical proteins 
HPG27_773 hypothetical protein 1 
HPG27_936 hypothetical protein 1 
HPG27_1131 hypothetical protein 1 
HPG27_1133 hypothetical protein 1 
HPG27_1275 hypothetical protein 1 
HPG27_1282 hypothetical protein 1 
HPG27_1358 hypothetical protein 1 
Others 
HPG27_487 cag pathogenicity island protein X 1 
HPG27_603 putative 3-hydroxy acid dehydrogenase 1 
HPG27_772 flagellar rotor protein 1 
HPG27_1129 alpha carbonic anhydrase 1 
HPG27_1138 aldo-keto reductase 1 
  plasmid 1 
  Different non coding regions 9 







H. pylori strains, infection of DCs and transposon library screening 
The following H. pylori strains were used for in vitro infection of BMDCs. Strains G27, SS1 
and PMSS1 have been described previously (1-3). NSH57 is a mouse-adapted derivative of 
strain G27 that was generated by three 3-week passages in FVB mice (4). To create the 
transposon library used here (generously donated by Nina R. Salama, Division of Human 
Biology, Fred Hutchinson Cancer Research Center, Seattle, USA), genomic DNA prepared 
from the original 10,000-clone G27 library (5) was transformed into NSH57 by natural 
transformation (4). For the analysis of individual clones with respect to their induction of IL-
1β secretion by BMDCs, bacteria were cultured from frozen stocks on horse blood agar 
supplemented with 25 µg/ml of chloramphenicol at 37°C for 2 days under microaerophilic 
conditions. Colonies were picked and expanded individually o/n on fresh horse blood plates 
prior to inoculation of 100µl liquid cultures (Brucella broth (Difco) containing 10% FBS (Life 
Technologies)) in 96 well format. Liquid cultures were grown for 6h with shaking at 37°C 
and used for BMDC infection in 96 well flat bottom plates and for cryopreservation of 
individual clones. The supernatants of infected BMDCs were subjected to IL-1β ELISA after 
16h of co-culture. For sequencing of the transposon flanking regions, the following primer 
was used: 5’-CAG TTC CCA ACT ATT TTG TCC-3’. The screen was saturated after 
examination of ~2500 mutants. All H. pylori liquid cultures were routinely assessed by light 
microscopy for contamination, morphology, and motility prior to use in infections.  
 
Generation and infection of BMDC, spleen DCs and human blood-derived DCs 
For the generation of BMDCs, single cell suspensions were prepared from hind leg bone 
marrow and seeded at 105 cells per well in 96 well plates for ELISA or at 2x106 cells per well 
in 6 well plates for Western blotting  in RPMI/10% FCS and 4ng/ml GM-CSF and cultured 
for 6 days. BMDCs were infected for 16h with H. pylori at a multiplicity of infection of ~50. 
BMDCs were pretreated for 3h with 5ng/ml LPS (Sigma Aldrich) to stimulate Il1b expression 
where indicated. BAY11-7082 (Sigma Aldrich) was added at 1µM final concentration 1h 
prior to infection of BMDCs to inhibit NF-κB signaling. For the isolation of splenic DCs, 
spleen cell suspensions were prepared by digestion using 1mg/ml CollagenaseD and 0.1% 
DNaseI (both from Roche) in serum-free RPMI for 1h at 37°C. DCs were 
immunomagnetically isolated using CD11c MicroBeads (Miltenyi Biotec) according to the 
manufacturer’s instructions and seeded at 2x105 cells per well in 96 well round bottom plates. 
For the generation of human DCs, peripheral blood mononuclear cells (PBMC) were isolated 
from buffy coats of healthy volunteer blood donors obtained from the blood donation center Zürich 
(ZHBSD) using Ficoll-PaqueTM (GE Healthcare). CD14+ monocytes were isolated from 
PBMCs using CD14 MicroBeads (Miltenyi Biotec) according to the manufacturer’s 
instructions and cultured in CellGro DC medium (Cellgenix) supplemented with 1000U/ml 






Induction and quantification of allergic asthma 
Ovalbumin model: Mice were sensitized by i.p. injection of 20µg ovalbumin (Sigma-Aldrich) 
emulsified in 2.25mg aluminum hydroxide (Alum Imject; Pierce) at 6 and 8 weeks of age. 
Sensitized mice were challenged with 1% aerosolized ovalbumin using an ultrasonic nebulizer 
(NE-U17; Omron) for 20 min daily on days 31, 32 and 33 post initial sensitization. For Treg 
transfer experiments, neonatally infected donor mice were sacrificed at the age of 5 weeks and 
Tregs were immunomagnetically isolated from MLN and Peyer’s Patches single cell 
suspensions (CD4+CD25+ mouse regulatory T cell isolation kit; R&D). 1x106 Tregs were 
injected per animal into sensitized wild type recipient mice one day before the first allergen 
challenge. House dust mite (HDM) model: Mice were sensitized by intranasal administration 
of 1µg HDM (Greer) at 6 weeks of age. Mice were challenged with 10µg HDM per animal on 
five consecutive days, starting on day 8 after sensitization. Anti-IL-18 antibody (YIGIF74-
1G7, BioXCell) was applied weekly (50µg per dose) starting at 7 days of age. After sacrifice, 
lungs were lavaged via the trachea with 1ml PBS. Bronchoalveolar lavage fluid (BALF) cells 
were counted using trypan blue dye exclusion. Differential eosinophil counts were performed 
on cytocentrifuged preparations stained with the Microscopy Hemacolor Set (Merck). Lungs 
were fixed by inflation and immersion in 10% formalin and embedded in paraffin. Tissue 
sections were stained with H&E and periodic acid-Schiff and examined in blinded fashion on 
a BX40 Olympus microscope. Peribronchial inflammation was scored on a scale from 0 to 4. 
PAS-positive goblet cells were quantified per 1mm of basement membrane. For lung re-
stimulation, single cell suspensions were prepared by collagenase 1A (Sigma Aldrich) 
digestion for 45min at 37°C. Cells were seeded at 5x105 cells per well and stimulated with 
250µg/ml ovalbumin for 3 days. Supernatants were analyzed for secretion of IL-5 by ELISA 
(eBioscience) according to the manufacturer’s instructions. For detection of HDM-specific 
IgE, plates were coated with 25µg/ml HDM antigen; HDM-bound IgE was detected using α-
mouse IgE-HRP (GTX77227, GeneTex). 
 
Western Blotting and ELISA of cell culture supernatants and extracts, and of gastric mucosal 
homogenates 
To detect proteins in cell culture supernatants, 500µl of supernatants were TCA-precipitated 
and subjected to Western blotting. Cell extracts and extracts of scraped and shock frozen 
murine gastric mucosa were prepared using RIPA-Buffer supplemented with protease 
inhibitors (complete Mini, Roche). For lysis of bacteria, 200µg/ml lysozyme (Sigma Aldrich) 
was added to the lysis buffer. For Lewis antigen detection, bacterial lysates were treated with 
125ng/ml Proteinase K (Macherey-Nagel) o/n. The following antibodies were used: α-Casp1 
p10/p45 (sc514, Santa Cruz), α-NLRP3 (ab91525, abcam), α-IL-1β (AF-401-NA, R&D 
Systems), α-actin (sc1616, Santa Cruz), α-GAPDH (G9545, Sigma Aldrich), α-H. pylori 
Urease (ab51954, abcam), α-LewisX (ab3358, abcam). Cytokines in gastric mucosal extracts 






1β and mouse IL-1β, both BD Biosciences; IL-18, eBioscience) according to the 
manufacturers’ instructions.  
 
 
Real time qRT-PCR of cytokines in cell extracts and gastric mucosal homogenates 
For real-time RT-PCR of shock frozen stomach mucosa or BMDC cell pellets, total RNA was 
isolated using NucleoSpin RNA II kits (Macherey-Nagel). For isolation of RNA from splenic 
DCs, the RNeasy microkit (Qiagen) was used. RNA was reversely transcribed into cDNA 
using superscript III (Invitrogen). The corresponding cDNA served as a template for real-time 
PCR performed using the LightCycler 480 SYBR Green I master kit (Roche). Samples were 
normalized to GAPDH expression (conditions: Tm 60°C, 50 cycles; primers: GAPDH fw: 5’-
GAC ATT GTT GCC ATC AAC GAC C-3’ / GAPDH rv: 5’-CCC GTT GAT GAC CAG 
CTT CC-3’, pro-IL-1β fw: 5’-TTG ACG GAC CCC AAA AGA TG-3’ / pro-IL-1β rv: 5’-
TGG ACA GCC CAG GTC AAA-3’, NLRP3 fw: 5’-CCC TTG GAG ACA CAG GAC TC-
3’ / NLRP3 rv: 5’-GGT GAG GCT GCA GTT GTC TA-3’, IFNγ fw: 5’-ATC TGG AGG 
AAC TGG CAA AA-3’ / IFNγ rv:  5’-TTC AAG ACT TCA AAG AGT CTG AGG TA-3’, 
AIM2 fw: 5’-CAG GCA ATT GCA TCT GAG AG-3’ / AIM2 rv: 5’-CGC CTC ACA AAG 
ATT TTC ACT-3’, NLRC4 fw: 5’-GAA GAA TCC TGT GAT CTC CAA GAG-3’ / NLRC4 
rv: 5’-GAT CAA ATT GTG AAG ATT CTG TGC-3’). 
 
 
Single cell preparations of MLN and Peyer’s patches and FACS staining 
Single cell suspensions of MLNs and Peyer’s patches were prepared by collagenaseIV (Sigma 
Aldrich) digestion for 25min at 37°C. For detection of intracellular cytokines, cells were 
seeded at 2x105 cells per well and treated with 100nM PMA (Sigma Aldrich), 1µg/ml 
Ionomycin (Sigma Aldrich) and 2µg/ml Monensin (Enzo LifeScience) for 4h. Fixation and 
permeabilization was performed with the Cytofix/CytopermTM Kit (BD Bioscience). The 
following antibodies were used for staining: CD4-FITC (RM4-5, Biolegend), CD25-Biotin 
(MAGM208, PartNo 860126, R&D), Streptavidin-eFluor450 (48-4317-82, eBioscience), 
IFNγ-PECy7 (XMG1.2, BD Biosciences), IL-17-APC (TC11-18H10.1, Biolegend) and 
FoxP3-APC (FJK-16s, eBioscience). 
 
 
Cloning, expression and purification of recombinant proteins 
UreaseA and UreaseB gene were amplified from bacterial genomic DNA using pfu-DNA 
polymerase (ThermoScientific) with the following primers: UreA fw: 5’-ATA TGA ATT 
CTT AAT TCT CCT TAA TTG TTT TT-3’, UreA rv: 5’- ATA TGG ATC CAA ACT CAC 
CCC AAA AGA-3’, UreB fw: 5’- ATA TGT CGA CCG AAC ACA TGG TAA GTT T-3’, 
UreB rv: 5’- ATA TGA ATT CAA AAA GAT TAG CAG AAA AGA-3’. Amplified 
fragments were inserted into the pGEX-4T-1 plasmid (GE Healthcare) using BamHI and 
EcoRI restriction sites for UreaseA and SalI and EcoRI restriction sites for UreaseB (all 






of the resulting plasmids, positive clones were transformed into E. coli BL21. Induction of 
overexpression of the GST-tagged proteins was done by the addition of 1mM IPTG. Bacterial 
cells were homogenized by sonication and precleared lysates were applied to GST GraviTrap 
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Đells  iŶ  all  gastroiŶtestiŶal  tissues  reƋuires  ĐellͲiŶtriŶsiĐ E>RWϯ eǆpressioŶ duriŶg  iŶfeĐtioŶ  aŶd  steadǇ 
state. CDϭϭď+ deŶdritiĐ Đells haǀe regulatorǇ aĐtiǀitǇ iŶ the ĐoŶteǆt of H. pylori iŶfeĐtioŶ aŶd produĐe I>Ͳ
ϭϬ upoŶ ĐoŶtaĐt ǁith ďaĐteria. ATFϯͲdepeŶdeŶt CDϭϬϯ+ DC liŶeages oŶ the other haŶd Ͳdespite their 
laĐk of direĐt ďaĐterial  ĐoŶtaĐtͲ are striĐtlǇ  reƋuired  for  loĐal Thϭ Đell eǆpaŶsioŶ aŶd H. pylori  ĐoŶtrol. 
HuŵaŶized ŵiĐe reĐoŶstituted ǁith huŵaŶ heŵatopoietiĐ steŵ Đells reĐapitulate seǀeral features of the 
















MoŶoŶuĐlear  phagoĐǇtes  ;MWsͿ  residiŶg  iŶ  the  laŵiŶa  propria  ;>WͿ  of  the  gastroiŶtestiŶal  ;GIͿ  traĐt 
ĐoŶtriďute ĐritiĐallǇ to the ĐoŶtrol of iŶǀadiŶg pathogeŶs aŶd the deǀelopŵeŶt of iŵŵuŶitǇ, as ǁell as the 




eǆpressioŶ  of  surfaĐe  ŵarkers  aŶd  liŶeageͲdefiŶiŶg  traŶsĐriptioŶ  faĐtors,  aŶd  their  fuŶĐtioŶal 
speĐializatioŶ, little is kŶoǁŶ aďout MWs residiŶg iŶ the gastriĐ laŵiŶa propria. IŶ the iŶtestiŶes, MWs are 









as  ǁell  as  the  traŶsĐriptioŶ  faĐtors  EotĐhͲϮ  ;ϱͿ  aŶd  IRFϰ  ;ϲͿ  for  deǀelopŵeŶt.  CDϭϬϯ+CDϭϭďͲ  DCs  iŶ 
ĐoŶtrast  reƋuire  the  ďasiĐ  leuĐiŶe  zipper  traŶsĐriptioŶ  faĐtor  ATFͲlike  ;ATFͿϯ  aŶd  IRFϴ  ;ϳͿ.  oth  >W 
deŶdritiĐ Đell suďsets haǀe lǇŵph Ŷode ĐouŶterparts iŶ the forŵ of CDϭϭď+ aŶd CDϴ?+ DCs that share the 
reliaŶĐe oŶ IRFϰͬEotĐhͲϮ aŶd IRFϴͬATFϯ, respeĐtiǀelǇ. FuŶĐtioŶallǇ, IRFϴͬATFϯͲdepeŶdeŶt populatioŶs 




















ĐoŵpletelǇ  ;ϭϲ,  ϭϳͿ.  Rather,  the  large  ƋuaŶtities  of  IFEͲ?  produĐed  ďǇ H.  pyloriͲspeĐifiĐ  Thϭ  Đells  are 














































iŶfeĐtioŶ.  To  address  these  ƋuestioŶs, ǁe  perforŵed  a  detailed  parallel  aŶalǇsis  of  the  gastriĐ,  sŵall 









ĐoloŶ aŶd  stoŵaĐh  that ǁere Ŷot  shared ďǇ  the SI:  iŶ partiĐular, ŵaĐrophage aŶd CDϭϬϯ+ CDϭϭď+ DC 
populatioŶs iŶĐrease steadilǇ iŶ the first ǁeeks of life, aŶd ĐoŶtraĐt agaiŶ at or ũust after ǁeaŶiŶg ;Figure 





















CDϭϬϯ+CDϭϭď+ DCs,  CDϭϭď+  DCs, ŵaĐrophages  aŶd ŵoŶoĐǇtes ǁere  reĐruited  as ǁell,  ďut  reaĐhed  a 
plateau  alreadǇ  after  ϭ  ŵoŶth  post  iŶfeĐtioŶ  ;Figure  ϮͿ.  The  reĐruitŵeŶt  of  MHCII+  aŶd  MHCIIͲ 
ŵoŶoĐǇtes, aŶd of ŵaĐrophages aŶd DC liŶeages to the ĐhroŶiĐallǇ iŶfeĐted stoŵaĐh depeŶded stroŶglǇ 






















To  address ǁhiĐh of  the ŵǇeloid  Đells  that ŵaǇ poteŶtiallǇ  eŶĐouŶter H.  pylori  iŶ  the  gastriĐ ŵuĐosa 
phagoĐǇtose aŶd saŵple the ďaĐteria, ǁe geŶerated ŵouseͲĐoloŶiziŶg H. pylori straiŶs eǆpressiŶg either 
GFW or RFW. oth fluoresĐeŶt proteiŶs ǁere eǆpressed, Đould ďe deteĐted ďǇ FACS iŶside Đultured ďoŶe 








ϯ,CͿ.  IŶfeĐtioŶ  of  yϯZϭͲGFW  reporter  ŵiĐe,  iŶ  ǁhiĐh  GFW  is  eǆpressed  iŶ  all  CXϯCRϭͲpositiǀe  Đells, 
ĐoŶfirŵed  that  the  RFW  sigŶal ǁas  restriĐted  to yϯZϭͲGFWhi FϰͬϴϬhi ŵaĐrophages,  CDϭϭď+  CXϯCRϭdiŵ 
FϰͬϴϬͲ DCs aŶd CXϯCRϭdiŵ ŵoŶoĐǇtes ;Figure ϯD aŶd data Ŷot shoǁŶͿ. A siŵilar distriďutioŶ of RFW sigŶal, 














lǇŵphoid  eŶgraftŵeŶt  ďoth  iŶ  the  spleeŶ  aŶd  the  GI  traĐt  laŵiŶa  propria  ;data  Ŷot  shoǁŶͿ.  HaǀiŶg 
reĐeŶtlǇ deǀeloped RagϮͲdefiĐieŶt,  IlϮR?ͲdefiĐieŶt huŵaŶized ŵiĐe eǆpressiŶg huŵaŶ ĐǇtokiŶes ĐeŶtral 









of  the populatioŶ upoŶ  iŶfeĐtioŶ  ;Figure ϰDͿ,  suggestiŶg  that huŵaŶ ŵoŶoŶuĐlear phagoĐǇtes  iŶdeed 
deǀelop ŶorŵallǇ aŶd aĐƋuire Đoŵparaďle effeĐtor fuŶĐtioŶs iŶ ŵuriŶe hosts. Although tǁo ŵaũor huŵaŶ 
DC  populatioŶs  ʹCDϭĐ+  DCs  aŶd  CDϭϰϭ+  DCsͲ  ǁere  deteĐtaďle  iŶ  the  gastriĐ  >W,  their  Ŷuŵďers  aŶd 







deteĐt  differeŶĐes  iŶ  ĐoloŶizatioŶ  leǀels  iŶ  reĐoŶstituted  relatiǀe  to  ŶoŶͲreĐoŶstituted  MISTRG  ŵiĐe 
;Figure ϰE aŶd data Ŷot shoǁŶͿ. IŶ suŵŵarǇ, MISTRG ŵiĐe are highlǇ perŵissiǀe to huŵaŶ ŵǇeloid Đell 
eŶgraftŵeŶt iŶ the gastriĐ >W; the reĐruitŵeŶt of phagoĐǇtes to the iŶfeĐted ŵuĐosa, aŶd their saŵpliŶg 







these  faĐtors  iŶ  gastriĐ  >W MW  liŶeages. We  first  surǀeǇed  T>RϮ  aŶd E>RWϯ  eǆpressioŶ  iŶ  ǀarious MW 




also  oŶ  the  surfaĐe  of  MHCIIͲ  ŵoŶoĐǇtes  aŶd  CDϭϬϯ+CDϭϭď+  DCs  aŶd  high  eǆpressioŶ  oŶ  MHCII+ 












I>ͲϭϬ;  Figure  ϱEͿ;  the  saŵe  sigŶature  ĐaŶ  ďe  deteĐted  iŶ  sorted ŵaĐrophages  aŶd  CDϭϭď+  DCs  froŵ 
iŶfeĐted relatiǀe to uŶiŶfeĐted ŵiĐe, eǀeŶ if RFW is Ŷot used as a ŵarker for sortiŶg ;suppl. Figure ϯͿ. Eo 
differeŶĐes  iŶ  T>RϮ eǆpressioŶ ǁere oďserǀed upoŶ  iŶfeĐtioŶ  iŶ MW populatioŶs of ŵeseŶteriĐ  lǇŵph 
Ŷodes ;Figure ϱFͿ, ǁhere T>RϮ positiǀitǇ ǁas also geŶerallǇ ŵuĐh loǁer, iŶdiĐatiŶg that the eǆpressioŶ aŶd 
























H.  pylori  ĐoloŶizatioŶ  leǀels  iŶ  the  kŶoĐkͲout  straiŶ  ;Figure  ϲDͿ.  To  address  ǁhether  the  E>RWϯ 
depeŶdeŶĐe of CDϭϭď+ DC differeŶtiatioŶ ǁas eǀideŶt Ŷot oŶlǇ duriŶg iŶfeĐtioŶ, ďut also iŶ the steadǇ 
state aŶd iŶ other gastroiŶtestiŶal tissues, ǁe Đoŵpared the freƋueŶĐies of CDϭϭď+ DCs ;Figure ϲEͿ aŶd of 






iŵportaŶt  thaŶ ŵiĐroďial  E>RWϯ  ligaŶds  iŶ  proŵotiŶg  the  differeŶtiatioŶ  of  CDϭϭď+  DCs.  To  address 





CDϭϭď+  DC  differeŶtiatioŶ  for  E>RWϯ ŵight  eǆteŶd  to  T>RϮ.  Although  T>RϮͲͬͲ ŵiĐe  eǆhiďited  siŵilarlǇ 
eleǀated gastriĐ >W Thϭ respoŶses ;Figure ϲH,IͿ aŶd the ĐoŶĐoŵitaŶt reduĐed ĐoloŶizatioŶ leǀels ;Figure 

















































reported  preǀiouslǇ  ;ϭϲͿ  oŶlǇ  the  eǆposure  of  adult  ŵiĐe  results  iŶ  stroŶg  TͲĐell  iŶfiltratioŶ  aŶd  a 















eǀeŶ  if  theǇ  laĐk  CCRϮ.  This  fiŶdiŶg  is  iŶ  agreeŵeŶt  ǁith  preǀious  reports  shoǁiŶg  that  >ǇϲChiCCRϮ+ 
ŵoŶoĐǇtes giǀe rise to ŵaĐrophages aŶd CǆϯCRϭdiŵ CDϭϭď+ MWs iŶ ďoth healthǇ aŶd iŶflaŵed ĐoloŶ iŶ a 
proĐess  that  iŶǀolǀes  doǁŶregulatioŶ  of  >ǇϲC,  aŶd  upregulatioŶ  of  MHCII,  CDϭϭĐ,  CXϯCRϭ  aŶd  ;iŶ 
ŵaĐrophagesͿ FϰͬϴϬ aŶd CDϲϰ ;ϵͿ, ǁhereas the tǁo CDϭϬϯ+ DC suďsets arise froŵ Fltϯ>ͲdepeŶdeŶt preͲ
DC  progeŶitors  that  Ŷeither  eǆpress  Ŷor  reƋuire  CCRϮ  ;Ϯϲ,  ϮϳͿ.  aiŶ  et  al  further  raise  the  iŶtriguiŶg 
possiďilitǇ that CǆϯCRϭdiŵ CDϭϭď+ MWs represeŶt aŶ iŶterŵediate Đell tǇpe iŶ arrested deǀelopŵeŶt uŶder 
ĐoŶditioŶs of iŶflaŵŵatioŶ ;ϵͿ. This ǀieǁ is ĐhalleŶged ďǇ geŶetiĐ traĐiŶg eǆperiŵeŶts liŶkiŶg CDϭϭď+ DCs 











MW  populatioŶs,  either  loĐallǇ  iŶ  the  iŶfeĐted ŵuĐosa,  or  iŶ  the  draiŶiŶg  lǇŵph  Ŷodes;  our  data  are 
reŵiŶisĐeŶt of a reĐeŶt report deŵoŶstratiŶg traŶsfer of ;fedͿ aŶtigeŶs froŵ iŶtestiŶal CXϯCRϭͲpositiǀe 
ŵaĐrophages to CDϭϬϯ+ DCs iŶ ŵodels of oral toleraŶĐe ;ϮϵͿ. The ďaĐteriallǇ deriǀed RFW sigŶal further 















thus  are  uŶlikelǇ  to  serǀe  as  iŵportaŶt  sourĐes  of  iŶflaŵŵasoŵeͲdepeŶdeŶt  ĐǇtokiŶes.  As  the 
T>RϮͬE>RWϯͬĐaspaseͲϭͬI>Ͳϭϴ aǆis is reƋuired for tolerogeŶiĐ respoŶses to H. pylori, ďut Ŷot for iŵŵuŶitǇ 





of  iŶflaŵŵasoŵe  aĐtiǀatioŶ  ĐurreŶtlǇ  reŵaiŶs  uŶĐlear.  It  ǁill  ďe  of  iŶterest  to  iŶǀestigate  ǁhether 
ŵiĐroďial or hostͲderiǀed WAMWs or DAMWs serǀe as sigŶals for CDϭϭď+ DC differeŶtiatioŶ iŶ tissues; our 
preliŵiŶarǇ  data  oďtaiŶed  iŶ  aŶtiďiotiĐͲtreated  ŵiĐe  iŶdiĐate  that  ŵiĐroďial  stiŵuli  are  Ŷot  the 
predoŵiŶaŶt sourĐe of E>RWϯ aĐtiǀatioŶ.  Also, it ǁill ďe iŶterestiŶg to see ǁhether CDϭϭď+ DCs at other 









































ŵaiŶtaiŶed uŶder speĐifiĐ pathogeŶʹfree ĐoŶditioŶs  iŶ aĐĐredited aŶiŵal  faĐilities at  the UŶiǀersitǇ of 
ZüriĐh. All aŶiŵal eǆperiŵeŶtatioŶ ǁas reǀieǁed aŶd approǀed ďǇ the ZüriĐh CaŶtoŶal seteriŶarǇ OffiĐe 






Đells per doŶor ;puritǇ хϵϬйͿ aŶd ǁere stored  iŶ  liƋuid ŶitrogeŶ uŶtil use. MiĐe ǁere  iŶfeĐted ǁith H. 
pylori  ϰ  ǁeeks  after  reĐoŶstitutioŶ  aŶd  aŶalǇsed  ϰ ǁeeks  later.  For  the  depletioŶ  of  gut  ĐoŵŵeŶsal 
ŵiĐroďiota, aŶiŵals ǁere giǀeŶ aŵpiĐilliŶ ;ϭരgരlоϭ; SigŵaͿ, ǀaŶĐoŵǇĐiŶ ;ϱϬϬരŵgരlоϭ; AppliĐheŵͿ, ŶeoŵǇĐiŶ 










































phorďol  ϭϮͲŵǇristate  ϭϯͲaĐetate  aŶd  ϭരʅM  ioŶoŵǇĐiŶ  ǁith  ϭ:ϭ,ϬϬϬ  refeldiŶ  A  ;eiosĐieŶĐeͿ  aŶd 
GolgiStop  solutioŶs  ;D iosĐieŶĐesͿ  at  ϯϳരΣC  iŶ  a  huŵidified  iŶ  a  huŵidified  iŶĐuďator ǁith  ϱй COϮ. 














AGC  CAC  ATG  CTC  CTA  GAͲϯ͛  ͬ  I>ͲϭϬ  rǀ:  ϱ͛ͲTGT  CCA  GCT  GGT  CCT  TTG  TT  Ͳϯ͛;  Tŵ  ϲϬΣC,  ϱϬ  ĐǇĐlesͿ 



















This  ǁork  ǁas  supported  ďǇ  the  Sǁiss  EatioŶal  SĐieŶĐe  FouŶdatioŶ  TeŵporarǇ  aĐkup  SĐheŵes 
CoŶsolidator  GraŶt  SCGIOͺϭϱϳϴϰϭͬϭ  to  A.M.  aŶd  the  ĐliŶiĐal  researĐh  prioritǇ  prograŵ  oŶ  HuŵaŶ 
HeŵatoͲ>ǇŵphatiĐ Diseases, UŶiǀersitǇ  of  ZuriĐh. We  thaŶk  all ŵeŵďers  of  the Müller  laď  as ǁell  as 












































CDϭϬϯ;ͲͿ  deŶdritiĐ  Đells  ŵigrate  iŶ  lǇŵph  aŶd  priŵe  effeĐtor  T  Đells.  DƵĐoƐal  /ŵŵƵŶol. 
ϮϬϭϯ;ϲ;ϭͿ:ϭϬϰͲϭϯ. 
ϭϭ.  SĐott C>, aiŶ CC, Wright W, SiĐhieŶ D, KotarskǇ K, WerssoŶ EK, >uda K, Guilliaŵs M, >aŵďreĐht 

































ϮϮ.  EŶgler  D,  >eoŶardi  I,  HartuŶg  M>,  KǇďurz  A,  Spath  S,  eĐher  ,  Rogler  G,  aŶd  Muller  A. 
HeliĐoďaĐter pǇloriͲspeĐifiĐ proteĐtioŶ agaiŶst  iŶflaŵŵatorǇ ďoǁel disease reƋuires the E>RWϯ 
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Ϯϯ.  RoŶgǀauǆ A, WilliŶger  T, MartiŶek  :,  Stroǁig  T, GeartǇ  Ss,  TeiĐhŵaŶŶ  >>,  Saito  z, MarĐhes  F, 



















ũuŶĐtioŶ  traŶsfer  of  fed  aŶtigeŶs  froŵ  CXϯCRϭ;+Ϳ  ŵaĐrophages  to  CDϭϬϯ;+Ϳ  deŶdritiĐ  Đells. 
/ŵŵƵŶity. ϮϬϭϰ;ϰϬ;ϮͿ:ϮϰϴͲϲϭ. 
ϯϬ.  EŶgler D, Reuter S, ǀaŶ WiũĐk z, UrďaŶ S, KǇďurz A, MaǆeiŶer :, MartiŶ H, zogeǀ E, WaisŵaŶ A, 


















Raatgeep HC, CeroǀiĐ s, et al. ColoŶiĐ  toleraŶĐe deǀelops  iŶ  the  iliaĐ  lǇŵph Ŷodes aŶd ĐaŶ ďe 
estaďlished iŶdepeŶdeŶt of CDϭϬϯ;+Ϳ deŶdritiĐ Đells. DƵĐoƐal /ŵŵƵŶol. ϮϬϭϲ;ϵ;ϰͿ:ϴϵϰͲϵϬϲ. 
ϯϱ.  Diehl  GE,  >oŶgŵaŶ  RS,  ZhaŶg  :X,  reart  ,  GalaŶ  C,  Cuesta  A,  SĐhǁaď  SR,  aŶd  >ittŵaŶ  DR. 

































froŵ  the  >W  of  stoŵaĐh,  sŵall  iŶtestiŶe  aŶd  ĐoloŶ  at  the  iŶdiĐated  age  aŶd  aŶalǇzed  ďǇ  floǁ  ĐǇtoŵetrǇ.    ;Ϳ 
























shoǁŶ.  ;'Ϳ H.  pylori  ĐoloŶizatioŶ  of  the ŵiĐe  shoǁŶ  iŶ  AͲF,  represeŶted  as  CFU  per  stoŵaĐh.  Data  iŶ  CͲG  are 
represeŶtatiǀe of Ϯ iŶdepeŶdeŶtlǇ ĐoŶduĐted tiŵe Đourses. ;,͕ /Ϳ Adult WT ŵiĐe ǁere reĐoŶstituted ǁith ϭ:ϭ ŵiǆed 
ďoŶe ŵarroǁ froŵ CDϰϱ.ϭ+ WT aŶd CDϰϱ.Ϯ+ CCRϮͲͬͲ doŶors. MiĐe ǁere alloǁed to reĐoŶstitute for siǆ ǁeeks prior 


























































































































































































^uƉƉl͘  &igure  3͘  CD11ď+  DCs  and  ŵaĐroƉŚages  resƉond  to  H͘  pylori  in  tŚe  gastriĐ  laŵina  ƉroƉria͘  


























































































































































































































































































































































































































ma	 104,168.	 In	DCs,	β-catenin	 can	be	activated	by	 several	 pathways.	One	of	 them	 is	















activation	of	β-catenin	 leads	 to	 its	 stabilization,	 the	protein	 level	 of	β-catenin	was	
studied	after	H.	pylori	 infection	by	means	of	Western	Blotting.	To	this	end,	BMDCs	
were	cocultured	with	wt-	or	ureaseB-deficient	H.	pylori.	The	results	showed	that	β-
catenin	 stabilizes	 after	 H.	 pylori	 infection,	 and	 this	 stabilization	 is	 at	 least	 partly	




infection	 is	 TLR2-mediated	 and	 β-catenin-dependent	 in	 DCs.	 Therefore	 CD11c+	
spleen	DCs	either	from	wt	or	TLR2-/-	mice	were	cocultured	with	H.	pylori	and	the	IL-
10	 expression	 was	 evaluated	 by	 RT-qPCR.	 In	 line	 with	 their	 reduced	 β-catenin	
signaling,	also	the	IL-10	expression	was	diminished	in	spleen	DCs	of	TRL2-/-	mice	(Fig-
ure	14F)	suggesting	that	β-catenin	signaling	might	be	part	of	the	pathway	activating	
IL-10	during	H.	pylori	 infection	of	DCs.	β-catenin	signaling	 is	known	to	 induce	 IL-10	
expression	in	DCs	after	exposure	to	various	stimuli	such	as	TGF-β	receptor,	WNT	or	





































β-catenin	 is	 known	 to	 promote	 intestinal	 DC	 tolerogenic	 activities	 in	 steady	 state.	
Less	is	known	about	the	role	of	β-catenin	in	gastric	DCs.	We	assessed	the	role	of	β-
catenin	in	CD11c+	cells	in	the	stomach,	first	focusing	on	its	role	in	controlling	H.	pylo-
ri	 colonization.	 We	 observed	 an	 H.	 pylori-mediated	 induction	 of	 β-catenin	
stabilization	 -	 and	 IL-10	 transcription	 in	 vitro,	which	points	 in	 the	direction	 that	β-




































































(Figure	16A).	As	expected	a	generally	 lower	colonization	 level	was	observed	 in	 the	
adult	infected	mice	after	one	month	of	infection	compared	to	the	neonatally	infect-
ed	mice.	 From	 previous	 studies	 we	 know	 that	 reduced	 colonization	 correlates	 in-
versely	 with	 the	 inflammation	 of	 the	 stomach,	 characterized	 by	 an	 increased	 TH1	
response.	 Therefore,	 we	 expected	 in	 the	 knockout	 mice,	 which	 show	 a	 reduced	
colonization,	an	accompanying	increase	in	IFN-γ	expression,	with	the	most	conspicu-
ous	differences	in	adult	infected	mice.	As	the	neonatal	tolerogenic	phenotype	leads	
to	 a	much	 lower	 T	 cell	 infiltration	 in	 the	 gastric	 LP	 compared	 to	 the	 adult	 LP,	we	
analyzed	 the	 IFN-γ	 expression	 with	 two	 different	 readouts.	 In	 neonatally	 infected	






























Figure	16:	β -catenin	signaling	 in	CD11c+	cells	plays	no	essential	 role	 in	controlling	TH1	re-
sponses	and	H.	pylori	colonization	in	the	gastric	mucosa	of	infected	mice	
β-cateninDCfl/fl,	 β-cateninDCfl/-	 and	 β-cateninDC-/-	 mice	 were	 infected	 with	 RFP-expressing	H.	
pylori	(PMSS1)	strain	at	six	to	seven	days	of	age	(grey	dots;	iN)	or	at	the	age	of	four	weeks	



































































































































































































































































we	wanted	to	address	 if	β-catenin	signaling	 is	 important	 in	 these	cells	 to	phagocy-





















































β-cateninDC-/-,	β-cateninDC-/fl	 and	 cre-	 littermates	were	 neonatally	 infected	with	H.	 pylori	 expressing	
RFP	 for	 one	month.	 RFP-positive	 signal	 was	 assessed	 by	 flow	 cytometry	 analysis	 in	 lamina	 propria	











































































































































































































































































































































































































in	 CD11c+	 cells	 during	H.	 pylori-mediated	 asthma	 protection.	β-cateninDC-/-	mice	β-
cateninDC-/fl	 and	 their	 cre-negative	 littermates	 were	 infected	 as	 neonates	 and	
sensitized	intranasally	with	house	dust	mite	(HDM)	extract	at	the	age	of	four	weeks	




ogy.	β-cateninDC-/-	mice	 are	 less	well	 protected	 compared	 to	 their	 cre-negative	 lit-
termates	and	their	β-cateninDCfl/-	littermates.	This	 is	 indicated	in	a	slightly	increased	
lung	 inflammation	 score	 (Figure	 18A)	 and	 goblet	 cell	metaplasia	 as	 determined	by	
PAS	staining	of	lung	sections	(Figure	18B).	Figure	18	C	and	D	done	in	separate	exper-
iments	show	that	β-cateninDC-/-	mice	induce	symptoms	of	allergic	asthma	after	sensi-





















































































































































































Figure	 18:	 β -catenin	 signaling	 in	 CD11c+	 cells	 contributes	 to	 H.	 pylori-induced	 allergic	
asthma	protection		
β-cateninDC-/-,	 β-cateninDCfl/-	 and	 wt	 littermate	 mice	 were	 neonatally	 infected	 with	 H.	 pylori	 and	
sensitized	 four	weeks	 after	 infection	 intranasally	with	house	dust	mite	 (HDM)	 allergen.	 Two	weeks	




























croaerophilic	 conditions.	 For	 in	 vitro	 infection	 H.	 Pylori	 was	 cultured	 for	 6hrs	 or	
overnight	for	in	vivo	infection.	The	Δurease	H.	pylori	mutant	was	cultured	on	plates	
and	 in	 liquid	 culture	 supplemented	 additionally	with	 25μg/ml	 of	 Chloramphenicol.	
Mice	 were	 infected	 intragastrically	 either	 on	 day	 7	 after	 birth	 or	 at	 the	 age	 of	 6	














tions	 were	 stained	 with	 H&E	 and	 periodic	 acid-Schiff	 and	 analyzed	 blindly	 with	 a	
BX40	Olympus	microscope.	Goblet	cell	metaplasia	was	quantified	as	the	number	of	




For	 the	 generation	 of	murine	 bone	marrow	 derived	 DCs	 (BMDCs),	 the	 femur	 and	
tibia	of	donor	mice	(C57BL/6,	TLR2-/-	and	β-CateninDC-/-)	were	flushed	with	full	RPMI	
medium	 (10%	 (vol/vol)	 FCS,	 100	 U/ml	 penicillin/streptomycin).	 Cells	 were	 treated	
with	red	cell	blood	lysis	buffer	(Roche)	for	1min,	the	reaction	was	stopped	with	RPMI	




For	 the	 isolation	of	 splenic	DCs,	 cell	 suspensions	were	prepared	by	digestion	using	
1mg/ml	CollagenaseD	and	0.1%	DNaseI	(both	from	Roche)	in	serum-free	RPMI	for	1h	
at	37°C.	Erythrocytes	were	 lysed	with	1ml	ACK	 lysis	buffer	for	2	min.	DCs	were	 im-
munomagnetically	 isolated	 using	 CD11c	MicroBeads	 (Miltenyi	 Biotec)	 according	 to	














with	10%	FCS	and	5	mM	EDTA	at	37°C.	To	digest	 the	stomach,	 it	was	 incubated	 in	
RPMI	 (10%	 FCS	 and	 100	 U/ml	 penicillin/streptomycin)	 supplemented	 with	 0.05	















0.1uM	 phorbol	 12-myriste	 13-acetate	 and	 1ul	 ionomycin	 with	 1:1000	 Brefeldin	 A	
(eBioscience)	and	GolgiStop	solution	for	3.5	hrs	at	37°C	with	5%	CO2.	After	the	stain-
ing,	 cells	 were	 fixed	 and	 permeabilized	 with	 Cytofix/Cytperm	 Fixa-
tion/Permeabilization	 Solution	 Kit	 following	 the	 manufacturer`s	 instruction.	 Cells	









um	 chloride,	 1%	NP-40,	 0.5%	 sodium	deoxycholate,	 0.1%	 SDS)	 supplemented	with	
2mM	sodium	orthovanadate,	15mM	sodium	pyrophosphate,	10mM	sodium	fluoride	
and	1X	complete	protease	inhibitor	cocktail	(Roche).	Samples	were	diluted	1:5	with	
loading	dye	and	heated	up	 to	90°C	 for	5min.	The	same	volume	of	 the	sample	was	
separated	 in	 an	 8%	 Tris-glycine	 SDS-Polyacrylamide	 gel	 followed	 by	 transfer	 onto	
nitrocellulose	 membranes.	 Membranes	 were	 probed	 with	 antibodies	 against	 β-









was	 used	 according	 to	 the	manufacturer’s	 instructions.	 	Samples	were	 diluted	 1:2	
using	assay	diluent.	Plates	were	analyzed	after	10-15	minutes	developing	time,	using	






kit	 (QIAGEN)	 according	 to	manufacture’s	 instructions.	 The	 RNA	 concentration	was	
determined	by	the	NanoDrop®	ND-1000	Spectrophotometer	(WITEC	AG)	and	adjust-
ed	to	1υg	RNA	per	sample.	Complementary	DNA	synthesis	was	performed	using	Su-
perScriptIII	 reverse	 transcriptase	 (Invitrogen)	 in	 a	 T3000	 Thermocycler	 (Biometra).	
Quantitative	 PCR	 reactions	 for	 the	 candidate	 genes	 were	 performed	 using	 either	
SYBER-Green	or	TaqMan	gene	expression	assay.	The	following	TaqMan	probes	were	
used:	 (Ifnγ	Mm01168134_m1,	 Il17a	Mm00439618_m1,	 Il10	Mm01288386_m1,	AX-
IN2	 Mm00443610_m1,	 HPRT	 Mm03024075_m1).	 SYBER	 Green	 primers	 are	 listed	














































































play	between	 immune	system,	microbiota	and	dietary	habits	179.	However,	 there	 is	





loid	cells	are	the	main	population	 in	the	gastric	mucosa	 in	steady	state,	which	 is	 in	
clear	contrast	to	the	colon	and	intestine,	where	lymphocytes	are	the	dominant	cell	
type.	 The	 gastric	 lamina	 propria	 is	 colonized	 with	 myeloid	 cells	 such	 as	 CD103+,	
CD11b+	DCs	and	macrophages,	which	decrease	from	neonatal	age	until	adult	age	 in	
steady	state.	One	week	after	birth	the	overall	amount	of	CD11b+	DCs	is	the	highest	
compared	 to	 all	 other	 cell	 types	 and	 decreases	 gradually	 afterwards.	 The	 same	 is	
true	 for	 the	 bona	 fide	 DCs	 three	 weeks	 after	 birth.	 At	 the	 time	 of	 weaning	 the	
amount	of	CD103+	DCs	decreases.	This	trend	stands	in	clear	contrast	to	the	myeloid	
compartment	of	the	small	intestine,	which	shows	a	gradual	increase	of	all	major	cell	
subsets.	 Overall,	 the	 colon	 and	 the	 gastric	 lamina	 propria	 show	many	 similarities	
except	the	development	of	CD11b+	DCs,	leading	to	the	hypothesis,	that	both	organs	
might	have	similar	functions	with	regard	to	their	immunologic	compartment.		
Several	studies	were	performed	mainly	 to	 identify	 the	tolerogenic	or	 inflammatory	
role	of	DCs	during	H.	pylori	infection,	but	did	not	focus	on	the	cell	composition	in	the	












of	 all	myeloid	 cells	 during	 infection.	 The	main	 incoming	 cells	 are	 lymphocytes	 fol-
lowed	 by	 neutrophils,	 macrophages,	 inflammatory	monocytes	 and	 the	 various	 DC	
subsets.	 In	 the	 adult	 infection	 model,	 these	 lymphocytes	 have	 a	 clear	 TH1	
polarization.	This	 goes	 in	 line	with	previous	 studies	 in	our	 lab,	 showing	 that	adult-
infected	mice	 induce	 a	 TH1	 response.	 In	 contrast,	 neonatally	 infected	mice	 fail	 to	
induce	a	TH1	response	and	rather	are	skewed	towards	Treg	differentiation.	This	dif-
ference	in	T	cell	differentiation	might	be	explained	by	the	fact	that	during	the	neona-








recruitment	 during	H.	 pylori	 infection,	 as	we	 could	 show	 in	 bone	marrow	 chimera	
experiments.	In	contrast	bona	fide	CD103+	DCs	do	not	rely	on	CCR2	and	are	present	
in	normal	 cell	 numbers	 in	 infected	mixed	chimera	mice.	 This	 leads	 to	 the	assump-
tion,	that	during	 inflammation,	Ly6ChiCX3CR1dim	monocytes,	resident	CX3CR1hi	mac-
rophages	 and	 CX3CR1dimCD11b+	 MPs	 are	 replenished	 by	 CCR2-dependent	 blood	
borne	Ly6Chi	monocytes,	which	enter	the	gastric	lamina	propria.	These	results	go	in	
line	with	previous	 studies	 in	 the	 intestine	 and	 colon	 66,183.	 Bain	et	 al.	 showed	 that	
also	in	the	colon	Ly6ChiCX3CR1dim	monocytes	and	CX3CR1hi	macrophages	are	replen-
ished	 by	 Ly6chi	 monocytes	 in	 a	 CCR2-dependent	 manner	 using	 a	 dextran-induced	















these	 cells	 in	 the	 gastric	mucosa	 exhibit	 properties	 of	bona	 fide	 DCs	 as	well	 as	 of	
macrophages.	Beside	this,	it	is	now	clear	that	some	bona	fide	CD11b+	DCs	are	able	to	







The	 gastrointestinal	 tract	 promotes	 the	 absorption	 of	 nutrients	 and	 allows	 the	
growth	of	commensals	but	at	 the	same	time	has	to	distinguish	them	from	harmful	
microorganisms.	 It	 is	 still	 a	 matter	 of	 discussion	 how	 antigen	 sampling	 pathways	
handle	 luminal	 antigens	 in	 the	 stomach	 and	 the	 intestine.	 It	 is	 now	well-accepted	
that	antigens	are	taken	up	by	specialized	microfold	cells	 in	the	Peyer`s	Patches	185.	
Several	papers	reported	that	CX3CR1-expressing	mononuclear	cells	are	able	to	form	
























macrophages	are	able	to	migrate	to	the	 lymph	nodes,	where	they	 induce	T	cell	 re-















cannot	detect	any	 live	bacteria	 in	 the	MLN	by	plating	even	under	conditions	when	
we	 detect	 a	 robust	 RFP	 signal	 in	 the	myeloid	 compartment	 of	 the	 stomach.	 Addi-
tionally,	a	technical	limitation	of	RFP-detection	in	MLN	cells	after	the	death	of	bacte-
ria	could	also	be	an	explanation.		
Until	 now,	 the	 importance	 of	 the	 CX3CR1-dependent	mechanism	 is	 still	 under	 de-
bate,	as	it	was	only	observed	in	the	duodenum	so	far	73.	However,	our	own	data	sug-
gest,	that	at	least	in	the	gastric	LP	CX3CR1	macrophages	are	able	to	take	up	H.	pylori.	






lori	 infection	 in	more	detail,	we	 are	 currently	 investigating	 the	phenotype	of	mice	
depleted	for	CD11c+CX3CR1+	cells	by	using	CD11cCre	x	CX3CR1Stop-DTR	mice.	In	the	
future	 we	 will	 also	 study	 the	 more	 specific	 depletion	 of	 macrophages	 by	 using	
LysMCre	or	CD64Cre	x	CX3CR1Stop-DTR	mice.		
To	sum	up,	we	could	show	that	H.	pylori	is	taken	up	by	CX3CR1hi	macrophages,	mon-








gating	 the	 transcriptional	 consequences	 for	 these	cells.	We	 focused	on	 IL-10,	TLR2	
and	 NLRP3	 expression.	 We	 and	 others	 could	 show	 that	 TLR2	 and	 NLRP3	 are	 im-
portant	 for	H.	 pylori	 detection	 and	 for	 the	 induction	 of	 a	 tolerogenic	 immune	 re-
sponse	 85,169,188.	 Specifically,	 we	 could	 show	 that	 the	 TLR2/NLRP3/IL-18	 axis	 is	 in-
duced	after	H.	pylori	infection	of	BMDCs,	leading	to	a	tolerogenic	phenotype	169.	This	
will	be	discussed	in	more	detail	in	the	next	chapter.	Additionally,	we	know	from	sev-






rophages	expressed	more	TLR2	and	NLPR3.	 In	 contrast	 to	CD11b+	DCs,	 the	expres-
sion	of	 TLR2	and	NLRP3	 in	CD103+	DCs,	which	do	not	 take	up	H.	pylori,	was	much	
lower	in	general	and	did	not	increase	after	infection.	We	hypothesized	based	on	the-
se	findings	that	the	contact	of	H.	pylori	leads	to	an	upregulation	of	TLR2/NLRP3	tran-
scription.	NLRP3	 and	 TLR2	 signaling	 are	 tightly	 linked	 to	 a	 tolerogenic	 immune	 re-
sponse	 during	 H.	 pylori	 infection.	 The	 combined	 results	 suggest	 that	 CD11b+	DCs	
favor	a	tolerogenic	immune	response	in	H.	pylori	infected	stomachs.	In	addition,	we	
found	this	cell	type	is	dominant	and	most	abundant	in	the	murine	gastric	LP	during	


















less	bacterial	colonization	 in	 the	gastric	mucosa,	supporting	the	tolerogenic	 role	of	
DC-specific	IL-10	signaling	190.	 In	contrast	to	the	sorted	DCs,	we	could	observe	a	re-
duction	 of	 IL-10	 transcripts	 in	 sorted	 RFP+	 CX3CR1hi	macrophages,	 suggesting	 a	 di-
minished	tolerogenic	function	after	H.	pylori	contact.	This	is	surprising,	as	we	know	
from	 literature	 that	 CX3CR1+	 macrophages	 regulate	 anergy	 during	 immune	
homeostasis	and	also	 inflammation	mainly	by	expressing	 IL-10.	 Further,	Bain	et	al.	
observed	 no	 significant	 changes	 in	 their	 transcription	 profiles	 during	 infection	 66.	






It	 is	known	that	 IL-18	signaling	 is	activated	upon	H.	pylori	 infection.	However,	for	a	
long	time	the	underlying	signaling	pathway	was	not	known.	To	this	end,	we	initially	
asked	 which	 pattern	 recognition	 receptor	 was	 able	 to	 induce	 caspase-1.	 Neither	
NLRC4,	NLRC6	nor	AIM2	were	required.	Only	NLRP3	and	ASC	were	essential.	 In	the	












of	 Salmonella	 Typhimurium	 and	Escherichia	 coli	 induced	 IL-1β	 by	 the	 activation	 of	
TLR2	and	NLRP3.	In	this	publication,	the	authors	studied	TLR2-induced	NLRP3	activa-
tion	 in	HEK	and	BMDM	cells.	 It	 suggests	 that	 this	pathway	 is	not	only	 restricted	to	
DCs	 in	 vitro	 193.	 This	 supports	our	 findings	of	 TLR2	and	NLRP3	upregulation	 in	DCs	
and	in	macrophages	upon	H.	pylori	encounter.	In	a	next	step	we	now	plan	to	investi-





pylori	 infection.	We	were	curious	to	know	which	bacterial	 factors	 induce	 IL-1β	and	
NLRP3	activation.	Therefore,	we	performed	a	screen	with	a	transposon	library	to	find	







terium	 194.	UreaseB	 can	be	 secreted	by	H.	pylori.	We	 consequently	 suggested	 that	
ureaseB	might	act	as	a	PAMP.	We	observed	that	only	ureaseB	but	not	A	was	able	to	










transcription	 of	 NLRP3	which	 elucidates	 that	 further	 factors	 are	 necessary	 for	 the	
assembly.	 Summarizing	 the	 literature,	 it	 seems	 that	H.	pylori	 infection	 induces	 the	













that	 CagA	might	 be	 important	 for	 NLRP3	 regulation,	 knowing	 that	 CagA	 interacts	
with	many	host	proteins	within	the	cell	to	regulate	growth,	morphology	and	motility	
198.	 If	we	 consider,	 that	more	 than	one	 factor	 induces	 the	assembly	of	 the	 inflam-
masome	it	might	be	of	interest	to	make	use	of	recombinant	proteins	to	analyze	the	
effect	more	in	detail.	





In	 the	 last	year,	 the	view	on	the	NLRP3	signaling	which	 favors	 the	secretion	of	 the	
cytokines	 IL-1β	 and	 IL-18	 as	 a	 sole	 pro-inflammatory	 mediator	 has	 changed.	 This	






al.	 identified	 IL-18	 as	 a	mediator	 regulating	 tolerogenic	 responses	 to	H.	 pylori	 141.	
Discussion	
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to	sense	diverse	danger	 signals,	 its	 functionality	and	 role	 in	MP	recruitment	 in	 the	
gastric	LP	is	poorly	investigated.	From	previous	studies	we	know	that	NLRP3	is	most-
ly	expressed	 in	macrophages	and	CD11b+	DCs	and	to	a	 lower	extent	 in	CD103+	DCs.	
To	further	investigate	NLRP3	function,	we	first	compared	the	MP	composition	in	wt	
and	 NLRP3-/-	mice.	 To	 our	 surprise,	 the	 NLRP3	 knockout	mice	 showed	 a	 defect	 in	
recruiting	 CD11b+	DCs	 in	 steady	 state	 and	 during	 H.	 pylori	 infection.	 By	 studying	
mixed	chimera	to	investigate	the	cell-intrinsic	requirement	of	NLRP3	during	H.	pylori	
infection,	 we	 observed	 a	 dependency	 of	 the	 CD11b+	DC	 differentiation	 on	 NLRP3	
expression	in	the	gastric	LP.	These	mice	are	characterized	by	a	reduced	colonization	










is	not	 caused	by	 the	absence	of	CD11b+	DCs.	As	we	know	 from	BDMC	studies	 that	
TLR2-deficient	cells	are	unable	to	produce	IL-10	we	could	in	the	next	step	investigate	













TH2	cells.	They	 identified	that	NLRP3	directly	binds	 IFR4	and	concomitantly	 induces	
IRF4	dependent	IL4	expression.	It	would	be	interesting	to	study	if	NLRP3	also	binds	
IRF4	 in	 CD11b+	 DCs.	 	 As	 IRF4	 is	 an	 essential	 transcription	 factor	 of	 CD11b+	DCs,	 a	
NLRP3	deficiency	might	 influence	the	differentiation	or	migration	of	CD11b+	DCs	as	







For	 the	 intestine,	 it	 is	 known	 that	 TLR2	 and	NLRP3	 have	 an	 additional	 function	 in	
epithelial	cells	by	regulating	the	barrier	function.	TLR2	and	NLRP3	are	important	for	
epithelial	 integrity	 in	 intestinal	 epithelial	 cells	 during	 colitis,	 which	 is	 disrupted	 in	
TLR2-	and	NLRP3-deficient	mice.	Moreover,	NLRP3	in	epithelial	cells	 is	essential	 for	
the	 protection	 against	 Citrobacter	 rodentium	 and	 subsequently	 the	 prevention	 of	
pathology	in	this	case	207,208.	As	we	made	use	of	whole	body	TLR2	and	NLRP3	knock-
out	mice,	we	might	have	caused	an	 imbalance	 in	the	barrier	 function,	which	might	
lead	to	a	dysregulation	of	the	TH1	response	in	the	gastric	mucosa	of	these	mice.	This	









































as	 cells	driving	 tolerogenic	 immune	 response	 in	 various	organs.	 Several	 studies	 re-
port	CD103+	DCs	in	the	gut	as	regulatory	mediators	by	providing	retinoic	acid	to	Treg	
cells	 leading	 to	 their	 induction	 35,212.	 CD103+	DCs	have	been	 reported	 to	 induce	de	
novo	 production	of	 Treg	 cells	 also	 in	 the	 spleen	 and	 lung	 38,213.	 These	 controversial	
results	together	suggest	a	high	plasticity	of	CD103+	DCs	at	least	in	the	gastrointesti-
nal	tract.	However,	the	observation	that	BATF3-dependent	CD103+	DCs	also	regulate	
immunity	 is	not	 limited	 to	 the	GI	 tract,	as	Furuhashi	et	al.	 showed	that	pulmonary	
CD103+	DCs	are	prone	to	prime	naïve	CD4	cells	towards	TH1/TH17	differentiation	214.	
These	 data	 are	 supported	 by	 an	 additional	 study,	 pointing	 out	 a	 high	 plasticity	 of	






























in	 DCs,	 either	 dependent	 or	 independent	 of	WNT	 is	 known	 to	 shape	 immune	 re-
sponses	 towards	 tolerance.	 Manoharan	 et	 al.	 reviled	 a	 TLR2	 induced	 β-catenin	
signaling	via	the	PI3K/AKT	pathway	promoting	vitamin	A	metabolism	and	IL-10	secre-
tion.	This	protected	the	mice	against	TH17/TH1-mediated	autoimmune	neuroinflam-
mation	 99,216.	 As	 TLR2	 is	 activated	 by	H.	 pylori	 secreted	 ureaseB,	we	 consequently	
wanted	 to	 study	 the	potential	 activation	of	β-catenin	upon	H.	pylori	 infection.	We	
observed	in	spleen	DCs	that	the	activation	of	β-catenin	target	genes	is	dependent	on	
TLR2	 receptor	 signaling.	 This	 goes	 in	 line	 with	 the	 literature,	 suggesting	 that	 β-
















significant,	we	 consequently	 suggest	 that	β-catenin	 is	 not	 exclusively	 activated	 via	
TLR2	signaling	in	spleen	DCs	upon	H.	pylori	 infection,	but	might	be	activated	by	dif-
ferent	pathways	as	discussed	in	the	following.	Beside	ureaseB	and	VacA,	also	CagA	is	
known	to	 induce	β-catenin	signaling	 independent	of	TLR2.	 In	the	context	of	gastric	
cancer	 it	 is	 known	 that	 CagA	 interacts	with	 E-cadherin	 and	 thereby	 inhibits	 the	β-
catenin/E-cadherin	interaction	in	gastric	cells	106.	This	leads	to	the	deregulation	of	β-




we	 could	 not	 observe	 that	 CagA	 is	 important	 for	 activating	 CyclinD1	 (data	 not	
shown),	arguing	that	this	might	be	an	epithelial	cell-specific	phenotype.		
One	possible	 signaling	 pathway	 that	 can	be	 studied	 in	DCs,	 and	 is	 independent	 of	
















IL-10	 signaling	 for	H.	 pylori-induced	 tolerogenic	 immune	 responses.	 Consequently,	
we	analyzed	the	IL-10	expression	in	BMDCs	of	TLR2-deficient	mice	and	mice	deficient	
for	β-catenin	 in	 CD11c+	cells	 after	H.	 pylori	 infection.	 IL-10	 signaling	 is	 strongly	 re-
duced	in	DCs	from	TLR2-deficient	mice	and	to	a	lesser	extent	in	β-catenin	deficient	
DCs.	 These	 results	 suggest	 that	 H.	 pylori	 infection	 induces	 IL-10	 signaling	 in	 DCs	
mainly	 via	 TLR2.	 It	 also	 points	 out	 that	 TLR2	 is	 able	 to	 induce	 IL-10	 synergistically	










We	 found	 that	 H.	 pylori	 exposure	 of	 DCs	 drives	 the	 TLR2-dependent	 and	 also	 -
independent	activation	of	β-catenin	 target	genes	 including	 IL-10.	We	consequently	
hypothesized	that	β-catenin	has	a	tolerogenic	function	in	DCs	in	vivo.	To	this	end,	we	
generated	mice	that	are	deficient	for	β-catenin	in	DCs	in	all	organs.	As	a	drawback	of	
this	model,	macrophages	 in	 the	gastrointestinal	 tract	 and	alveolar	macrophages	 in	
the	lung	also	express	high	levels	of	CD11c.	Therefore	we	could	not	rule	out	an	ectop-
ic	depletion	of	β-catenin	in	these	cells	as	well	221,222.	To	circumvent	this,	a	DC	specific	
Cre-	 strain	 such	as	FLT3	or	Zbtb46	should	be	used,	 to	nail	 the	phenotype	down	 to	
DCs.	We	first	studied	the	effect	of	β-catenin	on	the	colonization	level	of	H.	pylori	in	
the	stomach	mucosa.	As	expected,	we	observed	a	reduced	colonization	in	neonatally	
infected	and	slight	 reduction	 in	adult	 infected	mice.	This	observation	 is	underlined	
by	a	slightly	increased	IFN-γ	expression	in	the	stomach	mucosa	of	neonatally	infected	
β-catenin-deficient	mice.	In	the	adult	infection	we	did	not	observe	a	great	difference	








propria	 is	 locally	 shaping	 the	 inflammatory	 condition,	at	 least	 in	 the	neonatally	 in-






to	the	 literature,	showing	that	β-catenin	depletion	 leads	to	a	reduction	 in	 IL-10	se-
cretion	104.	However	it	also	underlines	the	complexity	of	IL-10	regulation	and	favors	
the	 controversial	 discussion	 still	 ongoing	 in	 literature.	 This	 suggests	 that	β-catenin	
might	have	a	negative	feedback	on	other	 IL-10	producing	cells,	as	for	 instance	TH1,	
TH2,	or	TH17	cells	189.	Another	observation	of	Cohen	et	al.	was	an	increased	IL-12	ex-





an	 intrinsic	 feedback	 loop	regulated	by	β-catenin	signaling.	The	only	difference	we	
observed	was	that	macrophages	of	mice	deficient	for	β-catenin	in	CD11c+	cells,	take	
up	slightly	less	H.	pylori.	If	this	is	a	direct	effect	of	the	depletion	of	β-catenin	in	these	
cells	or	a	bystander	effect	 from	DC	needs	 to	be	 further	 investigated	by	comparing	
the	expression	of	β-catenin	in	these	cell	populations.		
To	sum	up,	the	role	of	β-catenin	in	DCs	and	potentially	macrophages	during	H.	pylori	








Recently,	we	 and	others	 have	 shown	 that	DCs	 are	 essential	 for	 immune	 tolerance	
and	 to	 build	 up	 a	 TH2	 cell-driven	 airway	 inflammation	 164,224.	 Previous	 publications	




















infected	TLR2-/-	mice	are	not	able	 to	protect	 from	asthmatic	 symptoms.	 In	myeloid	
DCs	and	macrophages	MyD88,	 the	adapter	molecule	downstream	of	TLR2,	 induces	
IL-10	 expression	 230.	 Beside	 this	 IL-10	 can	 be	 regulated	 by	 several	 further	mecha-
nisms	like	DC-SIGN,	dectin1	or	as	discussed	above	via	β-catenin	231.	
We	also	started	to	elucidate	the	DC	subsets	regulating	the	IL-10	secretion	in	the	lung	
after	 H.	 pylori	 infection.	 We	 identified	 CD103+CD11b-	 DCs	 to	 be	 essential	 for	 an	











tial	macrophages	 169.	 In	 addition,	 the	 transfer	 of	 infected	 interstitial	macrophages	
into	 HDM-sensitized	mice	 would	 clarify	 if	 these	 cells	 were	 able	 to	 rescue	 asthma	
symptoms.	To	sum	up,	our	data	support	the	assumption	that	IL-10	signalling	in	DCs	is	
required	for	allergic	asthma	protection	conferred	by	 infection	and	also	by	H.	pylori	












ed	 with	 urease	 mutant	 H.	 pylori.	 This	 again	 indicates	 the	 importance	 of	 the	
TLR2/NLRP3/IL-18	pathway	for	an	H.	pylori-induced	tolerance,	by	priming	Treg	cells.	








pylori-infected	 versus	 Foxp3+	 cells	 from	MLNs	of	 uninfected	mice.	With	 the	use	of	
DNA	methylation	analysis	we	investigated	the	methylation	status	at	12	TSDR	regions.	









goes	 in	 line	with	 the	 literature,	as	 the	 role	of	Treg	 cells	 in	asthma	protection	 is	 still	
controversially	discussed,	and	some	publications	support	the	idea	that	asthma	pro-













cesses	 in	 allergic	 asthma.	 β-catenin	 signaling	 has	 immunosuppressive	 functions	
mainly	in	DCs,	preventing	the	induction	and	secretion	of	pro-inflammatory	cytokines	
and	 the	 subsequent	 airway	 inflammation	 238-240.	 We	 observed	 the	 H.	 pylori-
dependent	 activation	 of	β-catenin	 in	 vitro.	 Consequently,	we	wanted	 to	 study	 the	
role	 of	β-catenin	 in	 DCs	 during	H.	 pylori-induced	 allergic	 asthma	 protection.	Mice	
deficient	for	β−catenin	in	CD11c+	cells	were	not	protected	from	goblet	cell	metapla-
sia	and	 lung	 inflammation,	 two	hallmarks	of	allergic	asthma.	These	 results	 support	







and	 potentially	 also	macrophages	 during	H.	 pylori-induced	 allergic	 asthma	 protec-








We	 identified	 two	 immunomodulators	of	H.	pylori,	GGT	and	VacA,	which	are	both	




The	effect	of	GGT	might	be	 traced	back	 to	 the	general	 function	of	GGT	 to	convert	






thelial	cells	and	 is	known	to	 inhibit	TH1	responses	146,147.	These	data	go	 in	 line	with	
our	 experiments	 hinting	 towards	 an	 inhibition	 of	 Treg	 differentiation	 when	 co-
cultures	 of	 infected	 dendritic	 cells	 and	 T	 cells	were	 supplemented	with	 glutamine	
and	glutathione.	Käbisch	et	al.	recently	shed	light	into	the	molecular	mechanism	of	
GGT	on	human	dendritic	 cells.	 They	 reported	 that	 glutamate,	 the	product	 of	GGT,	
induces	DCs	by	inhibiting	cAMP	signaling	and	reducing	IL-6	secretion	in	response	to	


















The	 tolerogenic	 properties	 of	 VacA	 are	 further	 confirmed	 by	 the	 previously	 men-
tioned	DNA	methylation	of	the	TSD	region	in	the	Foxp3	locus.	We	observed	that	Va-
cA	treatment	increased	the	demethylation	of	the	regions	in	Foxp3+	cells	from	MLNs	
(manuscript	 Kyburz	et	al.,	 2017).	 This	might	 explain	one	 immunomodulatory	path-
way	how	VacA	favours	tolerogenicity	and	alleviates	asthma	symptoms.		
To	sum	up,	these	results	point	out	that	we	are	still	on	the	road	of	understanding	the	
complexity	 of	 this	 cellular	 interplay	 of	myeloid-	 but	 also	 other	 immune	 cells.	 This	
complexity	makes	us	aware	that	we	need	to	investigate	the	molecular	mechanisms	







































the	 stimuli	 they	 receive	 and	 the	 tissue	 they	 populate.	 It	 is	 known	 that	 H.	 pylori	
induces	 tolerogenic	 DCs,	 which	 favors	 bacterial	 persistence	 in	 the	 stomach.	 We	
could	 show,	 that	 this	 property	 is	 tightly	 linked	 to	 the	 protection	 against	 allergic	
asthma	247.	However,	not	much	more	was	known	about	the	role	of	DCs	in	the	gastric	
lamina	 propria.	 Here	we	 studied	 the	 function	 of	 DCs	 in	more	 detail	 during	 steady	
state	and	H.	pylori	infection	in	the	gastric	LP,	and	in	the	lung	during	allergic	asthma.		




ly	 upregulate	 NLRP3	 and	 TLR2	 expression.	 In	 contrast	 to	 tolerogenic	 CD11b+	DCs,	
CD103+	 DCs	 favor	 a	 TH1	 response	 in	 the	 gastric	 LP	 (manuscript	Arnold	et	 al.).	 This	
stands	in	contrast	to	our	findings	in	the	allergic	lung,	where	CD103+	DCs	are	infiltrat-





known	 regarding	 the	 cellular	 activation	 of	 IL-18	 in	 DCs	 during	H.	 pylori	 infection.	
Here	we	 identified	 the	urease	H.	pylori	 subunit	 ureaseB	as	 an	 immunosuppressive	




pylori	 infection	 and	 the	mechanism	of	 allergy	 protection.	 As	NLRP3	was	 shown	 to	
regulate	IRF4	expression	in	T	cells,	it	would	be	of	high	interest	to	follow	up	the	role	
of	NLRP3	in	IRF4-dependent	CD11b+	DCs	206.	Besides	it	would	be	of	interest	to	eluci-
date	 the	 role	of	macrophages	 as	we	observed	 that	macrophages	 take	up	H.	pylori	
and	therefore	might	also	represent	regulators	of	the	persistence.	In	addition,	it	was	
shown	that	 interstitial	macrophages	 in	 the	 lung	and	macrophages	 in	 the	gastric	 LP	








Taken	 together,	 with	 this	 work	 we	 gained	more	 insight	 into	 the	 division	 of	 labor	
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Objective Lymphotoxin β receptor (LTβR) signalling
has been implicated in inﬂammation-associated tumour
development in different tissues. We have analysed the
role of LTβR and alternative NF-κB signalling in
Helicobacter pylori-mediated gastric inﬂammation and
pathology.
Design We analysed several ligands and receptors of
the alternative NF-κB pathway, RelB, p52 nuclear
translocation and target genes in tissue samples of H.
pylori-infected patients with different degrees of gastritis
or early gastric tumours by in situ hybridisation,
immunohistochemistry, Western blot and real-time PCR
analyses. Molecular mechanisms involved in LTβR
activation by H. pylori were assessed in vitro using
human gastric cancer cell lines and distinct H. pylori
isolates. The effects of blocking or agonistically activating
LTβR on gastric pathology during challenge with a
human pathogenic H. pylori strain were studied in a
mouse model.
Results Among the tested candidates, LT was
signiﬁcantly increased and activated alternative NF-κB
signalling was observed in the gastric mucosa of H.
pylori-infected patients. H. pylori induced LTβR–ligand
expression in a type IV secretion system-dependent but
CagA-independent manner, resulting in activation of the
alternative NF-κB pathway, which was further enhanced
by blocking canonical NF-κB during infection. Blocking
LTβR signalling in vivo suppressed H. pylori-driven
gastritis, whereas LTβR activation in gastric epithelial cells
of infected mice induced a broadened pro-inﬂammatory
chemokine milieu, resulting in exacerbated pathology.
Conclusions LTβR-triggered activation of alternative NF-
κB signalling in gastric epithelial cells executes H. pylori-
induced chronic gastritis, representing a novel target to
restrict gastric inﬂammation and pathology elicited by H.
pylori, while exclusively targeting canonical NF-κB may
aggravate pathology by enhancing the alternative
pathway.
INTRODUCTION
Chronic gastritis induced by colonisation of the
gastric mucosa by Helicobacter pylori can progress
to atrophic gastritis, intestinal metaplasia, dysplasia
and ultimately to gastric carcinoma.1 The
pro-inﬂammatory environment triggered by the
Signiﬁcance of this study
What is already known on this subject?
▸ Activation of alternative NF-κB signalling
through Lymphotoxin β receptor (LTβR) has
been implicated in inﬂammation-driven tumour
development and progression in different
tissues.
▸ Helicobacter pylori infection leads to early
activation of the canonical NF-κB signalling
pathway.
▸ Polymorphisms in the LTA gene were associated
with increased risk for gastric cancer
development.
▸ Increased levels of chemokines regulated by
alternative NF-κB signalling (eg, CXCL13) have
been observed in H. pylori-infected subjects.
What are the new ﬁndings?
▸ H. pylori infection triggers LTβR signalling and
alternative NF-κB activation in gastric epithelial
cells, contributing to gastric inﬂammation.
▸ Blocking LTβR signalling during H. pylori
infection reduces gastric inﬂammation, while
activation of LTβR leads to a more severe
pathology.
▸ Activated alternative NF-κB exacerbates gastric
inﬂammation even in the absence of H. pylori.
How might it impact on clinical practice in
the foreseeable future?
▸ Our results suggest that blocking H.
pylori-induced LTβR signalling might represent
an interesting therapeutic approach after
antibiotic treatment to control the gastric
inﬂammation elicited by the bacterium. This
strategy might be also considered in combination
with inhibition of canonical NF-κB, since
blocking the canonical pathway alone might
have deleterious effects by enhancing the
alternative NF-κB pathway. This combinatorial or
sequential approach may be able to prevent the
well-described progression of gastric pathology
even after eradication of H. pylori and should be
evaluated in clinical trials in high-risk
populations.
Mejías-Luque R, et al. Gut 2016;0:1–13. doi:10.1136/gutjnl-2015-310783 1
 Gut Online First, published on April 13, 2016 as 10.1136/gutjnl-2015-310783
Copyright Article author (or their employer) 2016. Produced by BMJ Publishing Group Ltd (& BSG) under licence. 
group.bmj.com on March 29, 2017 - Published by http://gut.bmj.com/Downloaded from 
Appendix	
	 163	
bacterial infection initiates rapid activation of distinct signalling
cascades, particularly NF-κB, thereby setting the molecular basis
for malignant transformation.2
The severity of the inﬂammatory response to the bacterium
and the risk for gastric cancer (GC) development upon infection
have been directly linked to the presence of certain bacterial
virulence factors, mainly the cag pathogenicity island (cagPAI),
which encodes different components of a type IV secretion
system (T4SS) necessary for translocation of Cytotoxin-asso-
ciated gene A into the host cells.3 Another component of this
T4SS, the CagL protein, interacts with and activates the integrin
α5β1 on gastric epithelial cells, which initiates the delivery of
CagA into the target cells.4 Inside the epithelial cell, CagA inter-
acts with host cell molecules such as the phosphatase SHP-2 and
triggers a number of downstream signalling pathways with onco-
genic activity. At the same time, inﬂammatory signalling is
induced as a consequence of this interaction. While CagA deliv-
ery mainly results in the induction of interleukin (IL)-8, the acti-
vation of canonical NF-κB signalling is mainly T4SS
dependent,5 highlighting the important role of this pathway in
H. pylori-induced pathology.
Activation of canonical NF-κB signalling in gastric epithelial
cells and inﬁltrating immune cells has been well documented
during H. pylori infection;2 6–8 however, only few data about
the functional role of alternative NF-κB pathway in the context
of H. pylori-driven pathology are available.
The alternative NF-κB pathway is activated via a distinct set
of receptors of the tumour necrosis factor superfamily
(TNFSF),9 including BAFFR, Fn14, CD40, herpes virus entry
mediator and the lymphotoxin β receptor (LTβR). The latter is
triggered by either binding of LTα1β2 heterotrimers expressed
by activated T, B, natural killer (NK) cells and lymphoid tissue
inducer cells, or LIGHT (homologous to lymphotoxin exhibits
inducible expression and competes with HSV glycoprotein D
for binding to herpes virus entry mediator, a receptor expressed
on T lymphocytes), a TNFSF member expressed on T lympho-
cytes.9–11 Under pathological conditions, LTs and LIGHT can
also be expressed by epithelial cells.12 13 LTβR is mainly
expressed on epithelial and stromal cells, thereby enabling the
communication with lymphocytes. Receptor activation leads to
the formation of the RelB/p52 NF-κB complex, which mechan-
istically relies on inducible processing of the precursor p100 to
p52 after activation of NF-κB inducing kinase (NIK). The pre-
cursor p100 functions as an IκB-like molecule that keeps RelB
located in the cytoplasm.14 Following ligand binding, proteoso-
mal processing of p100 to p52 results in the formation of RelB/
p52 heterodimers capable of translocating into the nucleus,15 16
inducing the expression of several target genes, including alter-
native NF-κB-speciﬁc CXCL13 and other NF-κB target genes
(CXCL10, CCL2 or CCL20) that could be linked to active alter-
native NF-κB signalling.12 17 Interestingly, some of these chemo-
kines have been reported to be upregulated in stomachs of H.
pylori-infected subjects.18–21 However, the upstream events
leading to the secretion of these chemokines during H. pylori
infection are still mostly uncharacterised.
The LT system (LT/LIGHT and LTβR) is crucial for formation
and maintenance of tertiary lymphoid organs (TLOs), thereby
contributing to cancer development in several tissues.22–25
However, the role of LTβR signalling in H. pylori-driven gastri-
tis and progression to GC remained unknown. Here, we
provide evidence that LTβR signalling is essential in executing
H. pylori-induced chronic inﬂammation, a precursor of gastric
carcinogenesis.
MATERIAL AND METHODS
Cell culture and H. pylori strains
AGS, Kato III and SNU-1 (American Type Culture Collection
(ATCC)), AZ521 ( Japanese Collection of Research Biosources),
St3051 and St2957, NUGC-4 and MKN45 were grown in
Dulbecco’s Modiﬁed Eagle Medium (DMEM)/10% fetal calf
serum (FCS) (Gibco).26 Cells were maintained at 37°C in a CO2
atmosphere and routinely tested for Mycoplasma
contamination.
H. pylori strains G27,27 SS1, PMSS128 and P1229 were grown
on Wilkins–Chalgren blood agar plates and maintained under
microaerophilic conditions. G27 isogenic strains G27ΔCagA,
G27ΔCagE, G27ΔCagF and G27ΔCagI, G27ΔBabA, G27ΔSabA,
G27ΔVacA, G27ΔgGT, G27ΔUreA/B, PMSS1ΔCagE30 and P12slt
(kindly provided by Ivo Boneca) were grown in plates contain-
ing either 20 μg/mL of kanamycin or 15 mg/mL of chloram-
phenicol under the same conditions. H. pylori clinical isolates
were obtained from the Städtisches Klinikum München. Two of
the seven clinical isolates were CagA positive (see online supple-
mentary ﬁgure S4B).
Histology and immunohistochemistry
Human gastric tissue samples were obtained from the
parafﬁn-embedded tissue bank of the Institut für Pathologie,
Klinikum Bayreuth Germany, after approval of the local ethics
committee. Patients did not receive antibiotics, nonsteroidal
anti-inﬂammatory drugs (NSAID) or proton pump inhibitor
(PPI) drugs before biopsy. Parafﬁn sections were stained with
H&E or various primary and secondary antibodies (see online
supplementary table S2). Brieﬂy, sections were incubated in
Bond Primary antibody diluent (Leica) and staining was per-
formed on a BOND-MAX immunohistochemistry robot (Leica
Biosystems) using BOND polymer reﬁne detection solution for
diaminobenzidine (DAB). Image acquisition was performed with
a Leica SCN400 slide scanner. The number of cells positively
stained for different markers was determined using
SlidePathTissueIA image analysis software (Leica) on whole
gastric mucosa sections and normalised to tissue area. Pictures
for representation were taken by scanning whole tissue sections
using a Leica SCN400 slide scanner.
Animal experiments
Female C57BL/6 mice (6–8 weeks) were obtained from Harlan
Laboratories (Rossdorf, Germany). All animal studies were con-
ducted in compliance with European guidelines for the care and
use of laboratory animals (licenses 63/2008 and 24/2013 to
AM) and were approved by the Zurich Cantonal Veterinary
Ofﬁce.
The systemic antagonist mLTβR-mIgG1 (LTβR–Ig) and a
control murine monoclonal IgG1 antibody, MOPC-21, were
prepared at Biogen Idec and stored at −80°C until used. One
week prior to infection, mice were injected intraperitoneally
with 100 μg of either substance on day 7 and day 2. On day 0,
2 and 5, mice were infected orogastrically with one dose of 109
colony-forming units (cfu) of the H. pylori strain PMSS1 and
further injected once per week with 100 μg of either LTβR–Ig
or MOPC-21 for 1 month. H. pylori infection was conﬁrmed
by counting cfu from stomach homogenates and efﬁcacy of
LTβR–Ig treatment was conﬁrmed by loss of splenic follicular
dendritic cell (FDC) networks visualised by anti-FDC-M1 stain-
ing. Agonistic activation of the alternative NF-κB signalling
pathway was performed by treating mice twice a week with
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50 mg ACH6 antibody (kindly provided by Dr Jeffrey
Browning/Biogen Idec).
Statistics
Normally distributed data were analysed by one-way analysis of
variance (ANOVA) with Dunnett’s or Bonferroni’s correction
for multiple comparisons or Student’s t test where indicated,
while Mann–Whitney U test or ANOVA Kruskal–Wallis with
Dunn’s comparison test was used to compare not normally dis-
tributed data. Statistical signiﬁcance was deﬁned when p<0.05.
RESULTS
LTβR ligand expression and activation of alternative NF-κB
signalling in H. pylori-induced gastritis and early gastric
tumours
We ﬁrst assessed mRNA expression of several ligands activating
the alternative NF-κB signalling (eg, BAFF, CD40L, LTα, LTβ
and TWEAK). We observed signiﬁcant induction of LTβ mRNA
in H. pylori-induced gastritis (see online supplementary ﬁgure
S1A). Thus, we investigated the identity of putative LTβ-
responsive cells by in situ hybridisation for LTβR in human
gastric tissue samples presenting different degrees of gastric
inﬂammation or early gastric tumours associated with H. pylori
infection (see online supplementary table S1). We observed that
gastric epithelial cells display LTβR mRNA expression that was
not affected by the severity of gastric disease (ﬁgure 1A and see
online supplementary ﬁgure S1B). In the same stomach samples
increased levels of LTβ were corroborated on protein level, pre-
dominantly expressed by inﬂammatory cells (T and B cells) in-
ﬁltrating the gastric mucosa (ﬁgure 1B, C and see online
supplementary ﬁgure S1C). Moreover, we detected LTβ protein
expression in LTβR+ epithelial cells in H. pylori-induced gastri-
tis as well as in gastric tumours (ﬁgure 1C and see online
supplementary ﬁgure S1D), suggesting cell autonomous and
non-autonomous LTβR signalling. Interestingly, LTβ expression
was higher in intestinal-type compared with diffuse-type GCs
(see online supplementary ﬁgure S1E).
Alternative NF-κB signalling activation was assessed by RelB
and p52 nuclear translocation in epithelial cells, which was
higher in gastritis and in gastric tumour samples, when compared
with controls (ﬁgure 1B, D, E and see online supplementary
ﬁgure S1F).
Furthermore, we analysed expression of LTβR downstream
target genes in H. pylori-induced moderate gastritis samples
(ﬁgure 1F). Enhanced expression of CXCL13 and several other
chemokines related to LTβR signalling (CCL17, CCL20, CXCL10
and CCL2) was found in patients with H. pylori-associated gastritis
compared with controls (ﬁgure 1F). Furthermore, increased
expression of A20, an endogenous inhibitor of canonical
NF-κB, corroborated concomitant canonical NF-κB signalling
activation in H. pylori infection.
H. pylori activates LTβR signalling and alternative NF-κB in
human GC cells
To investigate whether H. pylori activates LTβR signalling in
gastric epithelial cells and to deﬁne the molecular mechanisms
involved, we initially characterised a panel of human GC cell
lines. Except AZ521, all cell lines analysed expressed LTβR (see
online supplementary ﬁgure S2A). Interestingly, constitutive
p100 processing was detected in some cell lines including
AZ521 and NUGC-4 (see online supplementary ﬁgure S2B).
Constitutive activation of alternative NF-κB signalling was not
LTβR-ligand dependent, since under basal conditions none of
the cell lines studied expressed LTα, LTβ or LIGHT (see online
supplementary ﬁgure S2C). In parallel, we also analysed canon-
ical NF-κB signalling. All GC cell lines analysed expressed
TNFR1 at different levels, while canonical NF-κB activation—
examined by pRelA—was observed in most of the cell lines
independently of basal expression of TNFα (see online supple-
mentary ﬁgure S2C,D). Based on these results, we selected the
cell lines MKN45 and St3051, which express LTβR at different
levels but lack constitutive activation of the alternative NF-κB
pathway, for further experiments.
We ﬁrst infected these GC cell lines with the H. pylori strain
G27 at different multiplicity of infection (MOI) for 12 h. H.
pylori stimulation at low MOI (2–10) resulted in dose-
dependent induction of p100 expression and cleavage to p52
(ﬁgure 2A and see online supplementary ﬁgure S2E). At higher
infectious doses (MOI 20–50) we found a reduction in p100
processing, which we observed to be a consequence of cell
death occurring at high MOI (data not shown). Thus, we
selected MOI 10 for further investigations. As expected, H.
pylori infection also resulted in a dose-dependent phosphoryl-
ation of p65 (see online supplementary ﬁgure S2F), demonstrat-
ing activation of canonical NF-κB.
We next examined the kinetics of alternative NF-κB signalling
activation in a time course study. p100 expression was upregu-
lated 6 h post-infection, while its processing was apparent earli-
est after 8 h (ﬁgure 2B and see online supplementary ﬁgure
S2G), reaching a plateau of p52 at 10 h, which was maintained
even at 24 h post-infection. Using different clinical H. pylori iso-
lates we conﬁrmed p100 processing (ﬁgure 2C).
We further investigated whether p100 processing to p52 cor-
related with LTβR-ligand expression. We detected LT mRNA
upregulation already 3 h post-infection (ﬁgure 2D), which was
approximately 4–5 h before ﬁrst signs of p100 processing
(ﬁgure 2B). Notably, expression of LTβ was induced at a much
higher level when compared with LTα in both cell lines, while
LTβR expression did not change (see online supplementary
ﬁgure S2H).
Next, we analysed the expression of different chemokines
regulated by LTβR signalling at 12 h post-infection. Similar to
results obtained from patients, signiﬁcant induction of
CXCL13, CXCL10 and CCL20 in response to H. pylori infec-
tion was found in GC cells (ﬁgure 2E and see online
supplementary ﬁgure S2I). A20 levels were also signiﬁcantly
enhanced (ﬁgure 2E and see online supplementary ﬁgure S2I).
H. pylori-induced LTβR ligand upregulation activates
alternative NF-κB in a secondary loop post-infection
H. pylori can interact with host receptors, for example,
MUC5AC31 or TNFR1,32 which prompted us to investigate
whether H. pylori directly interacted with the LTβR and trig-
gered downstream signalling. However, no interaction between
LTβR and H. pylori was detected via immunoprecipitation (see
online supplementary ﬁgure S3A).
As H. pylori-induced LT expression precedes p100 processing
(shown in ﬁgure 2B, D), we hypothesised that LTs might activate
LTβR signalling in a secondary loop post-infection. Thus, we
scavenged LTα1β2 and LIGHT using an LTβR–Ig fusion protein.
LTβR–Ig treatment during H. pylori infection did not affect LTα
and LTβ mRNA levels (see online supplementary ﬁgure S3B and
data not shown). However, LTβR–Ig treatment suppressed p100
processing, whereas the isotype control MOPC-21 did not
(ﬁgure 3A). This suggests that LTβR ligands induce activation of
LTβR signalling in response to H. pylori infection.
LT expression can be regulated by canonical NF-κB.33
Therefore, we analysed whether this pathway also regulates LT
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Figure 1 Lymphotoxin β receptor (LTβR) signalling is activated in Helicobacter pylori-induced gastritis and gastric tumours. (A) LTβR mRNA
expression detected in human normal gastric mucosa, in mild, moderate and severe gastritis caused by H. pylori infection, as well as in early gastric
adenocarcinomas detected by in situ hybridisation. (B) Representative images of LTβ and RelB expression in human gastric tissue samples detected
by immunohistochemistry. Arrowheads indicate RelB nuclear expression in epithelial cells. Arrows denote expression in immune cells. (C)
Quantiﬁcation of LTβ+ cells (median and minimum to maximum values) in human normal gastric mucosa (n=20), mild (n=26), moderate (n=24) and
severe gastritis (n=17), as well as in early gastric adenocarcinoma (n=23) tissue samples. (D) Representative image of RelB expression in gastric
tumours detected by immunohistochemistry. Arrows indicate RelB+ nuclei. (E) Representative images of p52 expression in human gastric samples.
Arrowheads indicate p52 nuclear expression in epithelial cells. Arrows denote expression in immune cells. (F) Whiskers (median and minimum to
maximum) box plots show relative mRNA levels of CXCL13, CCL17, CXCL10, CCL20, CCL2 and A20 detected in human normal gastric mucosa
(n=11) and H. pylori-induced gastritis (n=11). *p≤0.05, **p≤0.01, ***p≤0.001. (analysis of variance Kruskal–Wallis, Dunn’s multiple comparison
test.)
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expression in GC cells. Upon TNFα stimulation, LTβ expression
was signiﬁcantly induced, while only minor effects were
detected on LTα mRNA levels. As a control, A20 was induced
(see online supplementary ﬁgure S3C). We conﬁrmed regulation
of LTα and LTβ by canonical NF-κB upon H. pylori infection by
using an inhibitor of human IκB kinase 2 (IKK2)
Figure 2 Helicobacter pylori activates alternative NF-κB signalling. (A) MKN45 and St3051 cells were infected with H. pylori G27 strain at the
indicated MOI and p100 processing to p52 was analysed by western blot. The agonist of lymphotoxin β receptor (LTβR) signalling BS-1 (0.5 mg/mL)
was used as positive and β-actin as loading control. One representative blot and band quantiﬁcation showing the ratio between p100 and p52
levels from three independent experiments is shown. OD, optical density (arbitrary units). (B) MKN45 GC cells were infected with H. pylori G27
strain at MOI 10 for different time points and processing of p100 to p52 was analysed by western blot. The agonist BS-1 (0.5 mg/mL for 12 h) was
used as positive control. β-actin was used as loading control. One representative blot is shown. (C) p100 processing to p52 detected by western blot
in MKN45 cells infected with different clinical isolates (I–VII) at MOI 10 for 12 h. One representative of three independent experiments is shown. (D)
mRNA expression levels (mean±SD) of LTα and LTβ upon H. pylori G27 strain infection at MOI 10 for 3 (n=3), 6 (n=4) and 12 h (n=4) in MKN45
and St3051 cells (ANOVA, Dunnett’s multiple comparison test). (E) CXCL13, CXCL10, CCL20 and A20 mRNA expression upon H. pylori G27 strain
infection at MOI 10 for 12 h. The agonist BS-1 (0.5 mg/mL) was used as positive control. Ct values were normalised to Glyceraldehyde-3-phosphate
dehydrogenase (GADPH). Results (mean±SD) from three independent experiments are presented as fold induction. *p≤0.05, ***p≤0.001. (Control
and H. pylori-infected cells were compared using Student’s t test.)
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Figure 3 Activation of lymphotoxin β receptor (LTβR) signalling is induced by secreted LT and LIGHT (homologous to lymphotoxin exhibits
inducible expression and competes with HSV glycoprotein D for binding to herpes virus entry mediator, a receptor expressed on T lymphocytes) in
response to Helicobacter pylori infection. (A) MKN45 cells were incubated with LTβR–Ig or the isotype control MOPC21 for 1 h before H. pylori
infection at MOI 10. p100 processing to p52 was evaluated by western blot after 12 h infection. β-actin served as loading control. One
representative blot and quantiﬁcation of three independent experiments (mean±SD) are shown. (B) A20, LTα and LTβ mRNA levels were analysed by
real-time PCR in MKN45 cells after 12 h infection with the H. pylori strain G27 (MOI 10). Cells were incubated with the inhibitor of human IκB
kinase 2 (IKK2) TPCA-1 1 h prior to infection. Ct values were normalised to GADPH. Results expressed as mean±SD from three independent
experiments are shown. (C) MKN45 cells were incubated with TPCA-1 for 1 h before infection with the H. pylori strain G27 (MOI 10). Cell lysates
were obtained after 12 h infection and levels of p100/p52 were assessed by western blot. β-actin was used as loading control. One representative
blot and quantiﬁcation (mean±SD) of three independent experiments are shown. (D) LIGHT mRNA expression levels after infection of MKN45 cells
with the H. pylori strain G27 at MOI 10 for 12 h. Cells were incubated with TPCA-1 for 1 h before infection. Results (mean±SD) from three
independent experiments are shown. (E) CXCL13 and CCL22 mRNA levels in MKN45 cells infected with H. pylori G27 (MOI 10, 12 h). Where
indicated, cells were incubated with TPCA-1 1 h before infection. Ct values were normalised to GADPH. Results (mean±SD) from three independent
experiments are shown. (F) Whiskers (median and minimum to maximum) box plot showing relative mRNA levels of LIGHT in gastric H.
pylori-induced and H. pylori-negative gastritis (n=11). (G) Representative images of LIGHT expression in human gastric tissue samples detected by
immunohistochemistry. Arrows indicate positive cells. *p≤0.05, **p≤0.01, ***p≤0.001. ((A–E) analysis of variance (ANOVA), Bonferroni’s multiple
comparison test; (F) ANOVA Kruskal–Wallis, Dunn’s multiple comparison test.)
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supplementary ﬁgure S3D). Reduced levels of A20 were
detected after TPCA-1 treatment (ﬁgure 3B), while the expres-
sion of LTα was slightly affected. Remarkably, LTβ levels were
signiﬁcantly reduced (ﬁgure 3B), conﬁrming that LTβ expression
is regulated by canonical NF-κB in gastric cells. When assessing
p100 processing we observed lower levels of p100 in the pres-
ence of TPCA-1 (ﬁgure 3C and see online supplementary ﬁgure
S3E). Remarkably, cleavage of p100 to p52 was still found to a
similar extent when compared with untreated controls, suggest-
ing a canonical NF-κB-independent LTβR ligand to drive p100
processing in the absence of LTs.
Besides LTs, LIGHTwas reported to activate LTβR. Therefore,
we studied LIGHTexpression in gastric cells post-H. pylori chal-
lenge. While no or minor upregulation was detected after activa-
tion of canonical NF-κB using TNFα (see online supplementary
ﬁgure S3C), we observed induction of LIGHT expression upon
H. pylori infection (ﬁgure 3D), which was even further
enhanced when blocking canonical NF-κB by TPCA-1.
Likewise, expression of the LTβR signalling-speciﬁc target gene
CXCL13 was increased when blocking canonical NF-κB (ﬁgure
3E), while expression of the canonical pathway target CCL22
was completely abrogated (ﬁgure 3E). This suggests that canon-
ical NF-κB negatively regulates LTβR activation through repres-
sing LIGHT in H. pylori infection. Notably, expression of other
TNFSF ligands such as BAFF or CD40L was not detected,
neither under basal conditions nor after H. pylori infection or
TPCA-1 treatment in GC cells (data not shown). In line, the
expression of TWEAK was not upregulated upon bacterial infec-
tion or inhibition of canonical NF-κB (see online supplementary
ﬁgure S3F), supporting the fact that LIGHT may be responsible
for inducing p100 processing after blocking canonical NF-κB
pathway. In parallel, H. pylori-triggered upregulation of LIGHT
mRNA expression was conﬁrmed in human gastric biopsies with
moderate gastritis (ﬁgure 3F). LIGHT protein expression was
mainly increased in epithelial cells of human gastric tissue
samples presenting different degrees of gastric inﬂammation and
in early gastric tumours associated with H. pylori infection
(ﬁgure 3G).
H. pylori cagPAI but not CagA is required for LTβR-mediated
activation of alternative NF-κB
To determine whether the expression of LTs and subsequent
activation of LTβR signalling was inﬂuenced by H. pylori viru-
lence factors, we infected epithelial cells with different mutant
strains. A functional T4SS was necessary to induce LT expres-
sion, since cells infected with the mutant strain G27ΔCagE
expressed lower levels of LT compared with cells infected with
the wild-type strain (ﬁgure 4A). Notably, LIGHT expression did
not depend on a functional T4SS, conﬁrming canonical
NF-κB-independent regulation of LIGHT (see online supple-
mentary ﬁgure S4A).
When analysing p100 processing, we observed that lack of
CagA left p100 levels and p100 cleavage unaltered, while
Figure 4 Activation of alternative NF-κB is independent of CagA. (A) mRNA expression levels of lymphotoxin (LT)α and LTβ in MKN45 and St3051
cells after infection with wild-type Helicobacter pylori G27 strain and the isogenic mutant strains G27ΔCagA and G27ΔCagE. Ct values were
normalised to GADPH. Results (mean±SD) from four independent experiments are shown (analysis of variance, Bonferroni’s multiple comparison
test). (B) MKN45 cells were infected with the H. pylori wild-type strains G27, PMSS1 and SS1 and the G27 isogenic mutant strains G27ΔCagA,
G27ΔCagE, G27ΔBabA, G27ΔSabA, G27ΔVacA, G27ΔgGT and G27ΔUreA/B at MOI 10 for 12 h. p100 processing to p52 was detected by western
blot. β-actin was used as loading control. One representative blot and quantiﬁcation of three independent experiments is shown. *p≤0.05,
**p≤0.01, ***p≤0.001. (G27 wt and G27ΔCagE-infected cells were compared using Student’s t test.)
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bacteria devoid of functional cagPAI (SS1, G27ΔCagE,
G27ΔCagF, G27ΔCagI) did not induce p100 expression and
processing (ﬁgure 4B, see online supplementary ﬁgure S4B, C).
In line, clinical isolates lacking CagA induced p100 processing
(ﬁgure 2E and see online supplementary ﬁgure S4D). Thus,
CagA is not necessary for LT-mediated activation of alternative
NF-κB signalling in gastric cells.
Another described H. pylori effector molecule translocated
into target host cells through the T4SS is peptidoglycan.34 To
determine whether peptidoglycan could be involved in
LT-mediated activation of alternative NF-κB, we infected cells
with a strain deﬁcient in lytic transglycosylase activity (P12slt),
which is involved in bacterial muropeptide release. Processing of
p100 to p52 was reduced in cells infected with the slt-deﬁcient
strain (see online supplementary ﬁgure S4E), suggesting that
peptidoglycan may be involved in activation of alternative
NF-κB.
A functional T4SS is necessary to induce ligand expression
and alternative NF-κB activation in vivo
In order to validate our results in vivo, C57BL/6 mice were
infected with the pathogenic H. pylori strain PMSS128 30 and
analysed for LTα, LTβ and LIGHT mRNA expression. One
month post-infection, mice presented signiﬁcantly increased
gastric levels of all LTβR ligands (ﬁgure 5A), conﬁrming a cor-
relation between H. pylori infection and LT/LIGHTupregulation
in vivo. Since our in vitro data suggested the involvement of a
functional T4SS in alternative NF-κB activation, we also
infected mice with PMSS1 strain deﬁcient for CagE. mRNA
levels of LTα, LTβ and LIGHTwere lower in mice infected with
H. pylori PMSS1ΔCagE when compared with mice infected
with the wild-type strain (ﬁgure 5B), even though they were
colonised at higher levels (ﬁgure 5C). In addition, mice infected
with CagE-deﬁcient bacteria showed less gastric inﬂammation
(ﬁgure 5D), as previously reported.30 Speciﬁcally, lower inﬁltra-
tion of T and B cells was detected in the stomach of mice
infected with PMSS1ΔCagE when compared with mice infected
with wild-type bacteria (ﬁgure 5E). Infection of mice with wild-
type PMSS1 induced activation of alternative NF-κB in gastric
epithelial cells, as detected by nuclear translocation of RelB
(ﬁgure 5E). Notably, lack of CagE correlated with reduced
nuclear RelB translocation, conﬁrming that activation of alterna-
tive NF-κB signalling by H. pylori requires a functional T4SS.
Moreover, the expression of canonical as well as alternative
NF-κB signalling target genes such as A20, murine IL-8 homo-
logue KC, CXCL13, CXCL10, CCL2 and CCL20 was reduced
in the gastric mucosa of mice infected with bacteria deﬁcient for
CagE (ﬁgure 5F).
Blocking LTβR signalling in vivo reduces H. pylori-induced
gastric inﬂammation
We next assessed whether LTβR signalling is correlatively or
causally linked with gastric inﬂammation and pathology trig-
gered by H. pylori in vivo. Thus, we treated H. pylori-infected
mice with LTβR–Ig (see online supplementary ﬁgure S5A) to
study the effects of blocking LTβR signalling on bacterial colon-
isation and gastric inﬂammation induced by H. pylori. Efﬁcacy
of LTβR–Ig treatment was conﬁrmed by staining
LTβR-dependent FDCs in spleen25 (see online supplementary
ﬁgure S5B). Interestingly, LTβR–Ig-treated mice presented a
higher gastric bacterial load when compared with
MOPC-21-injected mice (ﬁgure 6A), suggesting that LTβR sig-
nalling is important to control bacterial burden. Higher H.
pylori colonisation was accompanied by less gastric
inﬂammation (ﬁgure 6B), indicating that LTβR signalling is an
important driver of gastric pathology induced by the bacterium.
Remarkably, LTβR–Ig-injected mice displayed less CD3+ and
CD4+ cells inﬁltrating the stomach (ﬁgure 6C and see online
supplementary ﬁgure S5C). In addition, less B220+ cells were
detected upon LTβR–Ig treatment in the gastric mucosa of
infected mice (ﬁgure 6C), demonstrating a reduced inﬂamma-
tory response after blocking LTβR signalling. Moreover, mice
treated with LTβR–Ig presented lower nuclear translocation of
RelB in gastric epithelial cells (ﬁgure 6C), conﬁrming treatment
efﬁcacy.
We further assessed whether blocking LTβR signalling upon
H. pylori infection altered the expression levels of several che-
mokines. We observed decreased levels of KC, CXCL10,
CCL20 and CCL2 in the stomach of mice injected with LTβR–
Ig (ﬁgure 6D), correlating with the lower inﬂammation found in
the gastric mucosa.
Activation of LTβR signalling enhances gastric pathology
induced by H. pylori
We next determined the effect of enhanced LTβR signalling
during H. pylori infection. We injected H. pylori-infected mice
with ACH6, a murine agonist of LTβR35 (ﬁgure 7 and see online
supplementary ﬁgure S5A). ACH6-triggered activation of LTβR
led to a decrease in gastric bacterial load (ﬁgure 7A), accompan-
ied by higher gastric inﬂammation (ﬁgure 7B). We observed
slightly lower levels of CD3+ cells in H. pylori-infected animals
treated with the agonist (ﬁgure 7C), while no major differences
were detected in CD4+ or F480+ macrophages (see online sup-
plementary ﬁgure S6A). Interestingly, animals treated with the
agonist presented more B cells than infected control mice (see
online supplementary ﬁgure S6B). In line, the expression of
CXCL13 was enhanced in mice injected with ACH6 (ﬁgure 7D).
We also observed increased expression of the LTβR target genes
LIGHT, ICAM—involved in leucocyte recruitment—and CCL2
(ﬁgure 7D), while KC and CCL20 levels remained unchanged
(see online supplementary ﬁgure S6C).
DISCUSSION
Activation of LTβR triggers and maintains TLOs during chronic
infection.36 Notably, lymphoid neogenesis and TLO formation
were reported as a histological hallmark of chronic H. pylori
infection,37–39 suggesting a possible role of the LTβR signalling
pathway in H. pylori-driven pathology.
The involvement of NIK in H. pylori-induced NF-κB activa-
tion was reported in gastric epithelial cells,40 41 and p100/p52
processing upon H. pylori infection was reported in B lympho-
cytes.42 However, in the latter study, activation of alternative
NF-κB reﬂected by p100 processing was not found in the GC
cell line AGS. In addition, p100/p52 staining of human gastric
samples from H. pylori-infected subjects showed only cytoplas-
mic staining that was weaker compared with inﬁltrating lympho-
cytes, leading to the conclusion that the alternative NF-κB
pathway was not activated in epithelial cells upon H. pylori
infection. In our study, we have detected p100 processing in dif-
ferent human gastric cell lines. Importantly, activation of the
alternative NF-κB pathway was corroborated in epithelial and
immune cells in gastritis and gastric tumour samples from H.
pylori-infected patients. Likewise, mice infected with H. pylori
showed increased nuclear translocation of RelB in gastric epithe-
lial cells, demonstrating that H. pylori activates alternative
NF-κB in vitro and in vivo.
Canonical and alternative NF-κB signalling are closely related
and crosstalk at different levels, for example, expression of
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Figure 5 Helicobacter pylori activates alternative NF-κB in vivo in a type IV secretion system (T4SS)-dependent manner. (A) Lymphotoxin (LT)α,
LTβ and LIGHT (homologous to lymphotoxin exhibits inducible expression and competes with HSV glycoprotein D for binding to herpes virus entry
mediator, a receptor expressed on T lymphocytes) mRNA levels in mice infected for 1 month with the H. pylori strain PMSS1. Ct values were
normalised to GADPH. (B–F) Mice were infected for 1 month with the H. pylori strain PMSS1 or an isogenic strain lacking CagE. (B) LTα, LTβ and
LIGHT mRNA levels in infected mice. Ct values were normalised to GADPH. (C) Colony-forming units (cfu) per mg of stomach. (D) Inﬂammatory
score. Activity and chronicity of infection was evaluated in antrum and corpus of murine stomach samples according to the updated Sydney system.
(E) Murine stomach samples were stained for CD3, B220 and RelB by immunohistochemistry. Representative pictures are shown. CD3+ and B220+
cells and RelB+ nuclei were calculated per area of tissue (mm2). (F) Relative mRNA expression levels of A20, KC, CXCL13, CXCL10, CCL20 and CCL2
in the stomach of H. pylori-infected mice. Ct values were normalised to GADPH. *p≤0.05, **p≤0.01, ***p≤0.001. ((A), (B) and (F) (Mann–Whitney
U test); (E) analysis of variance Kruskal–Wallis, Dunn’s multiple comparison test.)
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p100 and LTβ, have been reported to be regulated by canonical
NF-κB.33 43–45 In line, we detected enhanced expression of
p100 and LTs upon H. pylori infection, which was reduced
when activation of canonical NF-κB was blocked. However,
p100 processing was still observed, indicating that p100 overex-
pression is insufﬁcient to induce its processing.46 It rather
Figure 6 Blocking of lymphotoxin β receptor (LTβR) signalling during Helicobacter pylori infection reduces gastric inﬂammation. (A–D) C57BL/6
mice infected with the H. pylori strain PMSS1 were injected weekly with 100 mg of LTβR–Ig or the isotype control MOPC-21 (Control–Ig). Mice were
sacriﬁced after 1-month infection. Dots represent data of individual mice pooled from two independent experiments. (A) Colony-forming units (cfu)
per mg of stomach. (B) Inﬂammatory score. Activity and chronicity of infection was evaluated in antrum and corpus of murine stomach samples
according to the updated Sydney system. (C) Murine stomach samples were stained for CD3, B220 and RelB by immunohistochemistry.
Representative pictures are shown. CD3+ and B220+ cells and RelB+ nuclei were calculated per area of tissue (mm2). (D) Relative mRNA expression
levels of KC, CXCL10, CCL20 and CCL2 in the stomach of control or H. pylori-infected mice treated with LTβR–Ig or MOPC-21. Ct values were
normalised to GADPH. *p≤0.05, **p≤0.01, ***p≤0.001. (analysis of variance Kruskal–Wallis, Dunn’s multiple comparison test.)
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necessitates a speciﬁc activation by LTs through LTβR upon
infection. Further, p100 processing upon canonical NF-κB
blockade implied another canonical NF-κB-independent, LTβR
ligand to trigger this pathway, which we found to be LIGHT. In
contrast, treatment with LTβR–Ig, which scavenges all LTβR
ligands, fully disables alternative NF-κB signalling. Therefore,
our results demonstrate a tight crosstalk between canonical and
alternative pathway during H. pylori infection, since activation
of canonical NF-κB regulates the expression of ligands import-
ant for activation of the alternative pathway.
We observed that the T4SS played a crucial role in controlling
the expression of LTs and subsequent activation of LTβR signal-
ling in vitro and in vivo, whereas the presence of CagA was dis-
pensable. These results are in agreement with previous reports
Figure 7 Agonistic activation of lymphotoxin β receptor (LTβR) signalling during Helicobacter pylori infection increases gastric inﬂammation. (A–D)
C57BL/6 mice infected with the H. pylori strain PMSS1 were injected weekly with 50 mg of the agonist of LTβR signalling ACH6. Mice were
sacriﬁced after 1-month infection. Horizontal bars indicate medians. (A) Colony-forming units (cfu) per mg of stomach. (B) Gastric inﬂammatory
score evaluated according to the updated Sydney system. (C) Representative pictures of murine stomach samples stained for CD3, B220 and RelB.
CD3+ and B220+ cells and RelB+ nuclei were calculated per area of tissue (mm2). (D) Relative mRNA expression levels of CXCL13, ICAM, CCL2 and
LIGHT (homologous to lymphotoxin exhibits inducible expression and competes with HSV glycoprotein D for binding to herpes virus entry mediator,
a receptor expressed on T lymphocytes) in stomach samples. Ct values were normalised to GADPH. *p≤0.05, **p≤0.01, ***p≤0.001. ((A) (Mann–
Whitney U test); (B–D) analysis of variance Kruskal–Wallis, Dunn’s multiple comparison test.)
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showing that H. pylori CagA-deﬁcient but T4SS-proﬁcient
strains induce NF-κB activation almost as efﬁciently as wild-type
bacteria,5 47 while the exact mechanism of T4SS-dependent
NF-κB activation is not fully understood.48 The presence of
CagA has been linked to more severe gastric pathology in
Western countries,49 yet, our results using CagA-negative H.
pylori isolates indicate that important inﬂammatory signalling
cascades, such as alternative NF-κB, can still be activated and
contribute to gastric inﬂammation in the absence of CagA.
Our in vivo experiments blocking or activating LTβR signal-
ling in mice during H. pylori infection showed an important
role for this pathway in the control of the inﬂammatory
response towards the bacterium. Reduction of chemokine
expression in the stomach of LTβR-treated animals conﬁrmed
LTβR inhibition at the site of infection. Depletion of FDCs and
secondary lymphoid organs was observed, suggesting an add-
itional systemic extra-gastric effect. However, our experiments
using the agonist of LTβR (ACH6) refute this possibility, since
no effects on FDCs or lymph nodes have been reported with
this antibody,35 but we still observed a reversed gastric pheno-
type (reduced bacterial load and increased gastric inﬂammation)
compared with LTβR inhibition.
Previous studies using transgenic mouse models suggested the
involvement of alternative NF-κB in gastric pathology: Knockout
mice lacking the terminal ankyrin domain of NF-κB2 and consti-
tutively expressing NF-κB2/p52 presented gastric hyperplasia in
the absence of Helicobacter infection.50 In line, infection experi-
ments of Nfkb2−/− mice suggested NF-κB2-mediated signalling to
be required for the development of H. felis-induced gastric path-
ology.51 However, the speciﬁc pathways upstream of NF-κB2
remained elusive. Our in vivo studies using human pathogenic
H. pylori reveal an essential function of LTβR signalling in
gastric pathology upstream of NF-κB2.
Taken together, our data indicate that both NF-κB pathways
are activated in the course of H. pylori infection. Our in vitro
data show that activation of the canonical NF-κB signalling pre-
cedes alternative NF-κB, regulating a feed-forward loop through
induction of LT expression (see online supplementary ﬁgure
S7A). Ligand engagement to LTβR expressed on epithelial cells
triggers p100/p52 processing and subsequent activation of the
expression of chemokines important for immune cell recruit-
ment (CXCL13, CXCL10 and CCL20). Recruitment of inﬂam-
matory cells (CD4+ T cells and B cells) to the stomach, which in
turn also express LTs and LIGHT, leads to a feedback loop, main-
taining H. pylori-induced gastric inﬂammation (see online supple-
mentary ﬁgure S7B). This is conﬁrmed by our observations in
human gastric tissue, where expression of LTs and target genes is
linked to the severity of the lesions in the presence of H. pylori.
Different studies have suggested inhibition of canonical
NF-κB as a therapeutic strategy to reduce H. pylori-triggered
gastric inﬂammation. Natural substances as capsaicin,52 antiulcer
drugs as ecabet sodium53 or probiotics54 have been proven to
inhibit in vitro NF-κB and IL-8 secretion in gastric epithelial
cells. Moreover, inhibition of IKK2 in Mongolian gerbils was
related to a reduced inﬁltration of neutrophils and mononuclear
cells in the stomach, while no differences in bacterial load were
detected,55 suggesting that inhibition of canonical NF-κB was
not sufﬁcient to control the infection in this model. In light of
our results showing that blocking of canonical NF-κB reduces
LT expression but induces LIGHT and CXCL13 upregulation
upon H. pylori challenge, it is tempting to speculate that inhib-
ition of canonical NF-κB might indeed not represent the best
therapeutic option to reduce gastric inﬂammation and pathology
elicited by H. pylori. On the contrary, it might imply other
adverse effects that have not been considered until now, such as
activation of LTβR signalling through LIGHT and concomitant
exacerbation of inﬂammation.
This, in context with the self-sustaining inﬂammatory alterna-
tive NF-κB signalling loop, may aggravate the deleterious
inﬂammatory effects induced by chronic H. pylori infection,
especially in patients presenting with a high degree of gastritis.
Having observed that blocking of LTβR signalling during H.
pylori infection in mice reduces gastric inﬂammation and inﬁl-
tration of inﬂammatory cells, we propose that such strategy
could be considered as a supplement after antibiotic treatment
or concomitant with inhibition of canonical NF-κB signalling.
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Supplementary Figure Legends 
Supplementary Figure 1. LTβR signaling is activated in H. pylori-induced gastritis and 
gastric tumors.  
(A) Whiskers (minimum to maximum) box plots show relative mRNA levels of LTα, LTβ, 
CD40L, TWEAK, BAFF in healthy human gastric mucosa and H. pylori-induced gastritis. 
Data from 12 (LTα and LTβ) or 6 (CD40L, TWEAK, BAFF) tissue samples of each condition 
are shown. Significances were calculated using Student’s t test. ***p≤0.001. (B) Negative 
(DapB) and positive controls (+, Pol2A and ++, UBC) used for LTβR in situ hybridization. (C) 
T cells (CD3), B cells (CD20) and macrophages (CD68) detected by immunohistochemistry 
in normal gastric mucosa, mild, moderate and severe gastritis as well as in tumor-associated 
gastritis. Representative images are shown. (D) Representative images of LTβ expression in 
human normal gastric mucosa, mild, moderate and severe gastritis as well as in early gastric 
adenocarcinoma biopsy samples, detected by immunohistochemistry. Thick arrows indicate 
expression of LTβ in epithelial cells. Thin arrows show expression of LTβ in immune cells. 
(Scale bar: 100µm). (E) Quantification of LTβ+ cells in intestinal-type and diffuse-type tumors. 
(F) RelB+ and p52+ cells in human normal gastric mucosa, mild, moderate and severe 
gastritis as well as in early gastric adenocarcinoma biopsy samples (n=10, each). *p≤0.05, 
**p≤0.01, ***p≤0.001. One-way ANOVA with Bonferroni’s multiple comparison test 
Supplementary Figure 2. H. pylori activates LTβR signaling. 
(A) LTβR expression on the surface of MKN45, KATOIII and St3051 GC cells detected by 
flow cytometry. HepG2 and HEK293 cells were used as positive and negative control, 
respectively. One representative experiment is shown. (B) p100/p52 basal protein expression 
levels in GC cell lines analyzed by western blot. β-actin served as loading control. (C) LTβR, 
TNFR1, TNFα, LTα, LTβ and LIGHT mRNA basal expression levels in gastric cancer cell 
lines. HepG2 or cells treated with the agonist of LTβR signaling BS-1 (0.5 µg/ml) were used 
as positive controls. Results (mean ± S.D.) of two independent experiments performed in 
duplicates are shown. (D) p-p65 and p65 basal protein expression levels in gastric cancer 
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cell lines analyzed by western blot. β-actin served as loading control. (E) St3051 cells were 
infected with H. pylori G27 at different MOI and p100 processing to p52 was detected by 
western blot. BS-1 (0.5 µg/ml) was used as a positive control. β-actin served as loading 
control. One representative blot of three independent experiments is shown. (F) MKN45 and 
St3051 cell were infected with H. pylori G27 strain at the indicated MOI and p-p65 and p65 
levels were analyzed by western blot. β-actin was used as loading control. One 
representative blot from three independent experiments is shown. (G) p100 and p52 levels in 
MKN45 and St3051 cells detected by western blot after infection with H. pylori G27 at MOI 
10 for different time points. BS-1 (0.5 µg/ml) was used as a positive control. β-actin served as 
loading control. (H) Gastric cancer cells MKN45 and St3051 were infected with H. pylori G27 
at MOI 10 for 12 hours. The mRNA expression levels of LTβR were analyzed by real time 
PCR. Ct values were normalized to GADPH. Results (mean ± S.D.) of three independent 
experiments are presented as fold induction. Significances were calculated using One-way 
ANOVA with Bonferroni’s multiple comparison test. (I) St3051 cells were infected with H. 
pylori G27 at MOI 10 for 12 hours. The mRNA expression levels of CXCL13, CXCL10, 
CCL20 and A20 were analyzed by real time PCR. Ct values were normalized to GADPH. BS-
1 (0.5 µg/ml) was used as a positive control. Results (mean ± S.D.) from three independent 
experiments are presented as fold induction. Control cells were compared to H. pylori-
infected cells and significances were calculated using Student’s t-test. *p≤0.05, **p≤0.01, 
***p≤0.001.  
Supplementary Figure 3. Activation of LTβR signaling is induced by secreted LT in 
response to H. pylori infection.  
(A) MKN45 cells were infected with G27 H. pylori strain for 3 hours and lysates were 
immunoprecipitated with anti-LTβR or anti-CagA antibodies. Irrelevant rabbit IgG were used 
as control. Immunoprecipitates were subjected to western blot for detection of H. pylori 
proteins. (B) MKN45 cells were incubated LTβR-Ig one hour prior to H. pylori infection. LTβ 
mRNA levels were measured after 12 hours infection. Values were normalized to GADPH. 
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Results (mean ± S.D.) of three independent experiments are shown. p values were 
calculated using One-way ANOVA with Bonferroni’s multiple comparison test. (C) LTα, LTβ, 
A20 and LIGHT mRNA expression levels in MKN45 cells after stimulation with 10ng/ml of 
TNFα for 12h. Values were normalized to GADPH. Results (mean ± S.D.) of three 
independent experiments are shown. p values were calculated using Student’s t-test. 
*p≤0.05. (D) MKN45 and St3051 cells were incubated with the inhibitor of human IțB Ninase 
2 (IKK2) TPCA-1 to block canonical NF-țB signaling. Cells were stimulated with 50ng/ml of 
TNFα or the LTβR agonist BS-1 (0.5µg/ml) where indicated. Cell lysates were obtained after 
12h infection with the H. pylori strain G27 and levels of p-p65 and p65 were assessed by 
western blot. β-actin was used as a loading control. One representative blot and 
quantification from three independent experiments is shown. (E) St3051 cells were incubated 
with TPCA-1 1h prior to infection with the H. pylori strain G27 (MOI 10). Cell lysates were 
obtained after 12h infection and levels of p100p52 were assessed by western blot. β-actin 
served as loading control. One representative blot of three independent experiments is 
shown. (F) TWEAK mRNA expression in MKN45 cells after inhibition of canonical NF-țB 
using TPCA-1. Values were normalized to GADPH. Results from three independent 
experiments are shown (mean ± S.D.).  
Supplementary Figure 4. Activation of non-canonical NF-țB is independent of CagA. 
(A) LIGHT mRNA expression in MKN45 and St3051 cells infected for 12 hours with the H. 
pylori strain G27 and the isogenic CagA and CagE mutants. Values were normalized to 
GADPH. Results from three independent experiments are shown (mean ± S.D.) (B) p100 
processing to p52 detected by western blot in St3051 cells infected for 12 hours with H. pylori 
G27, the isogenic mutant strains G27ΔCagA, G27ΔCagE, G27ΔBabA, G27ΔSabA, 
G27ΔVacA, G27ΔgGT, G27ΔUreA/B or the SS1 and PMSS1 wild type strains at MOI of 10. 
β-actin was used as a loading control. (C) p100 processing to p52 detected by western blot 
in MKN45 cells infected with H. pylori G27 or the isogenic mutant strains G27ΔCagA, 
G27ΔCagE, G27ΔCagF, G27ΔCagI at MOI of 10. β-actin was used as a loading control. (D) 
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Expression of CagA and isocitrate dehydrogenase (ICD), used as a housekeeping gene, 
detected by PCR in different H. pylori clinical isolates. (E) p100 processing to p52 detected 
by western blot in MKN45 cells infected with H. pylori P12 or the peptidoglycan mutant 
P12slt. Quantification of three independent experiments is shown.   
Supplementary Figure 5. BlocNing LTβR during H. pylori infection reduces gastric 
inflammation. 
(A) Time schedule of LTβR-Ig treatment. C5BL6 mice were inMected with 100g of LTβR-Ig 
or the isotype control MOPC-21 at the indicated time points ( ). At day 0, 2 and 5, mice 
were infected with a 109 orogastric dose of the H. pylori strain PMSS1. Mice were sacrificed 
at day 36 for analyses. (B) Immunohistochemical staining of FDC-M1 or CD21/35 in 
cryosections of spleens to detect follicular dendritic cells from MOPC-21 or LTβR-Ig-treated 
mice, infected with H. pylori PMSS1. (C) Representative pictures of CD4 T cells and 
macrophages (F4/80) detected in gastric tissue samples of control, MOPC-21 and LTβR-Ig-
treated mice infected with H. pylori PMSS1. (Scale bar 100µm).  
Supplementary Figure 6. Agonistic activation of LTβR-signaling during H. pylori infection 
increases gastric inflammation. 
(A) Representative pictures of CD4 T cells and macrophages (F4/80) detected in gastric 
tissue samples of control, H. pylori PMSS1-infected and ACH6-treated and PMSS1-infected 
mice. (Scale bar 100µm). (B) B220 positive cells calculated per area of tissue (mm2) in 
untreated and ACH6-treated control mice. Significances were calculated using Student’s t-
test. *p≤0.05. (C) Relative mRNA expression levels of KC and CCL20 in the stomach of 
control, H. pylori-infected mice and H. pylori-infected mice and treated with ACH6. Ct values 
were normalized to GADPH. Statistical significance was calculated by using One-way 
ANOVA Kruskal-Wallis with Dunn’s multiple comparison test. *p≤0.05, **p≤0.01.  
Supplementary Figure 7. Representative model of the alternative NF-țB activation via 
LTβR-activation upon H. pylori infection.  
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(A) H. pylori type IV secretion system-mediated activation of canonical NF-țB induces the 
expression of LTα and LTβ and low levels of LIGHT in gastric epithelial cells. Secreted 
LTα1β2 and LIGHT bind to LTβR expressed on the gastric epithelium leading to activation of 
alternative NF-țB and up-regulation of chemokines such as CXCL13, CCL17, CCL20 or 
CXCL10 in cis and in trans. These chemokines contribute to the recruitment of B and T cells 
and macrophages to the stomach, which once activated in turn secrete LTs (Chiang et al., 
2009) and possibly also LIGHT, enhancing LTβR-activation and chemokine secretion 
resulting in a feed-forward loop driving gastric inflammation. Treatment with LTβR-Ig 
increases bacterial load, while decreasing gastric inflammation and inflammatory chemokine 
expression. Conversely, agonistic activation of LTβR by ACH6 reduces H. pylori colonization, 
but increases gastric inflammation as well as chemokine expression. (B) Inhibition of 
canoncical NF-țB during H. pylori infection enhances the expression of LIGHT and strongly 
reduces LTβ expression. 8nder these conditions, LIGHT can signal through LTβR activating 
the expression of target chemokines such as CXCL13, leading to a positive feed-forward 




































































































































ŵeĐhaŶistiĐallǇ  froŵ  the  ďreakdoǁŶ  of  the  TͲĐell  suppressiǀe ŵeĐhaŶisŵs  ĐoŶferred  ďǇ  oral 
iŵŵuŶe toleraŶĐe. SǇŵptoŵs of food allergǇ usuallǇ oĐĐur ǁith a fast oŶset ;froŵ seĐoŶds to 
oŶe hourͿ aŶd iŶĐlude rashes, hiǀes, sǁelliŶg aŶd itĐhiŶg of parts or the ǁhole faĐe, ǁheeziŶg, 








iŶ WesterŶ  ĐouŶtries.  The  paradigŵatiĐ  eǆaŵple  of  a  ŵiĐroďe  that  is  iŶĐreasiŶglǇ  lost  froŵ 
huŵaŶ populatioŶs  is H. pylori.  ChroŶiĐ  iŶfeĐtioŶ ǁith  this  gastriĐ  ĐoloŶizer oŶ  the oŶe haŶd 
represeŶts aŶ iŵportaŶt risk faĐtor for the deǀelopŵeŶt of gastritis, ulĐers aŶd gastriĐ ĐaŶĐer ΀ϱ, 




gastroͲesophageal  refluǆ  disease  aŶd  esophageal  ĐaŶĐer,  as  ǁell  as  asthŵa,  allergǇ  aŶd 












epithelial  ďarrier  to  food  allergeŶs  due  to  the  ĐhroŶiĐ  iŶflaŵŵatioŶ  of  the H.  pyloriͲiŶfeĐted 
gastriĐ  ŵuĐosa,  ǁhereas  Ŷegatiǀe  assoĐiatioŶs  ǁere  attriďuted  to  the  iŵŵuŶoŵodulatorǇ 
aĐtiǀitǇ of H. pylori oŶ the aĐtiǀatioŶ aŶd polarizatioŶ of TͲĐell respoŶses.  
We haǀe preǀiouslǇ eǆaŵiŶed  the  role of H. pylori  iŶ ǀarious eǆperiŵeŶtal ŵodels of allergiĐ 








alleǀiate  the  ĐliŶiĐal  aŶd  iŵŵuŶologiĐal  sǇŵptoŵs  of  food  allergǇ  iŶduĐed  ďǇ  tǁo  differeŶt 
ĐoŵŵoŶ food allergeŶs. We used reĐoŵďiŶaŶt oǀalďuŵiŶ aŶd peaŶut eǆtraĐt, adŵiŶistered ǀia 





iŶ  the  three  eǆaŵiŶed  ŵodels  aŶd  reduĐed  ThϮ  ĐǇtokiŶe  produĐtioŶ,  ŵast  Đell  protease 














































to  three  freezeͲthaǁ ĐǇĐles aŶd hoŵogeŶizatioŶ usiŶg a pressure Đell hoŵogeŶizer  ;StaŶsted 
SWCHͲϭϴͿ. The hoŵogeŶate ǁas ĐeŶtrifuged at ϯϬϬϬǆ g,  the  resultiŶg  superŶataŶt ǁas  sterile 
filtered,  aŶd  the  proteiŶ  ĐoŶĐeŶtratioŶ  ǁas  deterŵiŶed  ďǇ  CA  WroteiŶ  AssaǇ  Kit  ;Therŵo 
SĐieŶtifiĐ  ϮϯϮϮϳͿ.  Sϭŵϭ  tǇpe  saĐA  ǁas  purified  froŵ  H.  pylori  straiŶ  ϲϬϭϵϬ  as  desĐriďed 
preǀiouslǇ  ΀ϮϮ΁. The dosage of eǆtraĐt aŶd saĐA ǁas adũusted to the age of the ŵiĐe aŶd the 
appliĐatioŶ ŵode: eǆtraĐt  i.p.  ϱͲϭϬϬ ʅg,  eǆtraĐt p.o.  ϱϬͲϮϬϬ ʅg, saĐA  i.p.  ϱͲϮϬ ʅg. MiĐe ǁere 
treated ǁith saĐA or eǆtraĐt oŶĐe a ǁeek. For the produĐtioŶ of peaŶut eǆtraĐt, partiallǇ defatted 
peaŶut  flour  ;GoldeŶ WeaŶut CoŵpaŶǇͿ ǁas eǆtraĐted oǀerŶight  iŶ ϭϬǆ WS,  solid parts ǁere 
reŵoǀed ďǇ ĐeŶtrifugatioŶ, aŶd eǆtraĐt ǁas ĐoŶĐeŶtrated usiŶg AŵiĐoŶ UltraĐel ϯK ĐeŶtrifugal 




For  OsAͲspeĐifiĐ  IgGϭ  E>ISA,  high  affiŶitǇ  plates  ǁere  Đoated  ǁith  ϭϬ  ʅg  OsA  iŶ  ĐarďoŶateͲ
ďiĐarďoŶate ĐoatiŶg ďuffer ;pH ϵ.ϲͿ oǀerŶight at ϰΣ C. After ǁashiŶg aŶd ďloĐkiŶg ǁith Ϯ й SA iŶ 
WS, seruŵ saŵples ǁere diluted iŶ ϭ й SAͬWS aŶd added for Ϯ hours at ϯϳΣC. After further 























tǇpe  Is  ;Sigŵa  CϱϭϯϴͿ  digestioŶ  aŶd  pushiŶg  through  a  Đell  straiŶer.  After  fiǆatioŶ, 
perŵeaďilizatioŶ  aŶd  ǁashiŶg,  the  Đells  ǁere  staiŶed  ǁith  aŶtiͲŵouse  CDϰͲFITC  ;iolegeŶd 
ϭϬϬϱϭϬͿ aŶd FoǆpϯͲAWC aŶtiďodies ;eiosĐieŶĐe ϭϳͲϱϳϳϯͲϴϮͿ. CDϰ+Foǆpϯ+ aŶd CDϰ+FoǆpϯͲ Đells 








aŵouŶt  of  ϭϬϬ  й  ethaŶol  the  folloǁiŶg  purifiĐatioŶ  steps  ǁere  perforŵed  aĐĐordiŶg  to  the 
ŵaŶufaĐturer͛s  protoĐol.  GeŶoŵiĐ  DEA  ǁas  ĐoŶǀerted  ǁith  ďisulfite  usiŶg  the  EZ  DEA 
MethǇlatioŶ Kit ;ZǇŵo ResearĐhͿ aĐĐordiŶg to the ŵaŶufaĐturer͛s iŶstruĐtioŶs. The TregͲspeĐifiĐ 






GraphWad  Wrisŵ  ϲ  ǁas  for  all  statistiĐal  aŶalǇses.  IŶ  all  graphs  eaĐh  sǇŵďol  represeŶts  aŶ 


























of  OsAͲspeĐifiĐ  IgE  aŶd  IgGϭ  aŶd  eleǀated  leǀels  of MCWTϭ,  a  sǇsteŵiĐ  ŵarker  of  ŵast  Đell 
degraŶulatioŶ  ;Figure  ϭͲD,  suppl.  Figure  ϭA,Ϳ.  The  reͲstiŵulatioŶ  of  spleŶiĐ  siŶgle  Đell 
preparatioŶs ǁith OsA reǀealed a ĐlearlǇ eleǀated produĐtioŶ of I>Ͳϱ aŶd I>Ͳϭϯ relatiǀe to ĐoŶtrol 
groups that had Ŷot ďeeŶ seŶsitized ;ďut ĐhalleŶgedͿ or had Ŷeǀer ďeeŶ eǆposed to OsA ;Figure 
















soĐieties,  ǁe  opted  for  peaŶutͲspeĐifiĐ  seŶsitizatioŶ  aŶd  ĐhalleŶge.  MiĐe  reĐeiǀed  four 
iŶtragastriĐ ǁeeklǇ  doses  of  Đholera  toǆiŶͲadũuǀaŶted  peaŶut  eǆtraĐt  ;WEͿ  for  the  purpose  of 
seŶsitizatioŶ, folloǁed ďǇ iŶtragastriĐ ĐhalleŶge ǁith WE oŶ four ĐoŶseĐutiǀe daǇs ďegiŶŶiŶg oŶe 
ǁeek after  the  last  seŶsitizatioŶ  ;Figure ϮAͿ. EeoŶatallǇ  iŶfeĐted ŵiĐe aŶd ŵiĐe  treated ǁith 




OsA  ŵodel,  H.  pylori  iŶfeĐtioŶ  aŶd  eǆtraĐt  treatŵeŶt,  aŶd  also  regular  treatŵeŶt  ǁith  the 
purified iŵŵuŶoŵodulator saĐA, effeĐtiǀelǇ reduĐed the aŶaphǇlaǆis sĐores, ďut failed to affeĐt 




















ǁere  reduĐed  ďǇ  all  iŶterǀeŶtioŶs  ;liǀe  ŶeoŶatal  iŶfeĐtioŶ,  eǆtraĐt  adŵiŶistered  either  i.p.  or 












aŶd  fuŶĐtioŶallǇ  differeŶt  iŶ  ŶaŢǀe  aŶd  iŶfeĐted  aŶiŵals  ΀ϭϴͲϮϬ΁.  To  assess  ǁhether  the 
iŶterǀeŶtioŶs shoǁŶ here to ĐoŶfer food allergǇ proteĐtioŶ affeĐt the differeŶtiatioŶ aŶd staďilitǇ 
of Tregs, ǁe set out to ƋuaŶtifǇ the ŵethǇlatioŶ status of CpG ŵotifs ;Figure ϰAͿ loĐalized ǁithiŶ 






ŵethǇlatioŶ  did  Ŷot  ĐhaŶge  upoŶ  iŶterǀeŶtioŶ  ;data  Ŷot  shoǁŶͿ.  IŶ  ĐoŶtrast,  FoǆWϯ+  TͲĐells 
shoǁed differeŶĐes iŶ their ŵethǇlatioŶ status: ǁhereas FoǆWϯ+ TͲĐells that had ďeeŶ harǀested 






































ŵaŶifestatioŶs  ΀ϭϬ, ϭϴͲϮϬ, Ϯϲ, Ϯϳ΁,  little eǆperiŵeŶtal or epideŵiologiĐal eǀideŶĐe  is aǀailaďle 
that addresses a possiďle iŶǀerse ĐorrelatioŶ, or proteĐtiǀe effeĐt, of H. pylori iŶ food allergǇ. OŶe 
of the reasoŶs for this  laĐk of data proďaďlǇ  lies  iŶ the faĐt  that Ŷo uŶiǀersallǇ aĐĐepted food 
allergǇ ŵodel eǆists that ǁould faithfullǇ refleĐt all or ŵost aspeĐts of the huŵaŶ ĐoŶditioŶ. We 
haǀe adapted aŶd optiŵized three ĐoŵpleŵeŶtarǇ food allergǇ ŵodels, usiŶg ǀarious routes of 








H. pylori  oŶ  food allergǇ ǁere Ŷot as  iŵpressiǀe as  its ďeŶefiĐial  effeĐts  iŶ ŵodels of  allergiĐ 
asthŵa  iŶ ǁhiĐh ŶeoŶatal  eǆposure  to  the ďaĐteria  esseŶtiallǇ  reduĐes paraŵeters of  airǁaǇ 





















properties,  ŵediated  at  least  iŶ  part  ďǇ  the  saĐA  proteiŶ,  that  alloǁ  it  to  ŵodulate  TͲĐell 
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ǁere  seŶsitized  tǁiĐe  iŶtraperitoŶeallǇ  ;i.p.Ϳ  ǁith  ϱϬ  ?g  of  aluŵͲadũuǀaŶted  OsA  aŶd  orallǇ 
ĐhalleŶged four ǁeeks later oŶ four ĐoŶseĐutiǀe daǇs ǁith ϲϬ ŵg OsA ;sͬĐ; positiǀe ĐoŶtrolsͿ. 



























to  ďodǇ  ǁeightͿ  of  ϱͲϮϬ  ?g  purified  saĐA  ;saĐA  i.p.Ϳ  startiŶg  oŶ  daǇ  ϲ  or  ϳ  after  ďirth.  ;Ϳ 
Cuŵulatiǀe aŶaphǇlaǆis sĐore assigŶed upoŶ ĐhalleŶge ;suŵ of three sĐoresͿ.  ;C,DͿ Seruŵ WEͲ










;ǁith  a  tǁo  daǇ  iŶterǀalͿ  ǁith  ϭ  ŵg  OsA  ;positiǀe  ĐoŶtrolsͿ.  Eegatiǀe  ĐoŶtrol  aŶiŵals  ǁere 
















&igure  ϰ͘  DeĐreased  ŵetŚylation  of  tŚe  dregͲsƉeĐifiĐͲdeŵetŚylatedͲregion  ;d^DRͿ  uƉon  H͘ 
pyloriͲsƉeĐifiĐ treatŵent͘ ;AͿ SĐheŵatiĐ oǀerǀieǁ of the &KyWϯ loĐus ǁith the TSDR upstreaŵ of 
the  TSS  ;retrieǀed  usiŶg  >ASTͿ.  The  CGͲĐoŶtaiŶiŶg  regioŶ  is  ŵarked  iŶ  ďlue  aŶd  CG ŵotifs 
Đoǀered  ďǇ  pǇroseƋueŶĐiŶg  are  ŵarked  iŶ  ďold  red.  ;Ϳ  MethǇlatioŶ  patterŶ  of  ϭϬ  CG 
diŶuĐleotides ǁithiŶ the TSDR, of FACSͲsorted M>EͲderiǀed CDϰ+Foǆpϯ+ aŶd CDϰ+FoǆWϯͲ TͲĐells. 
AŶiŵals ǁere treated as iŶdiĐated. The ŵethǇlatioŶ status of the iŶdiǀidual CGs is ĐolorͲĐoded 



















































pylori  eǆtraĐt  treatŵent  in  an  KsͲinduĐed  food  allergy  ŵodel͘  MiĐe  ǁere  seŶsitized, 






represeŶts  oŶe  ŵouse.  Graphs  shoǁ  pooled  data  froŵ  ϱ  ;iŶ  AͿ  aŶd  ϰ  ;iŶ  Ϳ  eǆperiŵeŶts. 
HorizoŶtal liŶes iŶdiĐate ŵediaŶs; aŶ uŶpaired MaŶŶͲWhitŶeǇ U test ǁas used for ĐalĐulatioŶ of 
pͲǀalues. * pфϬ.Ϭϱ, *** pфϬ.ϬϬϭ. 
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ʹ		
^uƉƉl͘ &igure Ϯ 
 
^uƉƉl͘ &igure Ϯ͘ PͲsƉeĐifiĐ /g and ŵast Đell Ɖrotease 1 leǀels are Ɖartially reduĐed uƉon H͘ 
pylori eǆtraĐt treatŵent or infeĐtion͘ MiĐe ǁere seŶsitized, ĐhalleŶged aŶd treated as desĐriďed 
iŶ Figure ϯ. ;Ϳ WEͲspeĐifiĐ OsAͲspeĐifiĐ IgE leǀels iŶ seruŵ, as deterŵiŶed ďǇ E>ISA, of aŶiŵals 
that ǁere seŶsitized aŶd ĐhalleŶged ;sͬĐͿ ǁith WE aŶd iŶfeĐted or Ŷot ǁith H. pylori. AdditioŶal 
ŵiĐe reĐeiǀed regular doses of H. pylori eǆtraĐt ďǇ oral gaǀage ;p.o.Ϳ or i.p., or ǁere treated i.p. 
ǁith saĐA. ;Ϳ  IŶ A aŶd , eaĐh sǇŵďol represeŶts oŶe ŵouse. Graphs shoǁ pooled data froŵ ϱ 
;iŶ AͿ aŶd ϲ ;iŶ Ϳ eǆperiŵeŶts. HorizoŶtal liŶes iŶdiĐate ŵediaŶs; aŶ uŶpaired MaŶŶͲWhitŶeǇ U 
test ǁas used for ĐalĐulatioŶ of pͲǀalues. * pфϬ.Ϭϱ, *** pфϬ.ϬϬϭ. 
